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Synthesis And Reactivity Of Flexible Dicopper Bis(pyridyldiimine) Macrocyclic
Complexes
Abstract
Methanol is a viable fuel source and a common feedstock in the chemical industry. Currently, much of the
methanol produced by industry is derived from natural gas (methane). Yet, the one-step selective
oxidation of methane to methanol remains challenging due to the potential formation of overoxidation
products (CO2, H2O, etc.). Within the past 20 years, the reactive Cu2(II,II)-µ-O site within Cu(II)-ZSM-5 has
been shown capable of the selective oxidation of methane to methanol through a hydrogen atom transfer
(HAT)/radical rebound mechanism. The proximity of the metals and geometric constraints may allow for
the copper centers to work in concert when facilitating HAT. To probe how metal-metal distance and
coordination geometry influence C–H bond oxidation, it is highly desirable to study the properties and
reactivity profile of discrete multinuclear model complexes. Here, we report a new protocol for the
synthesis of homobimetallic copper(II) complexes using various derivatives of a macrocycle containing
two pyridyldiimine units. A series of Cu2-(µ-X)n bis(4-tert-butylpyridyldiimine) macrocyclic complexes (n =
1, 2; X = Cl, Br, N3, NO2, OTMS, OH) were synthesized and crystallographically characterized. The
development of new macrocyclic ligands was also undertaken to provide a modular synthesis of
bis(pyridyldiimine) ligand scaffolds, in which the steric and electronic profiles can be easily tuned. Using
the newly established synthetic protocols and macrocyclic ligands, two Cu2(II,II)-µ-OH complexes were
prepared and analyzed by cyclic voltammetry and low-temperature 1H NMR spectroscopy. The
macrocyclic complexes differed in the aliphatic linkers between the pyridyldiimine units (ethylene vs.
propylene linker). New Cu2(II,II)-µ-O complexes were accessed through deprotonation of the hydroxide
starting materials. The µ-oxo complexes were found competent for hydrogen atom transfer reactions,
showing reactivity towards weak C-H and N-H bonds. From these studies, the size of the macrocycle was
found to influence the reactivity of the µ-oxo complexes. The HAT reactions afforded Cu2(I,II)-µ-OH
complexes, and O-H BDFEs of 74.3 ± 1.4 (propylene-linked complex) and 79.0 ± 1.5 kcal/mol (ethylenelinked complex) were estimated using Bordwell’s thermodynamic square scheme approach.
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ABSTRACT
SYNTHESIS AND REACTIVITY OF FLEXIBLE DICOPPER BIS(PYRIDYLDIIMINE)
MACROCYCLIC COMPLEXES

Sam H. Brooks
Neil C. Tomson
Methanol is a viable fuel source and a common feedstock in the chemical industry.
Currently, much of the methanol produced by industry is derived from natural gas
(methane). Yet, the one-step selective oxidation of methane to methanol remains
challenging due to the potential formation of overoxidation products (CO 2, H2O, etc.).
Within the past 20 years, the reactive Cu2(II,II)-µ-O site within Cu(II)-ZSM-5 has been
shown capable of the selective oxidation of methane to methanol through a hydrogen atom
transfer (HAT)/radical rebound mechanism. The proximity of the metals and geometric
constraints may allow for the copper centers to work in concert when facilitating HAT. To
probe how metal-metal distance and coordination geometry influence C–H bond oxidation,
it is highly desirable to study the properties and reactivity profile of discrete multinuclear
model complexes. Here, we report a new protocol for the synthesis of homobimetallic
copper(II) complexes using various derivatives of a macrocycle containing two
pyridyldiimine units. A series of Cu 2-(µ-X)n bis(4-tert-butylpyridyldiimine) macrocyclic
complexes (n = 1, 2; X = Cl, Br, N3, NO2, OTMS, OH) were synthesized and
crystallographically characterized. The development of new macrocyclic ligands was also
undertaken to provide a modular synthesis of bis(pyridyldiimine) ligand scaffolds, in which
the steric and electronic profiles can be easily tuned. Using the newly established synthetic
protocols and macrocyclic ligands, two Cu2(II,II)-µ-OH complexes were prepared and
analyzed by cyclic voltammetry and low-temperature
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H NMR spectroscopy. The

macrocyclic complexes differed in the aliphatic linkers between the pyridyldiimine units
(ethylene vs. propylene linker). New Cu2(II,II)-µ-O complexes were accessed through
deprotonation of the hydroxide starting materials. The µ-oxo complexes were found
competent for hydrogen atom transfer reactions, showing reactivity towards weak C-H and
N-H bonds. From these studies, the size of the macrocycle was found to influence the
reactivity of the µ-oxo complexes. The HAT reactions afforded Cu2(I,II)-µ-OH complexes,
and O-H BDFEs of 74.3 ± 1.4 (propylene-linked complex) and 79.0 ± 1.5 kcal/mol
(ethylene-linked complex) were estimated using Bordwell’s thermodynamic square
scheme approach.
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CHAPTER 1 : INTRODUCTION
1.1 Dissertation Statement
This dissertation focuses on the design and synthesis of Cu2(II,II) clusters bound
by bis(pyridyldiimine) macrocycles for the application of selective hydrocarbon oxidation.
In particular, Cu2(II,II)-µ-oxo macrocyclic complexes are targeted to assess the
geometric/electronic factors that govern C-H bond oxidation.
1.2 Industrial Methanol Production
The growing energy demand by the world population necessitates a constant
source of fuel. In recent years, natural gas has risen as one of the prominent players and
is projected to surpass the use of petroleum fuel resources. 1 The gaseous hydrocarbon
methane (CH4) is the primary component of natural gas and has a greater energy density
compared with other hydrocarbons. The molecule provides a high value of mass heat (ca.
56 kJ/g), thus making natural gas an efficient fuel source. 2 Yet, methane is a potent
greenhouse gas and poses a global concern if natural gas cannot be transported safely
and efficiently once extracted from the Earth’s crust. 3 If transportation needs cannot be
met, natural gas may be burned (i.e. flared) to produce carbon dioxide, a less but still
harmful greenhouse gas. A proposed solution to transportation challenges involves the
conversion of methane to an easily transportable, safer liquid alternative. Methanol,
CH3OH, the partially oxidized form of methane, is liquid at room temperature and offers a
practical answer to the obstacles faced in natural gas transportation.
Methanol, the simplest alcohol, is a common C 1 building block in the chemical
industry with high potential as an alternative fuel source.4 With a low boiling point of 64.7
°C, methanol offers a safer advantage to transporting natural gas from both economic and
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environmental standpoints. The synthesis of methanol from methane, however, is
nontrivial. Industry performs this transformation over two steps in which methane is first
steam-reformed into synthesis gas (syngas, a mixture of carbon monoxide and
dihydrogen).5 The process is performed over a Ni/Al2O3 catalyst at temperatures ranging
from 900-1000 °C and pressures ranging from 15-30 bar (note: all C-H bonds in methane
are broken during this step). Syngas is then converted to methanol over a Cu/ZnO/Al2O3
catalyst using temperatures of 240-260 °C and pressures of 50-100 bar. While the overall
two-step synthesis achieves high conversion and selectivity for methanol, the energetic
requirements make this transformation infeasible at methane flaring sites that do not
house industrial plants.
Identifying new systems that mediate the one-step, selective oxidation of methane
to methanol may address the natural gas transportation dilemma. Importantly,
implementing a mild oxidation route that requires less energy and is atom economical has
its own challenges. Selectively oxidizing methane to methanol proves difficult due to the
high C–H bond strength of methane (105 kcal/mol).3 Moreover, methanol is prone to
overoxidation. An ideal pathway would include a catalyst capable of facilitating both
selective C–H bond activation and functionalization, in which an oxygen atom from the
oxidant is incorporated directly into methanol. The oxidant dioxygen is used in the
industrial production of many base chemicals. Dioxygen is abundant, environmentally
benign, and offers a green alternative to syngas in the production of methanol. Examples
of the oxidation of methane to methanol using dioxygen are scarce. The search continues
for a worthy, competent catalyst for the difficult C–H bond oxidation reaction.
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1.3 Selective Methane Hydroxylation by Cu-ZSM-5
Addressing alternative, milder means of oxidizing methane to methanol proves
challenging from selectivity, conversion and scale-up concerns. Within the last 20 years,
copper-exchanged zeolite materials have made a direct impact on the oxidation of
methane by allowing lower-temperature routes to be accessed.6 Zeolites are porous
materials composed of an aluminosilicate framework, which varies depending on the
zeolite topology. Transition metals, such as copper, are readily exchanged within these
frameworks and display varying degrees of reactivity toward small molecule activation and
functionalization. Regarding methane oxidation, numerous reviews cover the role of
copper-impregnated zeolites in mediating the oxidative transformation. 7-9 While this
dissertation does not cover the exhaustive list of zeolites used, the first example, Cu-ZSM5 (ZSM-5 = Zeolite Socony Mobil-5), is highlighted due to the well-defined nature of the
active site and thorough mechanistic studies on the oxidation of methane to methanol.
1.3.1 ZSM-5 Topology Defined
Zeolite pore sizes and shapes constitute the topology of the framework. The zeolite
ZSM-5

adopts a

three-dimensional

framework.

The

framework

contains

two

interconnected channels consisting of 10-membered aluminosilicate rings (Figure 1.1,
A).10,11 (Ring sizes are dependent on the number of aluminum and silicon vertices; each
aluminum and silicon are bridged by oxygen atoms.) The remainder of the ZSM-5 lattice
consists of 5- and 6-membered rings (Figure 1.1, B). Pore size dictates/constrains the
sizes of molecules that can move throughout the lattice. Within ZSM-5, CH4 and O2 are of
suitable size to pass through the 10-membered ring channels but are unable to pass
through the smaller-sized pores (Figure 1.1, C).12 Additionally, crystallographic analysis
by Mentzen and coworkers revealed that once copper is introduced to the ZSM-5 lattice,
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a dinuclear site is found within the 10-membered ring.13 Thus, with a dicopper site present
and accessible to small molecules, the larger pore is understood to house the active site
that is responsible for selective methane hydroxylation using dioxygen as the oxidant.

Si O Si

Si

O Si

O

O

O

O

O

Si

Si

Al

O Al

O
Si O Si

A

B

C

Figure 1.1 ZSM-5 framework: A) Three-dimensional interconnected channels in ZSM-5
(Adapted with permission from ref. 11. Copyright 1978 Spring Nature); B) Representation
of channels along face [010]; C) “Naked” 10-membered aluminosilicate ring.
1.3.2 Cu-ZSM-5 Promoted Activation of O2
Selective methane oxidation by Cu-ZSM-5 is achieved in a two-step process:
activation of O2 followed by C–H bond functionalization (vide infra). Groothaert and
coworkers previously described the treatment of Cu(II)-ZSM-5 at 450 °C with O2.14 The
oxygenated zeolite was found to be competent for the stoichiometric conversion of CH 4 to
CH3OH at 175 °C (Scheme 1.1). Examining the active oxidant by fiber-optic UV-vis
spectroscopy led to the assignment of an intense ligand-to-metal charge transfer (LMCT)
band at 22,700 cm-1, suggesting the formation of a Cu2(III,III)-bis(µ-oxo) core. Later
analysis by Solomon and coworkers using resonance Raman spectroscopy excluded the
presence of a bis(µ-oxo) core based on the observed Cu–O bond vibrational stretching
frequencies (rR vibrations – 456 cm-1 and 870 cm-1).12 Instead, a bent Cu2(II,II)-µ-oxo core
better described the active site in the ZSM-5 lattice.
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Scheme 1.1 Selective methane hydroxylation by Cu(II)-ZSM-5 using O2 as the oxidant.
Initial structural analysis of the Cu2(II,II)-µ-oxo core suggested a close Cu–Cu
distance of ~2.9 Å using EXAFS spectroscopy.15 However, the distance was brought into
question as the copper ions composing the µ-oxo active sites (~5% of the total Cu content
in ZSM-5) were indistinguishable from the spectator Cu ions in the EXAFS spectrum. A
Cu-O-Cu angle of 140° was identified using normal coordinate analysis calculations. DFT
(Density Functional Theory) calculations were able to reproduce the Cu2(II,II)-µ-oxo core
within a 10-membered aluminosilicate ring.12 The optimized structure displayed a Cu-OCu angle of 139° and a Cu–Cu distance of 3.29 Å, indicating a close distance of the copper
ions is required to stabilize the bridging oxo ligand.
The currently accepted mechanism of O2 activation by the dinuclear copper core
was elucidated by Solomon and coworkers (Scheme 1.2). 16 Exposure of Cu(I)-ZSM-5 to
O2 at room temperature led to the generation of Cu2(II,II)-µ(η2:η2)-peroxide intermediate
with a distinct LMCT band at 29,000 cm -1. Resonance Raman spectroscopy confirmed the
bridging peroxide unit with characteristic rR vibrations at 269 cm -1 and 736 cm-1. Upon
heating the zeolite, the peroxide intermediate converted to the bent µ-oxo, as evidenced
by UV-vis spectroscopy. Using

18

O2 in tandem with temperature-programmed desorption

experiments, Solomon found that the second oxygen atom of the peroxide intermediate is
lost to the zeolite lattice upon oxo formation. The electrons required for the reduction of
the peroxide intermediate are thought to originate from spectator Cu(I) ions within the
lattice.
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Scheme 1.2 Proposed mechanism of Cu2(II,II)-µ-oxo core formation in ZSM-5.
1.3.3 Selective Methane Oxidation within Cu-ZSM-5
Methane hydroxylation by the bent µ-oxo core in Cu(II)-ZSM-5 affords methanol
with 98% selectivity but low yield (8.2 µmol CH3OH per gram of ZSM-5). Solomon reported
a kinetic isotope effect of 3.1 (at 175 °C), indicating C–H bond cleavage plays a role in the
rate-determining step of oxidation. DFT calculations supported a hydrogen atom
abstraction/radical-rebound mechanism (Scheme 1.3), driven by the formation of a strong
O–H bond (BDE calc. = 90 kcal/mol). In the transition state, the Cu2O unit was found to
have significant oxyl-character at the bridging oxygen, which may facilitate hydrogen atom
abstraction through a radical-based mechanism.

Scheme 1.3 Hydrogen atom abstraction by a Cu2(II,II)-µ-oxo in ZSM-5.
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Following Solomon’s experimental/computational mechanistic analysis, Wu and
coworkers evaluated the mechanistic hypothesis using a combination of EPR and solidstate NMR spectroscopy.17 To support a radical-rebound mechanism, the spin-trapping
agent DMPO (DMPO = 5,5-dimethyl-1-pyrroline-N-oxide) was employed in the reaction
mixture. Both DMPO/·CH3 and DMPO/·OH adducts were observed by EPR spectroscopy,
supporting the radical-like mechanism for selective methane hydroxylation. Solid-state
NMR spectroscopy techniques were then used to discern the fate of the methanol product.
The spectral data indicated that methanol remained adsorbed on the zeolite surface in the
form of surface methoxy species. Upon extraction, free methanol was obtained.
1.3.4 Perspective on Advantages and Drawbacks of ZSM-5 in Methane Oxidation
The role of Cu(II)-ZSM-5 in selective methane oxidation to methanol offers a
promising alternative to the conventional industrial pathway. The zeolite-based
transformation is achieved at milder temperatures and achieves high selectivity.
Importantly, dioxygen is used as the oxidant, which is a less expensive and more atomeconomical alternative to the steam reformation process. Moreover, a successful catalytic
application of the zeolite has been demonstrated using a mixture of CH 4, O2 and water,
albeit with lower productivity than the stoichiometric pathway. 18
Despite these advantages, the zeolite system needs further refinement before
translation to industry, due to issues with conversion and scale-up. Low yields of methanol
continue to make the scale-up process cost-prohibitive. The most productive pathways
are achieved through a stepwise batch process, in which the zeolite is continuously
temperature-cycled, thus decreasing the industrial value of the system. While Cu(II)-ZSM5 mediates the stoichiometric/catalytic conversion of methane to methanol using dioxygen,
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new avenues of efficient catalysis are crucial to addressing the concerns of natural gas
transportation and flaring.
1.4 Synthetic Cu2(II,II)-µ-Oxo Complexes
The successful demonstration of methane C–H bond functionalization by Cu(II)ZSM-5 offers evidence for the highly reactive nature of a Cu2(II,II)-µ-oxo core. Designing
Cu2(II,II) complexes capable of housing such a core may lead to the discovery of new
systems

capable

of

hydrocarbon

oxidation

and

influence

future

homogeneous/heterogeneous catalyst designs. However, limited information remains
available on the synthesis and reactivity of Cu2(II,II)-µ-oxo complexes.19 Of the established
systems, few show reactivity towards hydrocarbon substrates, leaving the area in need of
further advancement. Selected examples of molecular Cu2(II,II)-µ-oxo complexes are
presented in sections 1.41 and 1.4.2 to highlight common synthetic techniques and
similarities/differences in reactivity.
1.4.1 Cu2(II,II)-µ-Oxo Complexes Supported by Mononucleating Ligands
Karlin and coworkers reported the synthesis of a Cu2(II,II)-µ-oxo complex bearing
the PhCH2(PY2) ligand (PY2 = bis(2-pyridylethyl)amine) (Scheme 1.4).20 Upon treating
the yellow mononuclear Cu(I) precursor with O 2 at 0 °C, a new green species was
observed. Dioxygen uptake experiments supported a Cu(I):O 2 ratio of 4:1, indicative of a
four-electron reduction of dioxygen. The same green species was obtained by treating 2.0
equiv. of the Cu(I) precursor with PhIO (iodosobenzene). From these experiments, along
with analytical characterization data, the product was identified as the bridging oxo
complex. Additional support for the bridging oxo was revealed through reactivity studies.
Treatment with excess PPh 3 led to the stoichiometric formation of PPh 3O, the product of
O atom transfer. The oxo complex was also prone to reversible hydrolysis. The Cu2(II,II)-
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di(µ-OH) complex was isolated from solutions treated with water, while the oxo complex
was isolated from heating the hydroxide complex under vacuum.

Scheme 1.4 Synthesis and reactivity of Karlin’s Cu2(II,II)-µ-oxo PhCH2(PY2) complex.
Further extension of Karlin’s work to other R(PY2) derivatives (R = CH 3, Ph)
showed similarities to the original PhCH 2(PY2) system in terms of synthesis and
reactivity.21 A new route to an oxo complex was revealed with the Me(PY2) scaffold by
oxidizing the Cu(I) precursor with a stoichiometric quantity of NO, affording N 2O as a
byproduct.22 All ligand scaffolds supported a dinuclear core, and the complexes were all
sensitive to water. Low-temperature oxygenation studies (-80 °C) allowed elucidation of
the mechanism of µ-oxo formation (Scheme 1.5). Similar to the Cu-ZSM-5 zeolite
activation of O2, a Cu2(II,II)-µ(η2:η2)-peroxide was first generated upon oxygenation. Upon
warming the sample, the bridging peroxide complex decomposes to the observed µ-oxo
intermediate. Additionally, no reactivity towards hydrocarbon substrates was reported for
the Cu2(II,II)-µ-oxo R(PY2) complexes.
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Scheme 1.5 Generation of R/PY2[Cu2O]2+ via a µ(η2:η2)-peroxide intermediate.
Analogous to the R(PY2) ligand system, the Tp Me (TpMe = hydrotris(3,5-dimethyl-1pyrazolyl)borate) ligand was found to stabilize a Cu2(II,II)-µ-oxo core at low
temperatures.23-25 Kitajima and coworkers accessed an µ-oxo complex by treating the
precursor TpMeCuPPh3 with excess PhIO. TpMe2Cu2(µ-O) displayed nucleophilic reactivity
towards water, CO2, and H2O2 (Scheme 1.6). Akin to the R(PY2) system, Tp Me2Cu2(µ-O)
reversibly hydrolyzed in the presence of water to generate the Tp MeCu2(µ-OH)2 complex.
Exposing the oxo to an atmosphere of CO 2 led to the clean formation of the µ-carbonato
complex, TpMe2Cu2(µ-CO3). The addition of H2O2 afforded the peroxide complex
TpMe2Cu2(µ-O2), in which the O2 adopts a η2:η2 bridging mode. The peroxide complex
decomposed upon warming to regenerate the oxo complex, similar to the observation
made by Karlin and coworkers.
In contrast to the nucleophilic reactivity described above for Tp Me2Cu2O, treating
this complex with an excess of PPh3 gave PPh3O along with stoichiometric amounts of
TpMeCuPPh3. This electrophilic reactivity was strictly observed for PPh 3, as TpMe2Cu2O
was unreactive towards other oxygen atom acceptors such as dimethylsulfide and
cyclohexene. However, oxidation of such substrates was achieved under UV irradiation,
in which dimethylsulfoxide and 2-cyclohexen-1-ol were observed, albeit in low yield. While
limited hydrocarbon oxidation was observed, the role of Tp Me2Cu2O in these reactions has
not been determined.
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Scheme 1.6 Reactivity of Kitajima’s TpMe-bound Cu2(II,II)-µ-oxo complex.
Recently, a unique approach to the generation of a Cu2(II,II)-µ-oxo complex was
reported using the TMPA ligand (TMPA = tris(2-pyridylmethyl)amine) by Kieber-Emmons
and coworkers.26 Deprotonation of [(TMPA)2Cu2OH][OTf]3 (TMPA[Cu2OH]3+) with the strong
Verkade

base,

2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane

(VerkadeiBu), afforded [(TMPA2Cu2O][OTf]2 (TMPA[Cu2O]2+) at -30 °C in MeCN (Figure 1.2).
Reversible protonation was also demonstrated upon the addition of 2,6-lutidinium triflate
to TMPA[Cu2O]2+. The µ-oxo complex was found to be thermally sensitive and decomposed
by warming or sitting in solution for prolonged periods (t1/2 = 3.5 hours at -30 °C). Reactivity
with weak E-H (E = O, C) bonds was observed at -30 °C, in which TEMPOH and 1,4cyclohexadiene (1,4-CHD) underwent hydrogen atom transfer reactions with TMPA[Cu2O]2+
to form the mixed-valent µ-hydroxide species [(TMPA2Cu2OH][OTf]2 (TMPA[Cu2OH]2+).
Additional details on the thermodynamics of hydrogen atom transfer by
presented in Chapter 4.
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TMPA

[Cu2O]2+ are

Figure 1.2 Synthesis of Kieber-Emmons’ TMPA[Cu2O]2+ complex.
1.4.2 Cu2(II,II)-µ-Oxo Complexes Supported by Dinucleating Ligands
Unlike their mononucleating counterparts, dinucleating ligands allow for the two
copper centers to be pre-oriented towards another. Réglier and coworkers took advantage
of this type of ligand design when attempting to design a Cu2(II,II)-µ-peroxide mimic of
tyrosinase. The BPImPy (BPImPy = 1,1’-biphenyl-2,2’-dimethylidene-N,N’-(2-(2-pyridyl)ethylamine)) scaffold was successfully metalated with Cu(I). 27 The biphenyl spacer was
implemented to allow for enough distance between the metal centers for a peroxide ligand
to bind. However, oxygenation of BPImPyCu 2 led to the formation of BPImPyCu2O, as
evidenced by oxygen uptake experiments (Figure 1.3). The room temperature-stable µoxo complex was found to exhibit electrophilic reactivity towards PPh 3, producing PPh3O
stoichiometrically.

Figure 1.3 Oxygenation of Réglier’s Cu2(I,I) BPImPy complex.
Limberg and coworkers designed the dinucleating FurNeu (FurNeu = 4,6(bis((N’,N’-dimethylaminoethyl)(2-pyridylmethyl)amine))dibenzofuran) ligand to allow for
adequate spacing between two metal centers.28 Upon the addition of either O2 or PhIO,
FurNeuCu2 reacted to form FurNeuCu2O (see Scheme 1.7 for structure) at room
temperature. Compared to previous examples of Cu2(II,II)-µ-oxo complexes, FurNeuCu2O
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appeared fairly inert. A significant decrease in nucleophilicity/basicity was observed; the
complex was unreactive towards water, CO2, and CS2. The complex reacted with a
stronger acid, acetic acid, but the identity of the product remains unknown. Furthermore,
minor quantities of PPh 3O were obtained when the complex was treated with an excess
of PPh3, demonstrating a decrease in electrophilic reactivity compared to previous
examples of Cu2(II,II)-µ-oxo complexes.
The FurNeuCu2O system did not show HAT reactivity towards external substrates,
such as 9,10-dihydroanthracene (DHA). However, prolonged periods in MeCN afforded
ligand C–H bond-oxidized products. A unique mode of oxidative reactivity was observed
through the reaction of FurNeuCu 2O with 2,4-di-tert-butylphenol (Scheme 1.7). Not only
was the ortho-coupled TBBP product (TBBP = 3,3’,5,5’-tetra-tert-butyl-2,2’-biphenol)
formed, but further oxidation occurred to generate TBOBF (TBOBF = 2,4,7,9-tetra-tertbutyloxepino[2,3-b]-benzofuran), an isomer of the diquinone species TBDQ (TBDQ =
3,3’,5,5’-tetra-tert-butyl-2,2’-diphenoquinone). FurNeuCu2O was found to be a competent
catalyst for this latter oxidation reaction under an atmosphere of O 2.

OH

OH
[O]

2

[O]
OH

MeCN
25 °C
3h

MeCN
25 °C
1h

- H2O

O
O

- H2O

DTBP

TBBP

TBOBF
2OTf

O

N
[O] =

N
N

Cu

N
Cu

O

N
N

FurNeu[Cu O]2+
2

Scheme 1.7 Oxidative coupling of DTBP using Limberg’s FurNeu system.
Although the FurNeu system provided access to a novel oxidation of 2,4-di-tertbutylphenol, the µ-oxo core oxygen atom was not incorporated into the oxidized
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hydrocarbon product, which differs from the reactivity observed for Cu(II)-ZSM-5. This
oxygenase-like reactivity remained elusive in molecular systems until 2021. Rübhausen,
Tuczek and coworkers synthesized a series of low-temperature stable Cu2O complexes
using the bdpdz (bdpdz = 3,6-bis(di(pyridin-2-yl)methyl)pyridazine) and bdptz (bdptz = 1,4bis(di(pyridin-2-yl)methyl)phthalazine) ligand frameworks.29 From either Cu2(I,I) complex
(bdptzCu2(MeCN)2 or bdptzCu2(MeCN)2), the respective oxo complex was generated at 25 °C using O2, PhIO or N2O (Figure 1.4). Intriguingly, oxygenation at -90 °C afforded a
new copper-oxygen species with spectroscopic characterization supporting the presence
of a tetracopper(II,II,II,II)-µ4-peroxide complex. Upon warming, the µ4-peroxide
intermediate decomposed to the µ-oxo complex.
Both bdpdzCu2O and bdptzCu2O displayed markedly higher reactivity towards
external hydrocarbon substrates than previous Cu2(II,II)-µ-oxo complexes. The oxidations
of xanthene, DHA, fluorene, triphenylmethane and diphenylmethane, were carried out
under catalytic conditions using O2 as the oxidant. As an example, the oxidized products
of DHA were the HAT product anthracene (A) and the four-electron oxidized product 9,10anthraquinone (AQ) (Figure 1.4). Isotopically-enriched (18O2) samples confirmed that the
oxygen atoms incorporated into the quinone product originated from O2. Although turnover
numbers were low for catalysis (TON = 1-5), Cu2(II,II)-µ-oxo complexes were shown to
catalyze C-H bond oxidation with the incorporation of oxygen atoms into the two- or fourelectron oxidized products.
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Figure 1.4 Catalytic oxygenation of DHA by Cu2(II,II)-µ-oxo complexes.
1.4.3 Outlook on Synthetic Cu2(II,II)-µ-Oxo Complexes
Since the discovery of the Cu(II)-ZSM-5 active site’s role in selective methane to
methanol oxidation, Cu2(II,II)-µ-oxo complexes are beginning to shift towards the forefront
of synthetic copper-oxygen chemistry. Dinucleating ligands have shown promise in
stabilizing the bridging oxo moiety but examples of intermolecular hydrocarbon oxidation
reactions are limited. New ligand systems capable of binding two copper centers bridged
by a single oxygen atom are desirable for the advancement of hydrocarbon oxidation
catalysts. Moreover, developing ligand systems with tunable sites for steric/electronic
modification may induce new reactivity at Cu2(II,II)-µ-oxo cores. Thus, the focus of this
dissertation aims to address these areas in need of advancement and further inform on
the role of dicopper-based systems in oxidation reactions.
1.5 Dissertation Overview
In the following chapters, this dissertation highlights work towards the development
of Cu2(II,II) bis(pyridyldiimine) macrocyclic complexes for the oxidation of organic
substrates. Specifically, hydrogen atom transfer pathways are targeted through the
generation of reactive Cu2(II,II)-µ-oxo complexes. Synthesis and characterization of a
series of Cu2(II,II)-µ-X(n) (X = Cl, Br, N3, OTMS, OH, n = 1,2) are first discussed in Chapter
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2. A simple protocol is presented for using the bis(4-tert-butylpyridyldiimine) macrocyclic
ligand in the stabilization of Cu2(II,II) complexes. Chapter 3 outlines progress towards a
modular bis(pyridyldiimine) ligand synthesis. A new synthetic route to substituted 4phenyl-2,6-dibenzoylpyridines is reported that allows for facile substitution at both the
pyridyl and imino moieties of the PDI unit. Moreover, new macrocyclic ligands with phenyl
substitution are synthesized. Chapter 4 then details the synthesis of various-sized
Cu2(II,II)-µ-hydroxide macrocyclic complexes using the synthetic techniques in Chapter 2
and the new ligand framework in Chapter 3. Deprotonation of each hydroxide complex is
achieved and subsequent hydrogen atom transfer reactivity is assessed. The efforts
outlined in this dissertation offer a new perspective on dinucleating ligands used to support
reactive dicopper-based fragments in oxidation pathways.
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CHAPTER 2 : ANION SUBSTITUTION AT AN “OPEN-CORE” DICOPPER(II,II) BIS(4TERT-BUTYLPYRIDYLDIIMINE) MACROCYCLE
2.1 Introduction
As detailed in Chapter 1, the first step in the selective oxidation of methane to
methanol by Cu(II)-ZSM-5 is the activation of dioxygen. At the active site, two
geometrically constrained copper(II) ions are involved in the binding of O 2 and subsequent
formation of a reactive Cu2(II,II)-µ-oxo active site (calc. Cu-Cu distance of 3.3 Å).
Constrained geometry sites for small molecule activation and functionalization are also a
defining feature in many multinuclear copper-containing proteins found in Nature.
Enzymes that selectively oxidize methane (particulate methane monooxygenase),
phenols (tyrosinase) and quinones (tyrosinase and catechol oxidase), or the dioxygencarrying protein hemocyanin, rely on multiple geometrically constrained copper sites at
fixed distances for substrate binding/activation.30
To further inform our understanding of the modes of reactivity demonstrated by
multinuclear copper sites in Nature, the design of synthetic homogeneous model copper
complexes offers a way forward. Copper-copper distances have been observed over a
range of 2.2 – 4.9 Å in numerous proteins and are known to change upon binding of
substrate.30 Modulating the distance between copper centers in molecular systems may
influence how a small molecule interacts at a multicopper active site and subsequent
reactivity therein. Accomplishing such a feat requires the use of suitable multinucleating
ligands that allow for tunable copper-copper distances with additional coordination sites
available for small molecule binding. The influence of copper-copper distance on reactivity
will be explored further in Chapter 4.
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Recent examples of ligands capable of housing multiple copper centers and
binding molecules of various size have been in the areas of anion-recognition/sensing,3133

dioxygen activation,28,29 organic azide reduction,34 aryl group transfer and alkyne

activation.35,36 From these studies, an important feature of ligand design is the
preorientation of the copper centers at defined distances for cooperative substrate
binding/activation and subsequent functionalization. Drew and Nelson (see section 2.1.2)
originally targeted this aspect in the 1980s when designing and synthesizing macrocyclic
bis(pyridyldiimine) ligands.37-40 The two pyridyldiimine (PDI) units linked by aliphatic
spacers were suitable for binding two copper(II) centers at specific distances and oriented
the metals towards one another in the macrocyclic cavity (Figure 2.1). The Cu–Cu
distance was influenced by the length of the linkers used in connecting the two PDI units.
Preliminary analysis also indicated that the macrocyclic ligands were flexible and allowed
for ligand conformational changes to support changes in Cu–Cu distances upon external
ligand binding.

Figure 2.1 Bis(pyridyldiimine) macrocyclic ligands developed by Drew and Nelson.
The bis(pyridyldiimine) macrocyclic ligands offer a platform to study multinuclear
copper chemistry. Yet, synthetic and structural information on these systems is limited.
Herein, new synthetic routes to Cu2(II,II) bis(pyridyldiimine) macrocyclic complexes are
explored with versatile ligand substitution being achieved. Selected examples of both
mononuclear and dinuclear copper PDI complexes are first introduced to demonstrate the
synthetic methods used thus far in designing copper-based PDI complexes.
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2.1.1 Mononuclear Copper PDI Complexes
The tridentate PDI ligand has been used over the last 50 years in stabilizing
numerous monocopper complexes with a range of ligand substitutions. Approaching 100
reported crystal structures, the CSD (Cambridge Crystallographic Data Centre) database
displays a large breadth of copper PDI complexes, spanning PDI derivatives with imino
substitutions including aromatic, heteroatom and tethered alkyl groups. 41 Other variations
include copper bound by two PDI units to afford octahedral complexes. Wieghardt and
coworkers have analyzed a host of these complexes, determining key structural features
of monocopper-PDI complexes.42 Typically, PDI binds to copper(II); only three copper(I)
examples have been reported (vide infra). Copper PDI complexes have been observed
as four-, five-, and six-coordinate species depending on the number of ancillary ligands in
addition to the PDI unit. An overview of selected monocopper PDI complexes with different
ligand substitutions is provided below.
The most common ligand bound to copper(II) in PDI-based complexes is the
chloride ligand.43-46 Copper(II) chloride dihydrate offers a simple starting material for the
synthesis of corresponding PDI complexes. Depending on the synthetic route, the
copper(II) center can bind up to two chloride ligands. When two chlorides are bound to the
copper(II) center, in all cases, the metal geometries are observed as distorted trigonal
bipyramidal or distorted square pyramidal in the solid-state. Many copper(II) dichloride PDI
complexes have been reported to date with various substitutions made at the imino
nitrogen (Figure 2.2)
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Figure 2.2 Synthesis of five-coordinate copper(II) chloride PDI complexes.
A notable example of a structurally characterized copper(II) monochloride PDI
complex was reported by Conan and coworkers (Figure 2.3).47 Treatment of a dippsubstituted (dipp = diisopropyl) PDI (dippPDI) unit with [Cu(MeCN)4][PF6] afforded a Cu(I)
complex which was susceptible to oxidation by CHCl3. Based on the solid-state structure,
the resulting monochloride complex appears to be the four-coordinate square planar
copper(II) PDI complex [dippPDICuCl][PF6]. However, the hexafluorophosphate anion
displays a weak axial Cu–F interaction of 2.485 Å, and the complex may thus be regarded
as five-coordinate. This same approach afforded the first copper(II) bromide PDI complex
when using CHBr3 ([dippPDICuBr][Br3]). A Br3 anion was found weakly coordinated instead
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of the PF6 anion. Later, Gorelsky, Richeson and coworkers showed synthetic access to a
five-coordinate copper(II) dibromide complex using a bulky 2,6-di-tert-butylphenylsubstituted PDI ligand (tBuPDI) and CuBr2 ([tBuPDICuBr2]).48

Figure 2.3 Other substitution patterns of copper(II) PDI complexes.
In addition to chloride and bromide ligands, the nitrate ligand was implemented in
the synthesis of a copper(II) bis(nitrate) complex. Alyea, Ferguson and coworkers
demonstrated

that

upon

the

addition

of

Cu(NO 3)2

to

N,N’-(2,6-

pyridinediyldiethylidyne)bis(benzenamine) (PhPDI), the copper(II) dinitrate PDI complex
[PhPDICu(NO3)2] formed.49,50 Crystallographic analysis was later performed by Ferguson.
The two nitrate ligands were found to have different coordination modes. One nitrate was
found to bind in a κ1 fashion and the other in a κ2 fashion. Thus, the complex is a unique
example of a six-coordinate copper(II) PDI complex.
The three examples of PDI ligands bound to Cu(I) were reported by Gilbertson and
coworkers (Scheme 2.1).51 Using the synthetic methodology developed by Conan,
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Gilbertson successfully characterized the solid-state structure of [dippPDICu(NCMe)][PF6].
The crystal structure displayed a four-coordinate copper(I) center in a distorted square
planar geometry. The copper(I) oxidation state was supported by reaction with CO to
afford the carbonyl-bound complex [dippPDICu(CO)][PF6] in a similar geometry. The
stabilization of copper(I) in a distorted square planar geometry was proposed to result
from the steric protection of the PDI ligand with the bulky dipp groups. Reducing the steric
protection to phenyl groups afforded the five-coordinate monocopper(I) bis(PDI) complex
[PhPDI2Cu][PF6].

Scheme 2.1 Gilbertson’s synthesis of square-planar copper(I) PDI complexes.
2.1.2 Dinuclear Copper PDI Complexes
Unlike the mononuclear counterparts, few Cu2(II,II) PDI complexes are structurally
characterized. To our knowledge, no reports of dicopper(I,I) or dicopper(I,II) PDI
complexes exist. Intriguingly, no Cu2(II,II) chloride, bromide or nitrate PDI complexes are
reported. Many of the Cu2(II,II) examples incorporate the use of a bis(pyridyldiimine)
macrocyclic ligands, with selected examples introduced below.
A useful feature of bis(pyridyldiimine) macrocyclic ligands is that the spacing
between the two PDI units is tunable. Drew, Nelson and coworkers originally
demonstrated this by using different aliphatic linkers to isolate Cu2(II,II) macrocyclic
complexes of different sizes. For example, a 3,6-dioxaoctylene spacer was incorporated
between the PDI subunits. Upon treating the

Cu2(II,II) macrocyclic complex

[OctPDI2Cu2][ClO4]4·3H2O (octPDI2 = two PDI subunits linked by two 3,6-dioxaoctylene
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spacers) with NaN3, the bridging azide complex [OctPDI2Cu2(N3)3][ClO4] was isolated.38 The
azide bridges in a 1,3-mode due to the large cavity of the macrocycle and long Cu–Cu
distance of 6.02 Å. Additionally, an azide ligand was terminally bound to each copper(II).
Later

studies

showed

that

different

anions

(Figure

2.4)

–

imidazolate

(A,

[OctPDI2Cu2(im)][ClO4]3) and hydroxide (B, [OctPDI2Cu2OH][ClO4]3·H2O) – could bridge the
two copper(II) centers.37 The Cu–Cu distance with the imidazolate bridge falls in a similar
range as the azide complex, 5.99 Å. However, to accommodate the smaller bridginghydroxide anion, the macrocycle contorts (the aliphatic linkers display flexibility) and the
Cu–Cu distance shortens to 3.57 Å.

Figure 2.4 Comparison of Cu2(II,II) bis(pyridyldiimine) macrocycles with 3,6-dioxaoctylene
spacers, and imidazolate and hydroxide bridging ligands.
Drew and Nelson also incorporated smaller aliphatic spacers between the PDI
units with the use of ethylenediamine and 1,3-diaminopropane. Molecular models
predicted that the smaller of the two macrocycles was not suitable for housing a Cu2(II,II)
core

with

a

bridging

ligand.

However,

the

Cu2(II,II)-µ-OH

complex

[EtPDI2Cu2OH][ClO4]3·H2O (EtPDI2 = two PDI subunits linked by two ethylene spacers) was
successfully isolated through reaction of [EtPDI2Ba][ClO4]2 with Cu(ClO4)2·6H2O (Figure
2.5).40 The formation of [EtPDI2Cu2OH][ClO4]3·H2O was thought to arise from the flexibility
of the ethylene linkers. Although no crystal structure was reported, the macrocycle most
likely folds to allow each copper(II) center to adopt a square pyramidal geometry with a
bridging hydroxide ligand occupying an equatorial position of each copper(II) center. The
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presence for a dinuclear core was further supported by elemental analysis and solutionstate magnetic susceptibility measurements.

Figure 2.5 Synthesis of [EtPDI2Cu2OH][ClO4]3 in MeOH.
Using the larger spacer, 1,3-diaminopropane, Drew and Nelson reported the
crystal structure of a related Cu2(II,II)-µ-OH complex [PrPDI2Cu2OH][ClO4]3·2H2O (PrPDI2 =
two PDI subunits linked by two propylene spacers) (Scheme 2.6).39 At first, infrared
spectroscopy suggested that treatment of [PrPDI2Ba][ClO4]2 with Cu(ClO4)2·6H2O afforded
the

bridging

methoxide

[PrPDI2Cu2(OMe)][ClO4]3·2H2O

[PrPDI2Cu2(OMe)][ClO4]3·2H2O.

complex
was

recrystallized

from

When

acetonitrile,

[PrPDI2Cu2OH][ClO4]3·2H2O was isolated (the likely source of the hydroxide anion was
water in the organic solvent). The crystal structure shows the macrocycle folds to
accommodate the Cu2(II,II) core. A shorter Cu–Cu distance of 3.145(4) Å was reported.
The bridging hydroxide was found occupying an equatorial position of each copper(II)
center and a Cu-O-Cu angle of 110.3(7)° was observed. Additionally, a weakly bridging
aqua ligand occupied the axial positions of each copper center at a distance of 2.519(12)
Å. Further substitution was carried out using NaN3 in an anion metathesis reaction with
[PrPDI2Cu2(OMe)][ClO4]3·2H2O to afford [PrPDI2Cu2(N3)][ClO4]3, as evidenced by the azide
stretching frequency at 2070 cm-1. However, no crystal structure was reported for the azide
complex.
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Scheme 2.2 Synthetic elaboration of Cu2(II,II) bis(pyridyldiimine) macrocycles.
2.2 Synthesis of an “Open-Core” Cu2(II,II) Macrocycle
The limited reactivity and structural data on Cu2(II,II) bis(pyridyldiimine)
macrocycles prompted further investigation into the synthesis of new macrocyclic
complexes. Previous work in our lab has shown that synthetic elaborations of dinuclear
first-row transition metal bis(pyridyldiimine) macrocyclic complexes were aided by the
installation of tert-butyl groups at the 4-position of the PDI units.52-59 The tert-butyl groups
allow for an enhancement in solubility in less polar organic solvents (THF, DCM, and
MeCN) compared to the original macrocycles reported by Drew and Nelson. We thus
sought to synthesize a new series of Cu2(II,II) bis(pyridyldiimine) macrocycles for
structural/solution-state characterization.
2.2.1 Isolation of n/Me[Cu2Cl2]2+ (n = 2,3) Complexes
The synthesis of a Cu2(II,II) bis(4-tert-butylpyridyldiimine) macrocyclic complex
was first carried out using the strontium-templated macrocycle [3/MePDI2Sr][OTf]2
(3/Me[Sr]2+, where 3 refers to the aliphatic chain length and Me refers to methyl group on
the imino moiety). Treatment of a yellow methanolic solution of 3/Me[Sr]2+ with 2.0 equiv. of
CuCl2·2H2O afforded the paramagnetic, dark green dinuclear macrocycle-bound complex
[3/MePDI2Cu2Cl2][OTf]2 (3/Me[Cu2Cl2]2+) in good yield (Scheme 2.3). Crystallographic
analysis revealed that the copper(II) centers are related by an inversion center (Figure
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2.6). The metal sites adopt a distorted octahedral geometry, with a meridional PDI subunit
and a bridging chloride occupying the equatorial positions, and a triflate anion and a
bridging chloride occupying the axial positions (selected bond metrics are presented in
Table 2.1). No six-coordinate mononuclear copper(II) chloride PDI complexes have been
reported in the literature. However, the Cu–N bond lengths are in good agreement with
the related four-coordinate [dippPDICuCl][PF6] reported by Conan. The equatorial Cu–Cl
bond length of 2.18602(11) Å agrees well with Conan’s observed Cu–Cl bond length of
2.1450(5) Å. The axial Cu–O (2.710 Å) and Cu–Cl (2.873 Å) distances are elongated,
owing to a strong Jahn-Teller distortion at the d9 Cu(II) ion. Due to this distortion, the
Cu2Cl2 diamond core exhibits a very acute Cu-Cl-Cu angle (75.05°).

Scheme 2.3 Synthesis of n/Me[Cu2Cl2]2+ complexes in MeOH.
An additional parameter that can be gleaned from the crystal structure of
3/Me

[Cu2Cl2]2+ is the oxidation state of the (redox-active) PDI ligand.42 Wieghardt and

coworkers previously reported the ∆ parameter as a means of identifying how much
electron density resides in the PDI π* manifold. Our lab recently adapted the ∆ parameter
in describing the bis(4-tert-butylpyridyldiimine) macrocyclic ligand oxidation state, which
includes the average of each ∆ parameter for each PDI subunit. 56 Using this analysis on
the crystal structure of

[Cu2Cl2]2+, the average ∆ parameter of 0.187 Å supports the

3/Me

assignment of a neutral physical oxidation state on the 3/MePDI2 ligand. A neutral ligand for
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copper PDI complexes is not uncommon, as both mononuclear Cu II(PDI0) and CuI(PDI0)
examples are well established in the literature. 42

Cl2

Cu2

Figure 2.6 Crystal structure of 3/Me[Cu2Cl2]2+ (thermal ellipsoids set at 50% probability;
hydrogen atoms and triflate disorder omitted for clarity).
Table 2.1 Selected bond metrics of copper(II) chloride PDI complexes.
3/Me

[Cu2Cl2]2+a 2/Me[Cu2Cl2]2+b [dippPDICuCl][PF6]
Cu(1) – N(1) / Å
2.056(4)
2.057
2.070(2)
Cu(1) – N(2) / Å
1.902(3)
1.903
1.922(2)
Cu(1) – N(3) / Å
2.047(3)
2.044
2.062 (2)
Cu(1) – Cl(1) / Å
2.1860(11)
2.2056
2.1450(5)
Cu(1) – Cl(2) / Å
2.873(1)
3.021
Cu(1) – O(1) / Å
2.710(1)
2.4015
Cu(1) – Cu(2) / Å
3.129(1)
2.9922
Cu(2) – N(4) / Å
2.041
Cu(2) – N(5) / Å
1.898
Cu(2) – N(6) / Å
2.042
Cu(2) – Cl(1) / Å
2.7273
Cu(2) – Cl(2) / Å
2.2043
75.05(4)
73.83
∠Cu(1)-Cl(1)-Cu(2) / °
67.80
∠Cu(1)-Cl(2)-Cu(2) / °
∆/Å
0.187
0.182
0.178
a – Macrocycle is symmetric; bond metrics are the same for Cu(2)
b – Average values; two macrocycles are present in the asymmetric unit
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The IR spectrum of

3/Me

[Cu2Cl2]2+ contained a characteristic imine stretching

frequency at 1601 cm-1. UV-vis-NIR spectroscopic analysis revealed an absorption profile
representative of bis(pyridyldiimine) macrocyclic complexes in an unfolded ligand
conformation.55 Distinct absorption bands at 237 nm (7.71 x 10 4 M-1 cm-1) and 676 nm
(242 M-1 cm-1) result from a π→π* transition and a d→d transition, respectively.
The successful synthesis and characterization of

3/Me

[Cu2Cl2]2+ prompted further

investigation into the effect of macrocycle size in the preparation of Cu2(II,II) macrocyclic
complexes. Upon addition of 2.0 equiv. CuCl 2·2H2O to the smaller macrocycle

2/Me

[Sr]2+,

an immediate color change from yellow to dark blue-green was observed. The macrocycle
[2/MePDI2Cu2Cl2][OTf]2 (2/Me[Cu2Cl2]2+) was isolated in good yield (Scheme 2.3). The solidstate structure of

2/Me

[Cu2Cl2]2+ depicts a similar ligand conformation to

3/Me

[Cu2Cl2]2+

(Figure 2.7). Two chloride ligands bridge between the copper centers; however, variations
in the Cu2Cl2 core are evident when compared to

3/Me

[Cu2Cl2]2+. Unlike the larger

macrocycle, each copper center adopts a different coordination geometry. One copper is
found in a distorted octahedral geometry, capped by a triflate anion and a bridging chloride
(analogous to

3/Me

[Cu2Cl2]2+). The second copper adopts a square pyramidal geometry

(avg. τ5 = 0.04),60 with the second triflate anion residing in the outer coordination sphere.
The difference in the coordination geometries about the copper centers is reflected in the
distortion of the Cu2Cl2 core, which now appears asymmetric [∠Cu(1)-Cl-Cu(2) = 73.83(4)°
and (∠Cu(2)-Cl-Cu(1) = 67.80(4)°]. Aside from the noted differences in the Cu 2Cl2 core,
the bond metrics remain comparable to

3/Me

[Cu2Cl2]2+ and [dippPDICuCl][PF6] (Table 2.1).
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Figure 2.7 Crystal structure of 2/Me[Cu2Cl2]2+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, solvent molecules and outersphere anions omitted for clarity; one
macrocycle of the asymmetric unit shown).

2.2.2 Chloride Abstraction from 3/Me[Cu2Cl2]2+
With

3/Me

[Cu2Cl2]2+ isolated, anion metathesis was targeted to introduce new

ligands at the copper(II) centers, but because of the strong bridging-chloride interactions,
little to no reactivity was observed. Chloride abstraction routes were thus employed to
enhance the reactivity of the pocket towards anion metathesis. Attempts at chloride
abstraction with traditional reagents (KOTf, AgnX [n = 1,2; X = BF4, SO4, OTf, BArF4 (BArF4
= tetrakis(3,5-bis(trifluoromethyl)phenyl)borate)]) were met with either intractable mixtures
or no reaction. Chloride abstraction was achieved with the addition of an excess of TMSOTf (TMS = trimethylsilyl) to

3/Me

[Cu2Cl2]2+ in MeCN. The formation of a new macrocyclic

product was apparent by a sharp color change from dark green to dark blue. Concentration
of the reaction mixture afforded the blue acetonitrile-coordinated macrocycle complex
[3/MePDI2Cu2(NCMe)2][OTf]4 (3/Me[Cu2(NCMe)2]4+) (Scheme 2.4). Unlike
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3/Me

[Cu2Cl2]2+,

3/Me

[Cu2(NCMe)2]4+ remained insoluble in common organic solvents (THF, DCM, MeCN),

which prohibited further solution-state characterization.

Scheme 2.4 Abstraction of bridging chlorides from 3/Me[Cu2Cl2]2+ using TMS-OTf in MeCN.
Owing to its partial solubility in MeCN, single crystals of

3/Me

[Cu2(NCMe)2]4+ were

grown from the slow diffusion of Et2O into a concentrated MeCN solution. The solid-state
structure was found to resemble that of

3/Me

[Cu2Cl2]2+, with the two chloride ligands

replaced by MeCN ligands (Figure 2.8). The macrocyclic ligand adopts an unfolded ligand
conformation, and the two Cu(II) centers are related by a center of symmetry with a
spacing of 3.3479(7) Å. Both Cu(II) centers adopt a distorted square pyramidal geometry
(τ5 = 0.36 for each Cu(II) center) with an evident Jahn-Teller distortion causing a long Cu–
O (2.275(2) Å) bond length. The axial Cu-NCMe bond lengths (3.160(3) Å) fall outside the
sum of the van der Waals radii of copper and nitrogen (2.95 Å). Thus, five-coordinate
copper(II) is a better description of the metal centers in this crystal structure. The
equatorial Cu-NCMe distance of 1.973(3) Å is significantly shorter than the reported
distance of 2.271(13) in McKee and coworkers’ related Cu2(II,II) alkoxy PDI macrocycle.61
However, the MeCN ligand occupies a distorted axial position of a square pyramidal Cu(II)
center in McKee’s example, rather than the equatorial position as observed in
3/Me

[Cu2(NCMe)2]4+. Gilbertson’s distorted square planar copper(I) acetonitrile PDI

complex displays a short Cu-NCMe distance of 1.907(7) Å, which better agrees with
3/Me

[Cu2(NCMe)2]4+.51
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Figure 2.8 Crystal structure of 3/Me[Cu2(NCMe)2]4+ (thermal ellipsoids set at 50%
probability; hydrogen atoms, solvent molecules and outersphere anions omitted for
clarity).
Surprisingly, the IR spectrum of

3/Me

[Cu2(NCMe)2]4+ includes three distinct nitrile

stretching frequencies in the expected region for acetonitrile (2307 cm -1, 2278 cm-1, 2255
cm-1). The presence of multiple signals may indicate more than one acetonitrile molecule
binds to each copper(II) center. Although satisfactory elemental analysis data was
collected, alternative routes of crystallization were assessed to address the discrepancy
in the IR spectral data. The product was found to be partially soluble in o-difluorobenzene.
Crystallization from this solvent afforded single crystals that were identified as the
monochloride product [3/MePDI2Cu2Cl][OTf]3 (3/Me[Cu2Cl]3+), indicative of incomplete
chloride abstraction. Prolonged reaction times in the presence of excess TMS-OTf were
not able to improve the purity of 3/Me[Cu2(NCMe)2]4+. Although not the desired product, the
crystal structure of

3/Me

[Cu2Cl]3+ offered insight into how the ligand is able to change in

conformation to accommodate one bridging ligand upon loss of a bridging chloride from
3/Me

[Cu2Cl2]2+.
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The solid-state structure of 3/Me[Cu2Cl]3+ introduces an arched ligand conformation
around the dinuclear Cu2Cl core (Figure 2.9). Both copper(II) centers adopt distorted
octahedral geometries, with two triflate anions occupying the axial positions cis to the µCl. Jahn-Teller distortions are evident by the elongated Cu–O axial bond lengths (avg.
2.5042 Å). A single chloride bridges the two copper(II) centers with a Cu-Cl-Cu angle of
108.50(3)° (an increase of 33° compared to

3/Me

[Cu2Cl2]2+). The bridging chloride ligand

sits above the Cu–Cu plane, and the Cu–Cl bond distances elongate to 2.2906(7) and
2.2739(7) Å. These longer bond distances are still in the expected range for copper(II)
chloride PDI complexes, agreeing well with related five-coordinate complexes. To
accommodate the increases in the Cu-Cl-Cu angle and the Cu–Cl distances upon loss of
a bridging chloride from 3/Me[Cu2Cl2]2+, the macrocycle conformation changes and the Cu–
Cu distance increases from 3.129(1) Å to 3.7045(7) Å.

Figure 2.9 Crystal structure of 3/Me[Cu2Cl]3+ (thermal ellipsoids set at 50% probability;
hydrogen atoms and triflate disorder omitted for clarity).

2.2.3 A Synthetic Route to an “Open-Core” Cu2(II,II) Macrocycle
Due to incomplete chloride abstraction from

3/Me

[Cu2Cl2]2+ we sought a new

approach to the synthesis of an “open-core” macrocycle. We proposed that strong bridging
interactions in

3/Me

[Cu2Cl2]2+ may limit the reactivity towards TMS-OTf. To address this
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concern, a single bridging halide may improve the outcome of the halide abstraction
reaction. Moreover, swapping the chloride ligand for a fluoride ligand would allow for the
generation of TMS-F, a stronger thermodynamic driving force due to the strong siliconfluorine bond formation.
The synthetic changes were carried out in a one-pot fashion (Scheme 2.5). A
mixture of

3/Me

[Sr]2+ and 2.0 equiv. Cu(OTf)2 was stirred in DCM and treated with

[NBu4][Ph3SiF2] to produce a new paramagnetic, blue macrocyclic product. The
monofluoride product [3/MePDI2Cu2F][OTf]3 (3/Me[Cu2F]3+) was identified using single crystal
X-ray crystallography as the first structurally-characterized example of a copper(II)fluoride PDI complex (Figure 2.10). Unlike the monochloride product

3/Me

[Cu2Cl]3+, the

dinuclear Cu2F core is accommodated by an unfolded conformation of the macrocyclic
ligand. The crystal structure also displays a linear arrangement of atoms within the
macrocyclic pocket leading to a Cu-F-Cu angle of 180.00°. In order for the fluoride ligand
to fit in this linear arrangement, the Cu–Cu distance increases to 3.7240(4) Å, a similar
distance to

3/Me

[Cu2Cl]3+. Each Cu(II) center is capped by a triflate anion (Cu–O distance

of 2.2707(19) Å) and adopts a square pyramidal geometry (τ5 = 0.03 for each Cu(II)
center). A large thermal ellipsoid is present on the µ-F, indicating that the bridging fluoride
unit is oscillating back and forth in the macrocyclic pocket. The short Cu–F bond length
(1.8620(3) Å) agrees with the related four-coordinate pyridyldiamide copper(II)-fluoride
complex reported by Zhang and coworkers (1.828(2) Å).62, 63

Scheme 2.5 Abstraction of bridging fluoride from 3/Me[Cu2F]3+ using TMS-OTf in DCM.

33

Figure 2.10 Crystal structure of 3/Me[Cu2F]3+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, triflate disorder and outersphere anions omitted for clarity).
Removal of the fluoride ligand using TMS-OTf was carried out in DCM at -78 °C.
The dark blue slurry became light blue upon the slow addition of TMS-OTf. Combustion
analysis supported the formation of the Cu2(II,II) tetratriflate macrocyclic complex
[3/MePDI2Cu2][OTf]4 (3/Me[Cu2(OTf)2]2+). The product, like 3[Cu2(NCMe)2]4+, was insoluble in
common organic solvents. Due to the increased insolubility, single crystals of the product
remained elusive. However, based on the structural data obtained for
3/Me

3/Me

[Cu2Cl2]2+ and

[Cu2(NCMe)2]4+, an unfolded ligand conformation is a reasonable assignment of the

product’s overall geometry, with two triflate anions now occupying the equatorial positions
of each copper(II) center rather than acetonitrile ligands.
2.3 Anion Substitution Reactions with 3/Me[Cu2(OTf)2]2+
2.3.1 Anion Substitution with Halides and Pseudohalides
To assess anion binding within the macrocyclic pocket of

3/Me

[Cu2(OTf)2]2+, the

material was first treated with 2.0 equiv. of NBu 4Cl to generate the previously isolated
3/Me

[Cu2Cl2]2+ (Scheme 2.6, Top). As the reaction proceeded in MeCN, the insoluble blue

3/Me

[Cu2(OTf)2]2+ was consumed. A sharp color change to dark green signified the
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conversion to the desired product. Qualitatively, the solubility profile and color of the
resulting product matched that of the independently synthesized 3/Me[Cu2Cl2]2+. Moreover,
both IR and UV-vis-NIR spectroscopic measurements confirmed the identity of the product
3/Me

as
3/Me

[Cu2Cl2]2+. Facile anion substitution demonstrated the enhanced reactivity of

[Cu2(OTf)2]2+ compared to the more inert 3/Me[Cu2Cl2]2+.

Scheme 2.6 Top) Anion metathesis with
metathesis with 3/Me[Sr]2+.

3/Me

[Cu2(OTf)2]2+ and Bottom) One-pot anion

Introducing a new bridging group was achieved by treating

3/Me

[Cu2(OTf)2]2+ with

2.0 equiv. NBu4Br (Scheme 2.6, Top). Upon the addition of NBu 4Br to a blue MeCN slurry
of

3/Me

[Cu2(OTf)2]2+, a reaction was signified by a color change to green. After two hours

of stirring, the solution appeared homogeneous. The product was obtained as a bright
green powder. Attempts at crystallization of the macrocyclic complex afforded powders.
The identity of product was confirmed through combustion analysis as the Cu2-di(µ-Br)
complex [3/MePDI2Cu2Br2][OTf]2 (3/Me[Cu2Br2]2+). The infrared spectrum displayed an imine
stretching frequency at 1600 cm -1. Further confirmation of the dinuclear product was
confirmed through UV-vis-NIR spectroscopy. Absorption bands were identified at 238 nm
(π→π transition) and 680 nm (d→d transition), which agree well

3/Me

[Cu2Cl2]2+.

Similarly, the treatment of 3/Me[Cu2(OTf)2]2+ with 2.0 equiv. NBu4N3 cleanly afforded
the paramagnetic, dark green complex [3/MePDI2Cu2(N3)2][OTf]2 (3/Me[Cu2(N3)2]2+).
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Crystallization of the product allowed for structural elucidation (Figure 2.11). Two azide
ligands now bridge the two copper(II) centers, while the macrocyclic ligand remains in the
unfolded ligand conformation. Each Cu(II) center adopts a distorted octahedral geometry.
The elongated Cu–N (2.5353(1) Å) and Cu–O (2.4361(9) Å) axial bond lengths are
consistent with Cu-d9 Jahn-Teller distortions. A symmetric Cu2(µ-N3)2 core is noted in the
crystal structure, with a Cu–Cu distance of 3.1362(6) Å and symmetry-related Cu-N-Cu
angles of 88.02(4)°. Although the Cu–Cu distance is similar to that in the analogous
3/Me

[Cu2Cl2]2+ complex, the bridging angle observed for

3/Me

[Cu2(N3)2]2+ is larger, owing to

the shorter equatorial Cu–N bond lengths of 1.936(1) Å. Further support for the di(µ-azide)
core was noted in the compound’s IR spectrum. An asymmetric azide stretching frequency
was observed at 2062 cm-1. Similar stretching frequencies have been observed in
analogous Schiff base complexes.64-67

Figure 2.11 Crystal structure of 3/Me[Cu2(N3)2]2+ (thermal ellipsoids set at 50% probability;
hydrogen atoms omitted for clarity).
Considering the ease of anion substitution displayed by
pursued a simplified one-pot protocol in which

3/Me

[Cu2(OTf)2]2+, we

3/Me

[Cu2(OTf)2]2+ would be formed in situ

and then treated with an external anion source (Scheme 2.6, Bottom) to reduce the
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number of steps to achieve anion metathesis. We were surprised to find that stirring
3/Me

[Sr]2+ and 2.0 equiv. Cu(OTf)2 in DCM afforded no reaction. However, found upon

addition of 2.0 equiv. of NBu 4X (X = N3, Br) to the mixture, an anion metathesis reaction
was initiated to yield the

3/Me

[Cu2(µ-X)2]2+ products. These results indicate that anion

metathesis is facile in this system and that the formation of

3/Me

[Cu2(OTf)2]2+ is not

necessary prior to the generation of the 3/Me[Cu2(µ-X)2]2+ products. While this one-pot route
afforded comparable yields to the stepwise procedure, the extended workup and
separation of multiple salt byproducts proved more challenging. Anion metathesis studies
with 3/Me[Cu2(OTf)2]2+ were continued to avoid such difficulties.
2.3.2 Anion Substitution with Nitrite and Trimethylsilanolate Anions
We next pursued the inclusion of the nitrite anion, which is known to be capable of
adopting a range of coordination modes at Cu(II) ions. To first probe if

3/Me

[Cu2(OTf)2]2+

was capable of binding nitrite, a similar protocol was followed as that described above, in
which NaNO2 was used in the anion metathesis reaction (Figure 2.12). Upon adding 2.0
eq. of NaNO2 to a slurry of 3/Me[Cu2(OTf)2]2+, the starting material was consumed over the
course of 2 hours to afford a dark blue-green solution. Diffusion of Et2O into a concentrated
MeCN solution afforded crystals suitable for X-ray diffraction. The product was identified
as the di(µ-κ1-ONO) macrocycle complex, [3/MePDI2Cu2(ONO)2][OTf]2 (3/Me[Cu2(ONO)2]2+).

Figure 2.12 Synthesis of 3/Me[Cu2(ONO)2]2+ in MeCN.
The solid-state structure of

3/Me

[Cu2(ONO)2]2+ depicts the macrocyclic ligand

enforcing a µ-κ1-binding of each nitrite anion (Figure 2.13). Limited examples of this
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geometry are found for Cu2(II,II) systems in the literature.68-71 In

3/Me

[Cu2(ONO)2]2+, each

copper is found in a distorted octahedral geometry, with the overall structure appearing
similar in form to

3/Me

[Cu2(N3)2]2+. The two copper(II) centers are related by a center of

symmetry in the crystal lattice and are separated by 3.2553(6) Å. The characteristic Cu(II)d9 Jahn-Teller distortions are observed through the elongated Cu–O bond lengths
(2.347(1) Å and 2.505(1) Å). Like

3/Me

[Cu2(N3)2]2+, the Cu2(ONO)2 core displays a larger

bridging angle [∠Cu-O-Cu = 94.18(5)°] than that observed in

3/Me

[Cu2Cl2]2+. The short

equatorial Cu–O bond lengths of 1.904(1) Å account for this difference.

Figure 2.13 Crystal structure of 3/Me[Cu2(ONO)2]2+ (thermal ellipsoids set at 50%
probability; hydrogen atoms and nitrite disorder omitted for clarity).
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Figure 2.14 Overlay of infrared spectra of 3/Me[Cu2(O14/15NO)2]2+.
The IR spectral data for

3/Me

[Cu2(ONO)2]2+ are consistent with the nitrite ligation

mode observed crystallographically. IR spectra of Cu2(II,II) complexes with κ1-ONO
ligands show asymmetric and symmetric stretching modes in the 1400-1100 cm-1
region.68,69 However, the bending and stretching frequencies associated with the
macrocyclic ligand convolute the IR spectrum of

3/Me

[Cu2(ONO)2]2+. To distinguish the

nitrite stretching frequencies from the macrocyclic ligand, the isotopically labeled complex
[3/MePDI2Cu2(O15NO)2][OTf]2 (3/Me[Cu2(O15NO)2]2+) was prepared. The IR spectrum of
3/Me

[Cu2(ONO)2]2+ contains two distinct stretching frequencies at 1473 cm -1 and 991 cm-1

that shift to lower energies (1447 cm -1 and 971 cm-1) when using

3/Me

[Cu2(O15NO)2]2+

(Figure 2.14). Thus, the stretching frequencies at 1473 cm-1 and 991 cm-1 are assigned to
the asymmetric and symmetric stretching frequencies of the nitrite ligand.
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Βridging alkoxy anions were next targeted as a way of expanding the scope of
substitution reactions available to 3/Me[Cu2(OTf)2]2+, but Cu2(II,II)-µ-(OR) (R = Me, tBu, Ph)
macrocyclic species eluded isolation. Instead, substitution was found to be successful
when using the trimethylsilanolate anion (Figure 2.15). Upon addition of 2.0 equiv.
NaOTMS to a slurry of

3/Me

[Cu2(OTf)2]2+, a rapid color change from blue to dark orange-

brown was observed. Low-temperature crystallization afforded single crystals of the
desired complex, [3/MePDI2Cu2(OTMS)2][OTf]2 (3/Me[Cu2(OTMS)2]2+). The crystal structure
confirms the presence of two bridging trimethylsilanolate ligands (Figure 2.16). The ligand
adopts an unfolded ligand conformation to support the two bridging ligands between the
two copper(II) centers. In the case of

3/Me

[Cu2(OTMS)2]2+, both Cu(II) centers were found

to adopt a distorted square pyramidal geometry with the triflate anions lying in the outer
coordination sphere (τ5 = 0.14 for each Cu(II)). The steric encumbrance of the TMS groups
may prevent the triflate anions from binding to the metal centers in a manner seen with
structurally related complexes presented above.
The Cu2(µ-OTMS)2 diamond core displays a Cu-O-Cu angle of 86.65(5)°, an
equatorial Cu–O bond length of 1.8969(14) Å, a distorted axial Cu–O bond length of
2.259(1) Å and a short Cu–Cu distance of 2.8639(4) Å. To date, no structurallycharacterized Cu2(II,II)-µ-OTMS complexes have been reported in the CSD. McGeary,
Caulton

and

coworkers

previously

reported

a

Cu2(I,I)-bis(µ-OSiPh3)-

bis(diphenylmethylphosphine) cluster.72 The cluster was found to contain an asymmetric
[Cu2(OSiPh3)2] core, with longer Cu–O bond distances of 1.9457(17) and 2.0456(17) Å.
The shorter equatorial bond distances observed in

3/Me

[Cu2(OTMS)2]2+ are as expected,

considering the higher oxidation states of the metal centers. A longer Cu–Cu distance of
2.9662(7) Å was also observed for the [Cu 2(OSiPh3)2] cluster. Compared with
3/Me

[Cu2(OTMS)2]2+, each copper center in McGeary and Caulton’s cluster is more
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sterically crowded, owing to the bulky diphenylmethylphopshine ligand. The combined
action of the lower oxidation states and increased steric bulk at the metal centers forces
a farther copper-copper distance.

Figure 2.15 Synthesis of 3/Me[Cu2(OTMS)2]2+ o-DFB/MeCN.

Figure 2.16 Crystal structure of 3/Me[Cu2(OTMS)2]2+ (thermal ellipsoids set at 50%
probability; hydrogen atoms and outersphere anions omitted for clarity).
2.3.3 Synthesis of 3/Me[Cu2OH]3+
The synthetic protocol for anion-exchange with
implemented with the hydroxide anion. Numerous

3/Me

[Cu2(OTf)2]2+ was next

Cu2(II,II)-di(µ-OH)-containing

complexes exist that are supported with mononucleating, multidentate ligands, such as
BDI (BDI = β-diketiminate),73 TpR (Tp = hydrotris(1-pyrazolyl)borate; R = Me, iPr)23,24 and
TACN (TACN = 1,4,7-triazacyclononane).74 However, isolation of a Cu2(II,II)-di(µ-OH)
complex with

3/Me

PDI2 has remained elusive. Instead, the monohydroxide product

[3/MePDI2Cu2OH][OTf]3
3/Me

(3/Me[Cu2OH]3+)

was

synthesized

through

treatment

[Cu2(OTf)2]2+ with LiOH, as confirmed by X-ray crystallography (Figure 2.17).
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of

Figure 2.17 Synthesis of 3/Me[Cu2OH]3+ in MeCN.
Growth of single crystals allowed for structure elucidation of

3/Me

[Cu2OH]3+. The

crystal structure was found to contain a planar macrocyclic ligand (Figure 2.18). Because
of this conformation, the Cu–Cu distance lengthens to 3.585(7) Å and 3.618(4) Å (the
asymmetric unit contains disordered macrocyclic complexes with distinct metrical
parameters). These distances lie at the longer end of the range of Cu–Cu distances
observed in the series of bis(4-tert-butylpyridyldiimine) macrocyclic complexes. Each
copper(II) center adopts a distorted octahedral geometry, with weakly-coordinating triflate
ligands occupying the axial positions of each copper(II) center. The PDI subunits and a
bridging hydroxide ligand occupy the equatorial plane. The Cu–O(H) distances of 1.872(2)
and 1.875(5) Å agree well with previously reported Cu2(II,II)-µ-OH complexes (Table 2.2),
including Drew and Nelson’s [PrPDI2Cu2OH][ClO4]3·2H2O. However the Cu-O(H)-Cu angle
of 149.98(16)° [140.2(2)°] significantly deviates from that of [PrPDI2Cu2OH][ClO4]3·2H2O
[110.3(7)°]. The less-strained

3/Me

[Cu2OH]3+ complex allows for the increased Cu–Cu

distance and corresponding increase in the Cu-O(H)-Cu angle. In fact, the observed angle
in

3/Me

[Cu2OH]3+ agrees better with the larger complex [ OctPDI2Cu2OH][ClO4]3·H2O

reported by Drew and Nelson [141.7(7)°]. As expected, the flexible aliphatic linkers
modulate the Cu–Cu distance to allow for variously-sized bridging ligands to be housed
between the two metal centers.
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Figure 2.18 Crystal structure of 3/Me[Cu2OH]3+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, solvent molecules, triflate disorder and macrocycle disorder omitted for
clarity).
Table 2.2 Selected bond metrics of copper(II) hydroxide PDI complexes.
3/Me

[Cu2OH]3+
2.097(2)
1.912(2)
2.040(3)
2.096a
1.926 a
2.038 a
1.872(2)
1.908 a
3.603 a
145.09a

[EtPDI2Cu2OH]3+b,c
2.066(12)
1.916(13)
2.061(13)
1.916(9)
3.145(4)
110.3(7)

[OctPDI2Cu2OH]3+c
2.039(11)
1.907(16)
2.060(9)
2.076(4)
1.925(12)
2.059(14)
1.866(13)
1.912(10)
3.57
141.7(7)

Cu(1) – N(1) / Å
Cu(1) – N(2) / Å
Cu(1) – N(3) / Å
Cu(2) – N(4) / Å
Cu(2) – N(5) / Å
Cu(2) – N(6) / Å
Cu(1) – O(1) / Å
Cu(2) – O(1) / Å
Cu(1) – Cu(2) / Å
∠Cu(1)-O(1)-Cu(2) / °
∆/Å
0.196 a
0.230
a – Average values based on disorder of molecule
b – Macrocycle is symmetric; bond metrics are the same for Cu(2)
c – Crystal structure obtained at room temperature

0.147

2.4 Summary of Cu2(II,II) 4-tert-butyl-bis(pyridyldiimine) Macrocycles
The

isolation

and

characterization of a

series of

Cu2(II,II)

bis(4-tert-

butylpyridyldiimine) macrocycles was carried out using a new “open-core” macrocycle,
3/Me

[Cu2(OTf)2]2+. The triflate complex is a suitable precursor to a host of novel Cu2(II,II)
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macrocycles through anion metathesis reactions. Through this work, a secondary pathway
to substituted Cu2(II,II) macrocycles was also found through a one-pot procedure in which
3/Me

[Sr]2+ was treated with 2.0 equiv. Cu(OTf)2 and a corresponding source of anion. Either

pathway was sufficient to achieve anion metathesis. The macrocycles were found to
exhibit greater solubility in lower-polarity organic solvents (THF, DCM, MeCN, etc.) than
analogous complexes reported by Drew and Nelson. The solid-state structures of each
new macrocyclic complex showed that the conformation of the macrocycle was able to
change depending on the number of bridging substituents between the copper(II) centers
(Table 2.3). If two bridging ligands were present, the macrocycle adopted an unfolded
conformation. If one bridging ligand was present, the macrocycle adopted an arched or
planar conformation. The geometric differences were enabled by the flexibility of the
macrocyclic aliphatic linkers, an observation also made by Drew and Nelson. The
electronic absorption spectra all displayed common features, including d-d transitions,
LMCT transitions, and π-π* ligand transitions. The robust synthetic protocol allowed
access to different bridging motifs, including a hydroxide anion, which is an ideal
intermediate to study in the pursuit of a bridging oxo complex and C-H bond oxidation.
Table 2.3 Summary of Cu2(II,II) bis(4-tert-butylpyridyldiimine) macrocycles

3/Me

[Cu2Cl]2+
2/Me
[Cu2Cl]2+
3/Me
[Cu2(NCMe)2]4+
3/Me
[Cu2Cl]3+
3/Me
[Cu2F]3+
3/Me
[Cu2(N3)2]2+
3/Me
[Cu2(ONO)2]2+
3/Me
[Cu2(OTMS)2]2+
3/Me
[Cu2OH]3+

Conformation
Unfolded
Unfolded
Unfolded
Arched
Unfolded
Unfolded
Unfolded
Unfolded
Planar

Cu-Cu / Å
3.129(1)
2.9922a
3.3479(7)
3.7045(7)
3.7240(4)
3.1362(6)
3.2553(6)
2.8639(4)
3.603a

a – Average values.
b – 1-X,1-Y,1-Z
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Cu-Xequatorial / Åa
2.1860
2.2056
1.973
2.2823
1.8620
1.936
1.904
1.8969
1.890

Cu-X-Cu / °a
75.05
70.82
77.64
108.50
180.00b
88.02
94.18
86.65
145.09

2.5 Experimental
2.5.1 General Considerations
Unless stated otherwise, all reactions were carried out under an inert atmosphere
of N2 using standard Schlenk techniques or a PureLab HE glovebox, then worked up in
air. Glassware, stir bars, filter aid (Celite), and 4 Å molecular sieves were dried in an oven
at 175 °C for at least one hour prior to use when applicable. Degassed anhydrous solvents
(Pentane, Et2O, THF, DCM, and MeCN) were dried by passage through activated alumina
using a Solvent Purification System and stored over 4 Å molecular sieves for at least one
day before use. Chloroform-d was purchased from Cambridge Isotopes Laboratories, Inc.
and was stored over 4 Å molecular sieves for at least one day before use. The macrocyclic
precursor

2/Me

[Sr]2+ was prepared according to a previous reported procedure.75

Tetrabutylammonium chloride (NBu 4Cl) was purchased from Sigma Aldrich, ground to a
fine powder with a mortar and pestle and dried under vacuum over P 2O5 for one week
before use. Tetrabutylammonium bromide (NBu4Br) was purchased from Sigma Aldrich
and dried under vacuum over P2O5 for one week before use. Sodium nitrite (NaNO2) was
purchased from Fisher Chemicals, ground to a fine powder with a mortar and pestle and
flame dried under dynamic vacuum, then stored under N 2 in an inert atmosphere glovebox.
15

N-labeled sodium nitrite (Na15NO2) was purchased from Cambridge Isotope

Laboratories, Inc., ground to a fine powder with a mortar and pestle, and flame dried under
dynamic vacuum. The isotopologue was then stored in the dark, in the glovebox. Sodium
trimethylsilanolate was purchased as a 1.0 M solution in THF from Sigma Aldrich in a
Sure/SealTM bottle and was stored under N2 in the glovebox. All other reagents were
purchased from commercial vendors and used as received.
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NMR Spectroscopy: NMR spectra were recorded on a NEO 600 spectrometers. All
chemical shifts are reported in units of ppm and referenced to the residual proteo-solvent
resonance for proton and carbon chemical shifts.

Elemental Analysis: Analytical data were obtained from the CENTC Elemental Analysis
Facility at the University of Rochester. Microanalysis samples were weighed with a
PerkinElmer Model AD6000 Autobalance and their compositions were determined with a
PerkinElmer 2400 Series II Analyzer. Air-sensitive samples were handled in a VAC
Atmospheres glovebox and combusted in a tin capsule that was crimp-sealed with a die
apparatus. For

3/Me

[Cu2(NCMe)2]2+, analytical data was collected using a Costech ECS

4010 analyzer in the Earth & Environmental Science Department at the University of
Pennsylvania.

Infrared Spectroscopy: Infrared spectra were recorded using a PerkinElmer Spectrum
Two FT-IR spectrometer. Samples were placed on an ATR crystal after collecting a blank
spectrum and spectral data was measured over the range of 450-4000 cm-1.

UV-vis-NIR Spectroscopy: Absorption spectra were collected over the range of 200-1000
nm using an Agilent Cary 60 UV-vis-NIR spectrophotometer. Stock solutions (3.0-11.0
mM) were prepared under an N2 atmosphere in the glovebox. Samples were then diluted
to obtain absorption profiles in the linear response range of the spectrophotometer. Each
measurement was obtained using a 10 mm path-length quartz cuvette with a screw cap.
The temperature of each measurement was maintained at 25 °C using an Unisoku USP203A cryostat. Five different concentrations were used for Beer’s Law analysis of each
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peak maxima. The absorption intensities for peak maxima were plotted vs. concentration
to ensure a linear fit was obtained (R2 > 0.990).

X-ray Crystallography: X-ray intensity data were collected on a Bruker D8Quest CMOS
(3/Me[Cu2Cl2]2+,

2/Me

[Cu2Cl2]2+

and

3/Me

[Cu2OH]3+)

and

a

Bruker

APEXII

CCD

(3/Me[Cu2(OTMS)2+) area detector diffractomer with graphite-monochromated Mo-Kα
radiation (λ = 0.71073 Å) at a temperature of 100 K. X-ray intensity data for 3/Me[Cu2Cl]3+,
3/Me

[Cu2F]3+ and

3/Me

[Cu2(ONO)2]2+ were collected on a Rigaku XtaLAB Synergy-S

diffractometer equipped with an HPC area detector (Dectris Pilatus3 R 200K) employing
confocal multilayer optic-monochromated Mo-Kα radiation (λ = 0.71073 Å) at a
temperature of 100 K. X-ray intensity data for 3/Me[Cu2(N3)2]2+ and 3/Me[Cu2(NCMe)2]3+ were
collected on a Rigaku XtaLab Synergy-S diffractometer equipped with an HPC area
detector (HyPix-6000HE) employing confocal multilayer optic-monochromated Mo-Kα
radiation (λ = 0.71073 Å) ( 3/Me[Cu2(N3)2]2+) or Cu-Kα radiation (λ = 1.54184 Å)
(3/Me[Cu2(NCMe)2]3+) at a temperature of 100 K. Rotation frames were integrated using
SAINT or CrysAlisPro, producing a listing of unaveraged F 2 and σ(F2) values. The intensity
data were corrected for Lorentz and polarization effects and for absorption using SADABS
or SCALE3 ABSPACK. The structures were solved by direct methods using either
SHELXT (3/Me[Cu2Cl2]2+,
3/Me

[Cu2(ONO)2]2+ and

2/Me

3/Me

[Cu2Cl2]2+,

3/Me

[Cu2(NCMe)2]3+,

3/Me

[Cu2F]3+,

3/Me

[Cu2(N3)2]2+,

[Cu2OH]3+) or SHELXS-97 (3/Me[Cu2(OTMS)2+) and refined by

full-matrix least-squares, based on F2 using SHELXL-2018. All reflections were used
during refinement. Non-hydrogen atoms were refined anisotropically and hydrogen atoms
were refined using a riding model. For

3/Me

[Cu2Cl2]2+ 3/Me[Cu2(N3)2]2+, the molecule lies on

a crystallographic center-of-symmetry (at ½, ½, ½). For 3/Me[Cu2(ONO)2]2+, the coordinate
NO2 is disordered by a slight rotation about the Cu1-O1 bond with relative occupancies of
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0.72/0.28. For

3/Me

[Cu2(OTMS)2+, the molecule lies on a crystallographic center-of-

symmetry (at 0, 0, 0).
2.5.2 Synthetic Procedures

3/Me

[Sr]2+. The following procedure was adapted from the literature report. 75 A 500 mL

round bottom flask was charged with 4-tert-butyl-2,6-diacetylpyridine (5.1349 g, 23.417
mmol, 2.00 equiv.), Sr(OTf)2 (4.5353 g, 11.757 mmol, 1.00 equiv.), and MeOH (250 mL).
The mixture was stirred until all solids were dissolved. To the pale-yellow solution, 1,3diaminopropane (2.00 mL, 23.9 mmol, 2.04 Eq.) was added. The solution became darker
and was heated to reflux (oil bath set to 75 °C) for 16 hours. The volatile materials were
then removed under vacuum. The crude product was extracted into ca. 25 mL DCM and
filtered over a pad of celite to remove insoluble materials. The yellow-orange filtrate was
then treated with ca. 300-400 mL hexanes to precipitate the product as an off-white
powder. The powder was collected via vacuum filtration, washed with an additional ca.
500 m L hexanes and dried under vacuum (9.6398 g, 91%). Analytical characterization
data matched those previously reported. 1H NMR (CDCl3, 600 MHz, 298 K): δ = 7.81 (s,
8H), 3.96 (t, J = 6.5 Hz, 8H), 2.46 (s, 12 H), 1.90 (quint, J = 6.5 Hz, 4H), 1.43 (s, 18H)
ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ = 167.1, 164.0, 155.6, 121.4, 120.1 (q, J
= 319.4 Hz), 46.7, 35.5, 30.67, 28.9, 15.2 ppm. 19F{1H} NMR (CDCl3, 565 MHz, 298 K): δ
= -78.06 ppm.
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3/Me

[Cu2Cl2]2+. The following procedure was carried out in air. A 100 mL round bottom flask

was charged with

3/Me

[Sr]2+ (553.4 mg, 0.6145 mmol, 1.00 equiv.) and MeOH (15 mL).

Once all starting material was dissolved, the golden-yellow solution was treated with a
solution of CuCl2·2H2O (209.8 mg, 1.231 mmol, 2.00 equiv.) in MeOH (10 mL). The
reaction mixture immediately became dark green and was stirred for 60 min at room
temperature. Solvent was then removed under vacuum. The product was extracted in 20
mL MeCN and filtered over a pad of Celite to remove insoluble byproducts. The dark bluegreen filtrate was then layered with 80 mL Et2O at room temperature. After one day, a
crystalline solid was collected via vacuum filtration and rinsed with 50 mL Et 2O. The
product was collected as a blue powder and dried under vacuum (517.0 mg, 83%). Anal.
% Calcd. for C34H46Cl2Cu2F6N6O6S2 (1010.88 g/mol): C, 40.40; H, 4.59; N, 8.31. Found:
C, 40.06; H, 4.51 N, 8.22. FT-IR (ATR): 1597 (C=N) cm-1. UV-vis-NIR (MeCN, 298 K): 238
nm (7.71 x 104 M-1 cm-1), 676 nm (242 M-1 cm-1).

2/Me

[Cu2Cl2]2+. The following procedure was carried out in air. A 100 mL round bottom flask

was charged with

2/Me

[Sr]2+ (520.9 mg, 0.5969 mmol, 1.00 equiv.) and MeOH (15 mL).

Once all starting material was dissolved, the golden-yellow solution was treated with a

49

solution of CuCl2·2H2O (206.9 mg, 1.214 mmol, 2.03 equiv.) in MeOH (10 mL). The
reaction mixture immediately became dark green and was stirred for 60 minutes at room
temperature. Solvent was then removed under vacuum. The product was extracted in ca.
20 mL MeCN and filtered over a pad of celite to remove insoluble byproducts. The dark
blue-green filtrate was then layered with ca. 80 mL Et2O at room temperature. After one
day, the crystalline solid was collected via vacuum filtration and rinsed with 50 mL Et 2O.
The product was collected as a blue powder and dried under vacuum (481.1 mg, 82%).
Crystals suitable for single crystal X-ray crystallography were grown by slow diffusion of
Et2O into a concentrated MeCN solution at room temperature. Anal. % Calcd. for
C32H42Cl2Cu2F6N6O6S2 (982.83 g/mol): C, 39.11; H, 4.31; N, 8.55. Found: C, 38.89; H,
4.19; N, 8.44. FT-IR (ATR): 1594 (C=N) cm-1. UV-vis-NIR (MeCN, 298 K): 236 nm (5.31
x 104 M-1 cm-1), 681 nm (228 M-1 cm-1).

3/Me

[Cu2(NCMe)2]4+. To a 100 mL Schlenk tube, [Cu2Cl2]2+ (1.094 g, 1.082 mmol, 1.00

equiv.) and MeCN (24 mL) were added. Once all solids were dissolved, the stirring, dark
green solution was cooled to 0 °C and treated dropwise with TMS-OTf (0.790 mL, 4.37
mmol, 4.04 equiv.). The solution immediately turned dark blue and was warmed to room
temperature over 30 minutes. Solvent was then removed under vacuum. The crude
product was triturated with ca. 25 mL Et2O and concentrated under vacuum to afford a
light blue solid. The solid was transferred to the glove box, collected on a fritted glass filter,
and washed with 4 x ca. 10 mL 1:1 MeCN/Et2O followed by ca. 50 mL Et2O. The product
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was then dried under vacuum. The resulting fine blue powder (1.232 g, 86%) was stored
at -35 °C in a glovebox. A sample suitable for X-ray crystallography was grown by slow
diffusion of Et2O into a concentrated MeCN solution at room temperature. From the same
batch of isolated material, single crystals of

3/Me

[Cu2Cl]3+ were grown by slow diffusion of

n-hexane into a concentrated o-F2-C6H4 solution at room temperature. Anal. % Calcd. for
C40H52N8Cu2F12O12S4 (1320.21 g/mol): C, 36.39; H, 3.97; N, 8.49. Found: C, 36.29; H,
4.05; N, 8.70.

3/Me

[Cu2F]3+. A 500 mL round bottom Schlenk flask was charged with Cu(OTf)2 (3.2736 g,

9.0513 mmol, 2.05 equiv.) and DCM (40 mL). The slurry was stirred and treated with a
solution of

3/Me

[Sr]2+ (3.9844 g, 4.4246 mmol, 1.00 equiv.) in DCM (40 mL) followed by a

solution of [NBu4][Ph3SiF2] (2.6507 g, 4.9099 mmol, 1.11 equiv.) in MeCN (80 mL). The
reaction mixture became dark blue and was stirred for 4 hours at room temperature. The
solution was filtered through a pad of Celite to remove insoluble materials. The Celite pad
was rinsed with an additional 40 mL of 1:1 DCM:MeCN. The dark blue filtrate was then
concentrated under vacuum to afford a crude blue oil, which solidified upon standing. The
flask was transferred to the glovebox. The crude blue solid was washed with 3 x 30 mL
2:1 Et2O:THF and collected over a fritted glass filter. The solid was washed with copious
amounts of Et2O followed by 3 x 25 mL THF (a dark impurity was removed). The remaining
crystalline blue solid was rinsed with ca. 50-60 mL pentane and dried under vacuum to
afford the desired product (3.7947 g, 77%). Crystals suitable for single crystal X-ray
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crystallography were grown by layering a concentrated MeCN solution with Et 2O at room
temperature and letting the two layers diffuse together overnight. Anal. % Calcd. for
C35H46Cu2F10N6O9S3 (1108.04 g/mol): C, 37.94; H, 4.18; N, 7.58. Found: C, 37.88; H, 4.16;
N, 7.58. FT-IR (ATR): 1589 (C=N) cm-1. UV-vis-NIR (MeCN, 298 K): 228, 667 nm (248 M1

cm-1).

3/Me

[Cu2(OTf)2]2+. To a 100 mL Schlenk tube was added

3/Me

[Cu2F]3+ (1.1099 mg, 1.0017

mmol, 1.00 equiv.) and DCM (25 mL). The blue slurry was cooled to -78 °C and treated
dropwise with TMS-OTf (0.200 mL, 1.11 mmol, 1.10 equiv.). The mixture was removed
from the cold bath and stirred for one hour. Over time, the dark blue slurry became light
blue. Solvent was then removed under vacuum affording a light blue solid. The solid was
transferred to the glovebox, triturated with ca. 100-200 mL Et2O and collected by vacuum
filtration. The product was then washed with ca. 100-200 mL pentane and dried under
vacuum (1.0966 mg, 88%). Anal. % Calcd. for C36H46Cu2F12N6O12S4 (1238.11 g/mol): C,
34.92; H, 3.75; N, 6.79. Found: C, 34.09; H, 3.53; N, 6.58.
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3/Me

[Cu2Br2]2+. To a 100 mL Schlenk tube, Cu(OTf)2 (433.2 mg, 1.198 mmol, 2.04 Eq.) and

DCM (5 mL) were added. The slurry was treated with a solution of

3/Me

[Sr]2+ (529.2 mg,

0.5877 mmol, 1.00 equiv.) in DCM (10 mL). No change occurred upon this addition. A
solution of NBu4Br (379.4 mg, 1.177 mmol, 2.00 equiv.) in DCM (10 mL) was then added.
The reaction mixture immediately became dark green. Within minutes, a bright green solid
precipitated from solution. The reaction was allowed to proceed for 4 h at room
temperature. To the solution, MeCN (35 mL) was added, and the dark green solution was
filtered over a pad of celite. The pad was rinsed with an additional 35 mL 1:1 DCM:MeCN,
and the filtrate was concentrated under vacuum. The resulting crude solid was triturated
with 10 mL THF and collected via vacuum filtration. The product was washed with 3 x 10
mL THF and 50 mL Et2O. The product was re-dissolved in ca. 45 mL MeCN and was
layered with 200 mL Et2O at room temperature. The product powdered out of solution as
a light green solid after three days. The solid was collected and rinsed with 50 mL Et 2O
before drying under vacuum (487.2 mg, 75%). Anal. % Calcd. for C34H46Br2Cu2F6N6O6S2
(1099.79 g/mol): C, 37.13; H, 4.22; N, 7.64. Found: C, 37.12; H, 4.04; N, 7.57. FT-IR
(ATR): 1600 (C=N) cm-1. UV-vis-NIR (MeCN, 298 K): 238 nm, 680 nm.
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3/Me

[Cu2(N3)2]2+. To a 100 mL Schlenk tube, Cu(OTf)2 (406.2 mg, 1.123 mmol, 2.02 equiv.)

and DCM (5 mL) were added. The slurry was treated with a solution of

3/Me

[Sr]2+ (501.1

mg, 0.5565 mmol, 1.00 equiv.) in DCM (10 mL). No change occurred upon this addition.
A solution of NBu4N3 (320.2 mg, 1.126 mmol, 2.02 equiv.) in DCM (10 mL) was then
added. The reaction mixture immediately became dark green. Within minutes, a dark
green solid precipitated from solution. The reaction was allowed to proceed for 4 hours at
room temperature. To the solution, MeCN (25 mL) was added, and the dark green solution
was filtered over a pad of celite. The pad was rinsed with an additional 35 mL 1:1
DCM/MeCN, and the filtrate was concentrated under vacuum. The resulting crude solid
was triturated with 10 mL THF and collected via vacuum filtration. The product was
washed with 3 x 10 mL THF and 50 mL Et2O. The product was re-dissolved in ca. 45 mL
MeCN and was layered with 200 mL Et 2O at room temperature. The product crystallized
as green needles after three days. The crystals were collected and rinsed with 50 mL Et2O
before drying under vacuum (424.7 mg, 75%). Crystals suitable for single crystal X-ray
crystallography were grown by vapor diffusion of Et 2O into a concentrated MeCN solution.
Anal. % Calcd. for C34H46Cu2F6N12O6S2 (1024.02 g/mol): C, 39.88; H, 4.53; N, 16.41.
Found: C, 39.91; H, 4.38; N, 16.25. FT-IR (ATR): 2063 (N3), 1602 (C=N) cm-1. UV-vis-NIR
(MeCN, 298 K): 227 nm, 365 nm (5.04 x 103 M-1 cm-1), 661 nm (418 M-1 cm-1).
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3/Me

[Cu2(ONO)2]2+. In a glovebox, a 20 mL scintillation vial was charged with

3/Me

[Cu(OTf)2]2+ (203.9 mg, 0.1647 mmol, 1.00 equiv.), NaNO2 (24.0 mg, 0.348 mmol, 2.11

equiv.) and MeCN (ca. 8 mL). The blue slurry was stirred for 2 h at room temperature, at
which point the dark blue-green solution appeared homogeneous. The sample was
removed from the glovebox and worked up under air. The crude reaction mixture was
diluted with DCM (10 mL) and filtered through a pad of celite to remove insoluble materials.
Solvent was then removed under vacuum. The crude dark green solid was washed with 3
x 5 mL THF. A blue crystalline solid was collected via vacuum filtration and dried under
vacuum to afford the desired product (59.5 mg, 35%). Crystals suitable for single crystal
X-ray crystallography were grown by vapor diffusion of Et2O into a concentrated MeCN
solution. Anal. % Calcd. for C34H46Cu2F6N8O10S2 (1031.99 g/mol): C, 39.57; H, 4.49; N,
10.86. Found: C, 39.61; H, 4.45; N, 10.72. FT-IR (ATR): 1603 (C=N), 1473, 991 (NO2) cm1

. UV-vis-NIR (MeCN, 298 K): 231, 638 nm (248 M -1 cm-1).

3/Me

[Cu2(O15NO)2]2+. In the glovebox, a 20 mL scintillation vial was charged with

3/Me

[Cu2(OTf)2]2+ (207.8 mg, 0.1678 mmol, 1.00 equiv.), Na 15NO2 (24.6 mg, 0.351 mmol,

2.09 equiv.) and MeCN (ca. 8 mL). The blue slurry was stirred for 2 hours at room
temperature, at which point the dark blue-green solution appeared homogeneous. The
sample was removed from the glovebox and worked up in air. The crude reaction mixture
was diluted with DCM (10 mL) and filtered over a pad of celite to remove insoluble
materials. Solvent was then removed under vacuum. The crude dark green solid was

55

washed with 3 x ca. 2 mL THF. A blue-green powder was collected via vacuum filtration
and dried under vacuum to afford the desired product (136.5 mg, 79%). FT-IR (ATR): 1604
(C=N), 1447, 971 (NO2) cm-1.

3/Me

[Cu2(OTMS)2]2+. In the glovebox, a 20 mL scintillation vial was charged with

3/Me

[Cu2(OTf)2]2+ (211.4 mg, 0.1707 mmol, 1.00 equiv.), o-DFB (ca. 5 mL) and MeCN (ca.

5 mL MeCN). The blue slurry was stirred at room temperature and treated dropwise with
1.0 M NaOTMS (0.350 mL, 0.350 mmol, 2.05 equiv.). The reaction mixture quickly became
dark orange-brown and was stirred for 2 hours. The mixture was then directly filtered over
a pad of celite, and the dark orange filtrate was concentrated under vacuum. The crude
product was triturated with 3 x ca. 2-3 mL THF. The remaining dark blue-green solid was
dissolved in minimal MeCN and filtered over celite. The sample was concentrated under
vacuum, triturated with ca. 15 mL Et2O and dried under vacuum (116.7 mg, 61%). Crystals
suitable for single crystal X-ray crystallography were grown by vapor diffusion of Et 2O into
a concentrated MeCN solution at -35 °C. Anal. % Calcd. for C40H64Cu2F6N6O8S2Si2
(1118.36 g/mol): C, 42.96; H, 5.77; N, 7.51. Found: C, 42.89; H, 5.57; N, 7.80. FT-IR
(ATR): 1603 (C=N) cm-1. UV-vis-NIR (MeCN, 298 K): 229 nm (5.51 x 10 4 M-1 cm-1), 481
nm (382 M-1 cm-1).
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3/Me

[Cu2OH]3+. In the glovebox, a 20 mL scintillation vial was charged with 3/Me[Cu2(OTf)2]2+

(208.1 mg, 0.1681 mmol, 1.00 Eq.), LiOH (4.0 mg, 0.17 mmol, 0.99 Eq.) and MeCN (ca.
8 mL). The blue slurry was stirred at room temperature for 2 hours, at which point the dark
blue solution appeared homogeneous. The sample was removed from the glovebox and
worked up in air. Solvent was removed under vacuum. The product was extracted in ca.
5 mL DCM and filtered over celite to remove insoluble materials. The dark blue filtrate was
layered with ca. 15 mL hexanes. After one day, a blue crystalline solid was isolated and
dried under vacuum (134.8 mg, 73%). Crystals suitable for single crystal X-ray
crystallography were grown by vapor diffusion of Et2O into a concentrated THF solution.
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Figure 2.20 13C{1H} NMR spectrum of 3/Me[Sr]2+ in CDCl3.
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Figure 2.19 1H NMR spectrum of 3/Me[Sr]2+ in CDCl3.
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Figure 2.21 19F{1H} NMR spectrum of 3/Me[Sr]2+ in CDCl3.
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2.5.4 Infrared Spectra

Figure 2.22 Infrared spectrum of 3/Me[Cu2Cl2]2+.

Figure 2.23 Infrared spectrum of 2/Me[Cu2Cl2]2+.
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Figure 2.24 Infrared spectrum of 3/Me[Cu2F]3+.

Figure 2.25 Infrared spectrum of 3/Me[Cu2Br2]2+.
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Figure 2.26 Infrared spectrum of 3/Me[Cu2(N3)2]2+.

Figure 2.27 Infrared spectrum of 3/Me[Cu2(ONO)2]2+.

62

Figure 2.28 Infrared spectrum of 3/Me[Cu2(O15NO)2]2+.

Figure 2.29 Infrared spectrum of 3/Me[Cu2(OTMS)2]2+.
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2.5.5 UV-vis-NIR Spectra

Figure 2.30 Beer’s law analysis of 3/Me[Cu2Cl2]2+ at 676 nm.
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Figure 2.31 Linear fit of 3/Me[Cu2Cl2]2+ absorbance data at 676 nm.
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Figure 2.32 Beer’s law analysis of 3/Me[Cu2Cl2]2+ at 238 nm.
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Figure 2.33 Linear fit of 3/Me[Cu2Cl2]2+ absorbance data at 238 nm.
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Figure 2.34 Beer’s law analysis of 2/Me[Cu2Cl2]2+ at 681 nm.
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Figure 2.35 Linear fit of 3/Me[Cu2Cl2]2+ absorbance data at 681 nm.
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Figure 2.36 Beer’s law analysis of 2/Me[Cu2Cl2]2+ at 236 nm.
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Figure 2.37 Linear fit of 2/Me[Cu2Cl2]2+ at 236 nm.
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Figure 2.38 Beer’s law analysis of 3/Me[Cu2F]3+ at 667 nm.
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Figure 2.39 Linear fit of 3/Me[Cu2F]3+ absorbance data at 667 nm.
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Figure 2.40 Beer’s law analysis of 3/Me[Cu2(N3)2]2+ at 661 nm.
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Figure 2.41 Linear fit of 3/Me[Cu2(N3)2]2+ absorbance data at 661 nm.
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Figure 2.42 Beer’s law analysis of 3/Me[Cu2(N3)2]2+ at 365 nm.
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Figure 2.43 Linear fit of 3/Me[Cu2(N3)2]2+ absorbance data at 365 nm.

70

0.110

Figure 2.44 Beer’s law analysis of 3/Me[Cu2(ONO)2]2+ at 638 nm.

Absorbance @ 638 nm

Absorbance

0.26

0.25

0.24

y = 0.2483x + 0.0147
R² = 0.9936

0.23
0.87

0.89

0.91

0.93

0.95

Wavelength (nm)
Figure 2.45 Linear fit of 3/Me[Cu2(ONO)2]2+ absorbance data at 638 nm.
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Figure 2.46 Beer’s law analysis of 3/Me[Cu2(OTMS)2]2+ at 481 nm.
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Figure 2.47 Linear fit of 3/Me[Cu2(OTMS)2]2+ absorbance data at 481 nm.
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Figure 2.48 Beer’s law analysis of 3/Me[Cu2(OTMS)2]2+ at 229 nm.
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Figure 2.49 Linear fit of 3/Me[Cu2(OTMS)2]2+ absorbance data at 229 nm.
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2.5.6 X-ray Crystallography
Table 2.4 Summary of structure determination of 3/Me[Cu2Cl2]2+.
Empirical formula

C34H46Cl2Cu2F6N6O6S2

Formula weight

1010.87

Temperature/K

100

Crystal system

monoclinic

Space group

P21/c

a

12.5444(7)Å

b

15.9671(9)Å

c

11.8223(7)Å

β

117.009(2)°

Volume

2109.7(2)Å3

Z

2

dcalc

1.591 g/cm3

μ

1.310 mm-1

F(000)

1036.0

Crystal size, mm

0.3 × 0.2 × 0.02

2θ range for data collection

6.272 - 55.24°

Index ranges

-16 ≤ h ≤ 16, -20 ≤ k ≤ 20, -15 ≤ l ≤ 15

Reflections collected

51161

Independent reflections

4881[R(int) = 0.0957]

Data/restraints/parameters

4881/84/339

Goodness-of-fit on F2

1.051

Final R indexes [I>=2σ (I)]

R1 = 0.0728, wR2 = 0.1776

Final R indexes [all data]

R1 = 0.0970, wR2 = 0.1998

Largest diff. peak/hole

1.03/-1.28 eÅ-3
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Table 2.5 Summary of structure determination of 2/Me[Cu2Cl2]2+.
Empirical formula

C36H48Cl2Cu2F6N8O6S2

Formula weight

1064.92

Temperature/K

100

Crystal system

triclinic

Space group

_
P1

a

12.6430(12)Å

b

13.7270(13)Å

c

28.579(3)Å

α

79.827(3)°

β

82.354(3)°

γ

68.329(3)°

Volume

4524.4(7)Å3

Z

4

dcalc

1.563 g/cm3

μ

1.228 mm-1

F(000)

2184.0

Crystal size, mm

0.38 × 0.32 × 0.25

2θ range for data collection

5.772 - 55.138°

Index ranges

-16 ≤ h ≤ 16, -17 ≤ k ≤ 17, -37 ≤ l ≤ 37

Reflections collected

108801

Independent reflections

20849[R(int) = 0.0472]

Data/restraints/parameters

20849/0/1142

Goodness-of-fit on F

2

1.023

Final R indexes [I>=2σ (I)]

R1 = 0.0664, wR2 = 0.2072

Final R indexes [all data]

R1 = 0.0739, wR2 = 0.2203

Largest diff. peak/hole

1.15/-0.69 eÅ-3
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Table 2.6 Summary of structure determination of 3/Me[Cu2(NCMe)2]4+.
Empirical formula

C44H58Cu2F12N10O12S4

Formula weight

1402.32

Temperature/K

100

Crystal system

triclinic

Space group

_
P1

a

9.5549(3)Å

b

12.0215(4)Å

c

13.3759(4)Å

α

103.747(2)°

β

105.331(3)°

γ

91.855(2)°

Volume

1431.84(8)Å3

Z

1

dcalc

1.626 g/cm3

μ

3.224 mm-1

F(000)

718.0

Crystal size, mm

0.11 × 0.04 × 0.03

2θ range for data collection

7.088 - 148.932°

Index ranges

-11 ≤ h ≤ 11, -12 ≤ k ≤ 15, -16 ≤ l ≤ 16

Reflections collected

18204

Independent reflections

5765[R(int) = 0.0476]

Data/restraints/parameters

5765/0/386

Goodness-of-fit on F2

1.074

Final R indexes [I>=2σ (I)]

R1 = 0.0520, wR2 = 0.1434

Final R indexes [all data]

R1 = 0.0628, wR2 = 0.1567

Largest diff. peak/hole

0.66/-0.85 eÅ-3
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Table 2.7 Summary of structure determination of 3/Me[Cu2Cl]3+.
Empirical formula

C35H46ClCu2F9N6O9S3

Formula weight

1124.49

Temperature/K

100

Crystal system

monoclinic

Space group

P21/n

a

15.4647(5)Å

b

11.5756(4)Å

c

25.5577(6)Å

β

96.493(3)°

Volume

4545.8(2)Å3

Z

4

dcalc

1.643 g/cm3

μ

1.227 mm-1

F(000)

2296.0

Crystal size, mm

0.46 × 0.16 × 0.06

2θ range for data collection

4.584 - 56.564°

Index ranges

-20 ≤ h ≤ 20, -15 ≤ k ≤ 15, -32 ≤ l ≤ 34

Reflections collected

79844

Independent reflections

11270[R(int) = 0.0508]

Data/restraints/parameters

11270/216/651

Goodness-of-fit on F2

1.033

Final R indexes [I>=2σ (I)]

R1 = 0.0485, wR2 = 0.1237

Final R indexes [all data]

R1 = 0.0618, wR2 = 0.1309

Largest diff. peak/hole

1.53/-0.75 eÅ-3
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Table 2.8 Summary of structure determination of 3/Me[Cu2F]3+.
Empirical formula

C35H46Cu2F10N6O9S3

Formula weight

1108.04

Temperature/K

100

Crystal system

monoclinic

Space group

P2/c

a

13.7556(5)Å

b

9.1159(3)Å

c

17.8988(6)Å

β

103.059(4)°

Volume

2186.37(13)Å3

Z

2

dcalc

1.683 g/cm3

μ

1.218 mm-1

F(000)

1132.0

Crystal size, mm

0.44 × 0.14 × 0.08

2θ range for data collection

4.672 - 56.564°

Index ranges

-18 ≤ h ≤ 17, -10 ≤ k ≤ 12, -23 ≤ l ≤ 23

Reflections collected

42756

Independent reflections

5424[R(int) = 0.0553]

Data/restraints/parameters

5424/0/336

Goodness-of-fit on F2

1.035

Final R indexes [I>=2σ (I)]

R1 = 0.0430, wR2 = 0.1037

Final R indexes [all data]

R1 = 0.0510, wR2 = 0.1077

Largest diff. peak/hole

1.88/-1.11 eÅ-3
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Table 2.9 Summary of structure determination of 3/Me[Cu2(N3)2]2+.
Empirical formula

C34H46Cu2F6N12O6S2

Formula weight

1024.03

Temperature/K

100

Crystal system

monoclinic

Space group

P21/c

a

7.6454(2)Å

b

12.0716(2)Å

c

23.2817(5)Å

β

94.729(2)°

Volume

2141.41(8)Å3

Z

2

dcalc

1.588 g/cm3

μ

1.175 mm-1

F(000)

1052.0

Crystal size, mm

0.18 × 0.17 × 0.12

2θ range for data collection

3.804 - 56.562°

Index ranges

-10 ≤ h ≤ 9, -16 ≤ k ≤ 16, -31 ≤ l ≤ 31

Reflections collected

42276

Independent reflections

5301[R(int) = 0.0338]

Data/restraints/parameters

5301/0/285

Goodness-of-fit on F2

1.042

Final R indexes [I>=2σ (I)]

R1 = 0.0236, wR2 = 0.0610

Final R indexes [all data]

R1 = 0.0262, wR2 = 0.0621

Largest diff. peak/hole

0.42/-0.32 eÅ-3
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Table 2.10 Summary of structure determination of 3/Me[Cu2(ONO)2]2+
Empirical formula

C34H46Cu2F6N8O10S2

Formula weight

1031.99

Temperature/K

100

Crystal system

monoclinic

Space group

P21/c

a

8.1673(3)Å

b

11.6841(4)Å

c

23.3957(7)Å

β

98.843(3)°

Volume

2206.06(13)Å3

Z

2

dcalc

1.554 g/cm3

μ

1.145 mm-1

F(000)

1060.0

Crystal size, mm

0.26 × 0.16 × 0.09

2θ range for data collection

4.958 - 56.56°

Index ranges

-10 ≤ h ≤ 10, -15 ≤ k ≤ 15, -31 ≤ l ≤ 30

Reflections collected

40925

Independent reflections

5463[R(int) = 0.0814]

Data/restraints/parameters

5463/18/294

Goodness-of-fit on F

2

1.066

Final R indexes [I>=2σ (I)]

R1 = 0.0304, wR2 = 0.0745

Final R indexes [all data]

R1 = 0.0373, wR2 = 0.0772

Largest diff. peak/hole

0.45/-0.45 eÅ-3
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Table 2.11 Summary of structure determination of 3/Me[Cu2(OTMS)2]2+/
Empirical formula

C20H32CuF3N3O4SSi

Formula weight

559.17

Temperature/K

100

Crystal system

monoclinic

Space group

P21/n

a

13.8850(14)Å

b

13.0849(13)Å

c

15.4405(15)Å

β

114.690(2)°

Volume

2548.8(4)Å3

Z

4

dcalc

1.457 g/cm3

μ

1.038 mm-1

F(000)

1164.0

Crystal size, mm

0.3 × 0.25 × 0.2

2θ range for data collection

4.484 - 55.018°

Index ranges

-18 ≤ h ≤ 17, -16 ≤ k ≤ 17, -20 ≤ l ≤ 20

Reflections collected

46045

Independent reflections

5846[R(int) = 0.0188]

Data/restraints/parameters

5846/18/306

Goodness-of-fit on F2

1.039

Final R indexes [I>=2σ (I)]

R1 = 0.0373, wR2 = 0.0967

Final R indexes [all data]

R1 = 0.0405, wR2 = 0.0995

Largest diff. peak/hole

1.32/-1.22 eÅ-3
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Table 2.12 Summary of structure determination of 3/Me[Cu2OH]3+.
Empirical formula

C39H55Cu2F9N6O11S3

Formula weight

1178.15

Temperature/K

100

Crystal system

triclinic

Space group

_
P1

a

12.1466(12)Å

b

14.6587(16)Å

c

14.8914(16)Å

α

67.013(4)°

β

81.872(4)°

γ

83.338(4)°

Volume

2411.0(4)Å3

Z

2

dcalc

1.623 g/cm3

μ

1.110 mm-1

F(000)

1212.0

Crystal size, mm

0.41 × 0.33 × 0.05

2θ range for data collection

5.976 - 55.158°

Index ranges

-15 ≤ h ≤ 15, -19 ≤ k ≤ 19, -19 ≤ l ≤ 19

Reflections collected

67617

Independent reflections

11091[R(int) = 0.0686]

Data/restraints/parameters

11091/259/753

Goodness-of-fit on F

2

1.127

Final R indexes [I>=2σ (I)]

R1 = 0.0564, wR2 = 0.0903

Final R indexes [all data]

R1 = 0.0800, wR2 = 0.0977

Largest diff. peak/hole

0.94/-0.59 eÅ-3
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CHAPTER 3 : BIS(PYRIDYLDIIMINE) MACROCYCLIC LIGAND DEVELOPMENT
3.1 Introduction
Pyridyldiimine (PDI) ligands are versatile molecules used in synthetic and catalytic
applications.76,77 Known initially for influencing the catalytic activity of iron and cobalt
toward the polymerization of ethylene,78,79 PDI ligands have now been shown to stabilize
a plethora of transition metal, main group, lanthanide, and actinide complexes. 42 Tuning
the PDI unit through synthetic tailoring shows striking differences in the redox properties
of the ligands and their resulting complexes. Considering the now well-known capacity of
the PDI moiety to serve as a redox non-innocent ligand in metal complexes, tuning the
redox properties of the PDI unit has the potential to dramatically affect the overall reactivity
of PDI-supported metal system.80
Numerous syntheses of substituted PDI ligands have been reported by way of
functionalization either at the 4-position of the pyridyl ring or at the imino moieties
appended to the 2- and 6-positions of the central pyridyl group. Importantly, these
synthetic routes are not general, highlighting the challenge of identifying a common
method for modifying the steric and electronic profile of the PDI ligand. Nocera and
coworkers have reported significant improvements with respect to the preparation of 4substituted-2,6-diacetylpyridine precursors (vide infra), but these lack generality in the
substitution pattern at the imino group. Herein, previous synthetic routes to 2,6pyridyldiketone precursors and PDI ligands are highlighted. Taking inspiration from these
synthetic methods, we have developed new derivatives of the bis(pyridyldiimine)
macrocycle used in Chapter 2. Moreover, a new, scalable, tunable synthetic route to 4aryl-2,6-dibenzoylpyridines is demonstrated, which allows for facile steric/electronic
modifications to the PDI units of the macrocyclic ligands.
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3.1.1 General Approach to the Synthesis of PDI Ligands
Typical synthetic pathways to either mononucleating PDI ligands or dinucleating
macrocyclic PDI-based ligands involve the use of 2,6-pyridyldialdehyde or 2,6pyridyldiketone starting materials. With an appropriate amine, an imine condensation
results in the formation of the corresponding PDI unit. Early examples of this reactivity
were demonstrated by Lions and Martin as well as Figgins and Busch. 81,82 In both cases,
2,6-diformylpyridine was converted to the corresponding 2,6-dialdiminopyridine using
aniline, benzylamine, or methylamine (Figure 3.1, left and right). The respective ligands
were found to bind Fe, Co, Ni and Cu in 2:1 stoichiometries. Following these preliminary
works, Alyea and Merrell showed 2,6-diacetylpyridine to be a suitable precursor to 2,6diiminopyridine using a similar protocol. 83 The PDI ligands were isolated following an imine
condensation with aniline, p-anisidine, or benzylamine (Figure 3.1, bottom). Unlike the
dialdehyde starting material, 2,6-diacetylpyridine required elevated reaction temperatures
and an acid catalyst to achieve optimal yields. Notably, Ni and Zn complexes were
synthesized in a 1:1 or 2:1 stoichiometry depending on the quantity of ligand used in the
reaction mixture. The initial synthetic reports paved the way for a multitude of PDI
derivatives containing an aldimino or methyl-substituted ketimino moiety.

Figure 3.1 Early synthetic routes of PDI Ligands using imine condensations.
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3.1.2 Substitution at the 4-Position of the PDI Unit
Substituents at the 4-position of PDI ligands are commonly introduced through 4substituted-2,6-diacetylpyridine precursors. Examples of direct substitution of PDI
derivatives are known but less common. Typically, alkylation,84-86 halogenation,87-92
oxidation,93 or C–H activation94 pathways are invoked to modify the 4-position of the pyridyl
unit. An overview of select methods focusing on the above pathways follows herein.
Alkylation at the 4-position of 2,6-diacetylpyridine and related PDI ligands may be
achieved

through

radical-based

Minisci

reactions,84

organometallic manganese

reagents85,86 or metal-free photocatalysis.95 Initially reported by Burger and coworkers, the
tert-butylation of 2,6-diacetylpyridine was carried out under Minisci conditions in
water/chlorobenzene (Figure 3.2, top). The tert-butyl group was found to improve the
solubility of Rh and Ir PDI complexes in nonpolar solvents. Inspired by Burger’s report and
the previous tert-butylation of dimethyl-2,6-pyridinedicarboxylate in water,96 our lab
recently developed a two-step, greener preparation of 4-tert-butyl-2,6-diacetylpyridine
(Figure 3.2, bottom).75

Figure 3.2 Preparation of 4-tert-butyl-2,6-diacetylpyridine.
Considering the successful tert-butylation of PDI precursors, the Minisci reaction
is highly dependent on the stability of the alkyl radical. The limited scope of alkylation
reactions led Cámpora and coworkers to develop a new alkylation procedure of PDI
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ligands by using dialkylmanganese(II) reagents (Figure 3.3). Treating

iPr

PDI with MnR2 (R

= CH2MePh, Bn, CH2CHCH2) followed by methanolysis, afforded a mixture of the 4alkylated products and 1,4-dihydropyridines. Subjecting the crude product to oxidizing
conditions allowed for full conversion to the desired 4-alkylated iPrPDI products. Cámpora
proposed an alkyl migration mechanism as a means of generating the observed organic
products.

Figure 3.3 Alkylation of iPrPDI using alkyl manganese reagents.
Nocera and coworkers introduced a scalable synthesis of 4-substituted-2,6pyridyldiketones for the synthesis of PDI ligands.97 Using commercially available 4substituted pyridines, a Minisci reaction was conducted using pyruvic acid to install acyl
groups at the 2- and 6-positions. The method avoids the use of harsh halogenation
conditions and eliminates the need for certain pyrophoric/toxic reagents used in other
procedures.
Halogenation offers another route to functionalization. A common means of
introducing

halides

to

the

4-position

of

PDI

ligands

is

first

through

the

chlorination/bromination of chelidamic acid (4-hydroxy-2,6-pyridinedicarboxylic acid).
Previous reports have established a routine procedure for chlorinating chelidamic acid
using

SOCl2

or

PCl5.87-89

The

resulting

chlorinated

product,

4-chloro-2,6-

pyridinedicarbonyl dichloride is subsequently converted to the appropriate 2,6pyridyldiketone, which can be condensed with an amine. Chirik and coworkers reported
this route was suitable for the synthesis of iPrPDI derivatives with 4-dimethylamino and 4trifluoromethyl substitutions (Scheme 3.1).90
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Scheme 3.1 Preparation of 4-substituted iPrPDI derivatives.
The bromination of chelidamic acid was first reported by Takalo and Kankare, in
which PBr5 was generated in situ and heated with chelidamic acid to afford 4-bromo-2,6pyridinedicarbonyl dibromide.92 Ivchenko and coworkers later introduced the bromination
procedure in the preparation of a 4-p-tolyl-2,6-diacetylpyridine (Scheme 3.2).91 The
addition of pyrrolidine to 4-bromo-2,6-pyridinedicarbonyl dibromide afforded the diamide
4-bromo-2,6-bis(1-pyrrolydinylcarbonyl)pyridine, which was then coupled to p-tolylboronic
acid using Suzuki conditions. Reduction of the cross-coupled product to 4-p-tolyl-2,6diacetylpyridine was carried out using an excess of MeMgCl. Through regioselective
bromination, a simple means of installing aryl groups at the 4-position of 2,6diacetylpyridine was achieved.

Scheme 3.2 Ivchenko’s bromination and cross-coupling procedure.
More recently, Burger and coworkers developed a one-pot borylation procedure
for both 2,6-diacetylpyridine (Scheme 3.3) and PDI derivatives. 94 The C–H activation
pathway was selective for the 4-position of the pyridine ring, allowing easy access to
borylated starting materials using B2pin2 (B2pin2 = bis(pinacolatodiboron). The products
were then suitable for Suzuki cross-coupling reactions with various fused arenes to afford
bis(2,6-diacetylpyridine) or dinucleating bis(PDI) compounds.
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Scheme 3.3 Burger’s borylation and cross-coupling procedure (BBBPY = 4,4’-di-tertbutyl-2,2’-bipyridine).

3.1.2 Substitution at the Imino Carbon of the PDI Unit
Another site at which substitution may influence the reactivity of a PDI ligand is the
imino moiety. The most common substitutions include a proton or methyl group. Several
examples have demonstrated unique approaches to generate 2,6-pyridyldiketones with
new imino carbon functionality, including the addition of phenyl, 98 tert-butyl,99 amino, ether
and thioether substituents.100 In particular, the synthesis of 2,6-dibenzoylpyridine was
carried out by Esteruelas and coworkers in the pursuit of a phenyl-substituted PDI ligand
for chromium(III). A Friedel-Crafts alkylation procedure was carried out using 2,6pyridinedicarbonyl dichloride, benzene and AlCl 3 (Figure 3.4). Alternatively, the phenylsubstituted Gilman reagent (LiCuPh2) may be used in the preparation of 2,6dibenzoylpyridine.101 The Friedel-Crafts synthetic pathway has displayed more versatility,
as other aryl groups were tolerated under the reaction conditions (bromobenzene and 2methylanisole).102,103

Figure 3.4 Synthesis of 2,6-dibenzoylpyridine.
3.2 Retrosynthetic Analysis
The current work aims to further macrocyclic ligand design for use in the
generation of reactive Cu2(II,II)-µ-oxo macrocyclic complexes. Tuning the electronics of
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the macrocycle is desirable, as the ligand will play an important role in dictating the basicity
and oxidizing strength of the Cu2(II,II)-µ-oxo moiety (see Chapter 4 for more details). We
sought to identify a modular ligand synthesis in which facile changes to the
steric/electronic profiles of the PDI units can be made. The development of this synthesis
focused on the incorporation of aryl substituents on the pyridyl and imino moieties of the
PDI units; numerous substituted (electron-rich/poor) arenes are commercially available
and eliminate the need for divergent syntheses to introduce bulky, electronic-donating or
electron-withdrawing groups to the PDI unit.
The macrocyclic ligand (5) intended for this study is shown in Figure 3.5. Each PDI
unit contains a phenyl group at the pyridyl and imino moieties. To synthesize 5, a [2+2]
imine condensation of 4-phenyl-2,6-dibenzoylpyridine (4) with 1,3-diaminopropane could
afford the desired macrocycle in analogous fashion to our previous macrocycle syntheses.
The formation of 4 would be accessible from the reduction of 4-phenyl-2,6-bis(1pyrrolidinylcarbonyl)pyridine (3) using PhMgBr. Installation of a phenyl group at the 4position of 3 was envisioned using a Suzuki cross-coupling reaction with phenylboronic
acid and 4-bromo-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (2). (Both the Grignard reduction
and Suzuki coupling steps are points at which substituted arenes could be introduced.)
Ivchenko and coworkers have previously reported the two-step synthesis of 2 from 4bromopyridine-2,6-dicarbonyl dibromide (1), which was prepared from the commercial
reagent chelidamic acid.
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Figure 3.5 Retrosynthetic analysis of Macrocycle 5.
3.3 Macrocyclic Ligand Synthesis
3.3.1 Synthesis of a Cross-Coupling Partner
Initial efforts were directed at the synthesis of 2 using the procedure developed by
Ivchenko and coworkers. However, attempts at repeating the regioselective bromination
were met with intractable mixtures at scale. To circumvent this issue, we modified the
retrosynthetic pathway to include an iridium-catalyzed C–H borylation step (Figure 3.6).
The synthesis of 2,6-bis(1-pyrrolidinylcarbonyl)pyridine-4-boronic acid pinacol ester (7)
would arise from the borylation of 2,6-bis(1-pyrrolidinylcarbonyl)pyridine (6) with B2pin2
(B2pin2 = bis(pinacolato)diboron). The borylation procedure proved quite robust, as 7 was
isolated in near-quantitative yield (Figure 3.7). The conversion of starting material was
evident by 1H NMR spectroscopy, as only a singlet at 8.13 ppm is present in the aromatic
region, indicating one set of equivalent pyridyl protons. Additionally, a singlet at 1.31 ppm
corresponds to the CH3 groups on the newly installed Bpin moiety.

Figure 3.6 Modified retrosynthetic pathway.
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Figure 3.7 Synthesis of borylated diamide 7.
3.3.2 Synthesis of 4-aryl-2,6-dibenzoylpyridine Derivatives
To install a phenyl group at the 4-position of pyridine ring, Suzuki cross-coupling
conditions were optimized through reaction screening. A high-throughput experimental
(HTE) study was carried out using 7 and bromobenzene. Twenty-four reactions were
performed with variations in solvent, base and palladium (pre)catalyst (Figure 3.8). The
best conditions, presented in Figure 3.9, were found to include DME (DME = 1,2dimethoxyethane) as the solvent, potassium carbonate as the base, and SPhos Pd G2 as
the palladium precatalyst. Using optimized conditions, the coupling of a phenyl group at
the 4-position of the pyridine ring was achieved in 81% yield on gram-scale.

91

%Pdt/%IS

14.0
12.0
10.0
8.0
6.0
4.0
2.0
0.0
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DME/K2CO3

DME/K3PO4

PhMe/K2CO3

PhMe/K3PO4

Figure 3.8 HTE screen of 7 and bromobenzene cross-coupling reaction (IS = Internal
Standard = 4,4’-di-tert-butylbiphenyl).
The optimized conditions were then applied to other aryl bromides to introduce
new substituents on the pyridyl unit. In some instances, a lower loading of catalyst was
found to improve the reaction outcome. A range of electron-donating and -withdrawing
aryl groups were well tolerated in the cross-coupling reaction. Coupling of 4-bromoanisole
with 7 afforded 4-methoxyphenyl-substituted 8 in good yield. (HTE optimization was also
carried out on the coupling of 7 to bromoanisole and is outlined in section 3.5.4).
Fluorinated derivatives were also explored and led to incorporation of fluoro or
trifluoromethyl substitution (9 and 10). Moreover, use of the electron-deficient 3,5bis(trifluoromethyl)bromobenzene yielded the desired coupling product with ease (11).
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Figure 3.9 Suzuki cross-coupling reactions with 7 (a = K3PO4 was used as the base; b =
Pd(PPh3)4 was used as the catalyst).
Following the cross-coupling step, the synthesis of 4 was carried out by treating 3
with an excess of PhMgBr. The desired triphenyl-substituted diketone was formed in 61%
yield. Upon acidic workup, 4 precipitates from solution, offering a convenient way to isolate
the product by filtration. In general, 4 was found to be fairly insoluble in common organic
solvents. The procedure was extended to other phenyl Grignard reagents, allowing for the
generation of a new series of triaryl-substituted 2,6-pyridyldiketones in moderate to good
yield (Figure 3.10, 12-18). Both electron-donating (p-tolylphenyl and p-methoxyphenyl)
and electron-withdrawing (p-fluorophenyl) aryl Grignard reagents were implemented and
afforded a diverse series of electron-rich and electron-poor triaryl-substituted diketones.
Notably, the procedure allowed for the construction of mixed-aryl substrates, in which the
aryl group at the 4-position of the pyridyl unit is different from the aryl group at the imino
moiety.
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Figure 3.10 Synthesis of 4-aryl-2,6-dibenzoyl pyridine derivatives (a = PhMgBr was added
at -78 °C and then mixture was warmed to room temperature).
3.3.3 Macrocyclization Examples
As depicted in Figure 3.7, the synthesis of macrocycle 5 was envisioned to occur
from macrocyclization of 4. Typically, bis(pyridyldiimine) macrocycles are synthesized
through a [2+2] imine condensation reaction using an alkaline-earth metal(II) template ion.
Using 4, Sr(OTf)2 and 1,3-diaminopropane, 5 was synthesized in 87% yield (Figure 3.11).
The formation of the desired macrocyclic product was evidenced by

1

H NMR

spectroscopy, in which the propylene linker protons were observed as a broad singlet at
3.93 ppm (8 protons) and a quintuplet at 1.77 ppm (4 protons). Additionally, a singlet
appears at 7.28 ppm (corresponding to the 4 pyridyl protons), which lies upfield from the
chemical shift observed for 4 (8.51 ppm).

Figure 3.11 Synthesis of alkaline-earth metal triflate macrocycles.
The solid-state structure of 5 was determined using single-crystal X-ray
crystallography (Figure 3.12). The structure is similar to

3/Me

[Sr]2+, in that the two PDI

subunits are linked by propylene units and a Sr(OTf) 2 unit lies at the center of the
macrocyclic cavity. The major difference is the phenyl substitution at both the pyridyl and
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imino moieties; each phenyl group is rotated out of the PDI plane. As expected for the
alkaline-earth metal(II) macrocycles, the ligand carries a neutral charge, as indicated by
the ∆ parameter of 0.188 Å.

Figure 3.12 Crystal structure of 5 (thermal ellipsoids set at 50% probability; hydrogen
atoms, disorder and solvent molecules omitted for clarity).
Previous work by our lab has demonstrated the isolation and synthesis of a series
of alkaline-earth metal triflate macrocycles using the bis(4-tert-butylpyridyldiimine)
macrocyclic ligand.75 Using MOTf2 salts (M = Ca, Sr, Ba) and alkyl diamines varying in
carbon length, macrocycles of different sizes were prepared. The same approach was
used in the preparation of smaller and larger macrocycle variants based on 4 (Figure 3.11).
The use of Ca(OTf)2/ethylenediamine and Ba(OTf)2/1,4-diaminobutane allowed for the
direct synthesis of macrocycles 19 and 20, respectively. Macrocycle formation was
confirmed by 1H NMR spectroscopy, as the pyridyl singlet is shifted upfield in both cases
(7.36 ppm for 19 and 7.30 ppm for 20). The ethylene linker protons are observed as a
singlet at 3.71 ppm (8 protons), while the butylene protons appear as two broadened
singlets at 3.76 ppm and 1.98 ppm (each corresponding to 8 protons). The synthesis of
macrocycles 5, 19, and 20 allows for direct comparison to be made between size and
reactivity (see Chapter 4 for further details using Cu2(II,II) macrocyclic complexes).
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In addition to changing the size of the macrocycle, the substituents on the PDI
units were varied. Any of the 4-aryl-2,6-dibenzoypyridines in Figure 3.11 are viable
candidates for macrocyclization. As a proof of concept, substrates 12 and 13 were used
in the preparation of fluorinated macrocycle derivatives (Figure 3.13). These diketones
were chosen to demonstrate macrocyclization with substituents at either the pyridyl or
imino moieties. Using the same synthetic protocol, macrocycles 21 (top) and 22 (bottom)
were prepared in good yield.

Figure 3.13 Synthesis of fluorinated macrocycle analogues.
3.4 Summary
A new modular synthetic route was developed for the synthesis of 4-aryl-2,6dibenzoylpyridines. The five-step synthesis was scalable, and a range of aryl substituents
were tolerated at the pyridyl and imino moieties. Macrocyclization was demonstrated using
diketone 4. Additionally, macrocycles of different size were prepared using different
diamine linkers and alkaline-earth metal triflate template salts (19 and 20). Fluorinated
analogues 21 and 22 were also prepared using the macrocycle synthesis. Good yields
were obtained in all cases. The new diketones offer a range of options for PDI-based
chemistry and allow for easy tuning of the steric/electronics of the resulting transition metal
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complexes if desired. In this case, macrocycles 5 and 19 will be further explored in Chapter
4 in the pursuit of Cu2(II,II)-µ-oxo complexes for hydrocarbon oxidation.
3.5 Experimental
3.5.1 General Considerations
Unless stated otherwise, all reactions were carried out under an inert atmosphere
of N2 using standard Schlenk techniques and worked up in air. Glassware, stir bars, filter
aid (Celite) and 4 Å molecular sieves, were dried in an oven at 175 °C for at least one hour
prior to use when applicable. Benchtop solvents (Pentane, Hexanes, Et 2O, Benzene,
Toluene, THF, DCM, CHCl3 and DMF) were purchased from Fisher Chemical or Millipore
Sigma and used directly. Degassed anhydrous solvents (n-hexane, DME, THF and DCM)
were dried by passage through activated alumina using a Solvent Purification System and
stored over 4 Å molecule sieves for at least one day before use. Chloroform-d was
purchased from Cambridge Isotopes Laboratories, Inc. and stored over 4 Å molecular
sieves for at least one day before use. Thionyl chloride was purchased from Millipore
Sigma in a Sure/SealTM bottle. The Grignard reagents phenylmagnesium bromide (3.0 M
in Et2O) and 4-fluorophenylmagnesium bromide (2.0 M in Et 2O) were purchased from
Millipore Sigma in Sure/SealTM bottles and stored between 2-8 °C. Both p-tolylmagnesium
bromide and 4-methoxyphenylmagnesium bromide were prepared as the lithium chloride
adducts in THF (1.0 M) and used directly. 104 All other reagents were purchased from
typical commercial vendors and used directly as received.

NMR Spectroscopy: 1H, 13C and 19F NMR spectra were recorded on either a Bruker AVII
400 MHz or a Bruker NEO 600 MHz spectrometer. All chemical shifts are reported in units
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of ppm, with references to the residual proteo-solvent resonance for proton and carbon
chemical shifts.

X-ray Crystallography: X-ray intensity data for 5 were collected on a Rigaku XtaLab
Synergy-S diffractometer equipped an HPC area detector (Dectris Pilatus3 R 200K) employing
confocal multilayer optic-monochromated Mo-Kα radiation at a temperature of 100K. Rotation

frames were integrated using CrysAlisPro, producing a listing of unaveraged F 2 and σ(F2)
values. The intensity data were corrected for Lorentz and polarization effects and for
absorption using SCALE3 ABSPACK. The structures were solved by dual methods using
SHELXT and refined by full-matrix least-squares, based on F2 using SHELXL-2018. All
reflections were used during refinement. Non-hydrogen atoms were refined anisotropically
and hydrogen atoms were refined using a riding model.

3.5.2 Synthetic Procedures

2,6-bis(1-pyrrolidinylcarbonyl)pyridine (6). The following procedure was adapted from
the literature.91 A 250 mL round bottom Schlenk flask was charged with pyridine-2,6dicarboxylic acid (10.6 g, 63.4 mmol, 1.00e equiv.), SOCl2 (20.0 mL, 274 mmol, 4.32
equiv.), and DMF (0.050 mL, 0.65 mmol, 1.0 mol %). The mixture was heated to reflux (oil
bath set to 90 °C) for 2 h. Excess SOCl2 was then removed under vacuum. The remaining
red oil was treated with PhMe (50 mL) and concentrated under vacuum to remove residual
SOCl2. The crude di(acid chloride) was dissolved in DCM (25 mL) and cooled to 0 °C. A
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solution of pyrrolidine (22.0 mL, 268 mmol, 4.22 equiv.) in DCM (25 mL) was then added
dropwise to the cooled solution. The flask was removed from the cold bath and stirred for
2 h while warming to room temperature. The red-orange reaction mixture was then treated
with 100 mL of 5% HCl. The organic layer was separated, and the aqueous layer was
washed with 3 x 30 mL DCM. The organic materials were combined and washed with 100
mL of sat. Na2CO3, then dried over Na 2SO4 and concentrated under vacuum to afford a
beige solid. The product was triturated with pentane and collected via vacuum filtration.
The product was dried under vacuum and used without further purification (15.2 g, 88%).
NMR spectroscopic data matched those previously reported. 1H NMR (CDCl3, 600 MHz,
298 K): δ = 7.84-7.75 (m, 3H), 3.66-3.51 (m, 8H), 1.90-1.79 (m, 8H) ppm. 13C NMR (CDCl3,
151 MHz, 298 K): δ = 165.9, 152.9, 137.7, 124.7, 49.0, 46.8, 26.5, 23.9 ppm.

2,6-bis(1-pyrroldinylcarbonyl)pyridine-4-boronic acid pinacol ester (7). To a 500 mL
Schlenk round bottom flask, was added [Ir(COD)(OMe)] 2 (515.3 mg, 0.7774 mmol, 1.06
mol%), 4,4’-di-tert-butyl-2,2’-bipyridine (223.6 mg, 0.8331 mmol, 1.13 mol%), B 2pin2
(20.5770 g, 81.031 mmol, 1.10 equiv.), and n-hexane (ca. 250 mL). After stirring the dark
red solution for one hour at room temperature, 2,6-bis(1-pyrrolidinecarbonyl)pyridine
(20.1098 g, 73.571 mmol, 1.00 equiv.) was added. The mixture was refluxed (oil bath set
to 75 °C) for 48 h. The heterogeneous mixture was directly filtered over fritted glass, and
the filtrand was rinsed with copious amounts of n-hexane. The tan solid was collected and
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dried under vacuum (28.1 g, 96%). 1H NMR (CDCl3, 400 MHz, 298 K): δ = 8.13 (s, 2H),
3.62 (dt, J = 29.9, 6.4 Hz, 8H), 1.95-1.82 (m, 8H), 1.31 (s, 12H) ppm.

13

C NMR (CDCl3,

151 MHz, 298 K): δ = 166.4, 152.5, 129.4, 84.7, 48.9, 46.6, 26.4, 24.8, 24.0 ppm.

4-phenyl-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (3). A 500 mL two-neck Schlenk
round bottom flask was charged with 2,6-bis(1-pyrrolidinylcarbonyl)pyridine-4-boronic acid
pinacol ester (5.077 g, 12.71 mmol, 1.00 equiv.), SPhos Pd G2 (187.6 mg, 0.2603 mmol,
2.0 mol%), bromobenzene (1.70 mL, 16.1 mmol, 1.27 equiv.), DME (125 mL), and a
solution of K2CO3 (5.2849 g, 38.24 mmol, 3.01 equiv.) in H2O (25 mL). The mixture was
then refluxed (oil bath set to 100 °C) for one hour. After the reaction mixture had cooled,
the mixture was diluted with 100 mL brine and extracted with 100 mL DCM. The organic
layer was separated, and the aqueous layer was washed with 2 x 100 mL DCM. Organics
were combined, dried over MgSO4, and concentrated under vacuum. The resulting redorange oil was purified via flash column chromatography (Biotage Isolera, 100 g Sfär
column, 50% - 100% EtOAc/hexanes). The product was collected as a white solid and
dried under vacuum (3.5795 g, 81%). 1H NMR (CDCl3, 600 MHz, 298 K): δ = 8.08 (s, 2H),
7.69 (d, J = 7.3 Hz, 2H), 7.48-7.41 (m, 3H), 3.70-3.68 (m, 8H), 1.95-1.88 (m, 8H) ppm. 13C
NMR (CDCl3, 151 MHz, 298 K): δ = 166.3, 153.8, 150.4, 137.2, 129.7, 129,3, 127.2, 122.7,
49.3, 47.0, 26.8, 24.2 ppm.
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4-(4-methoxyphenyl)-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (8). The reaction of 7
with 4-bromoanisole was carried out in similar fashion to the synthesis of 3. Modifications
were made as follows, 7 (5.0499 g, 12.647 mmol, 1.00 equiv.), 4-bromoanisole (1.90 mL,
15.2 mmol, 1.20 equiv.), K3PO4 (8.9188 g, 42.0 mmol, 3.32 equiv.) and SPhos Pd G2
(49.5 mg, 0.0687 mmol, 0.543 mol%), DME (100 mL) and H2O (25 mL). The product was
afforded as a white powder (3.87 g, 81%). 1H NMR (CDCl3, 400 MHz, 298 K): δ = 8.05 (s,
2H), 7.68 (d, J = 8.8 Hz, 2H), 6.99 (d, J = 8.9 Hz, 2H), 3.86 (s, 3H), 3.70 (t, J = 6.7 Hz,
8H), 2.00-1.86 (m, 8H) ppm.

4-(4-fluorophenyl)-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (9). The reaction of 7 with
4-fluorobromobenzene was carried out in similar fashion to the synthesis of 3.
Modifications were made as follows, 7 (2.1910 g, 5.487 mmol, 1.00 equiv.), 4fluorobromobenzene (0.730 mL, 6.66 mmol, 1.21 equiv.), K2CO3 (2.2930 g, 16.59 mmol,
3.02 equiv.) and SPhos Pd G2 (20.0 mg, 0.0278 mmol, 0.506 mol%), DME (40 mL) and
H2O (10 mL). Following flash column chromatography, the product was recrystallized from
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1:1 hexanes/EtOAc. The product was afforded as a white powder (1.3953 g, 69%).1H NMR
(CDCl3, 400 MHz, 298 K): δ = 8.03 (s, 2H), 7.67 (dd, J = 8.6, 5.4 Hz, 2H), 7.15 (t, J = 8.5
Hz, 2H), 3.73-3.62 (m, 8H), 1.96-1.86 (m, 8H) ppm. 19F NMR (CDCl3, 376 MHz, 298 K): δ
= -111.6 ppm (unreferenced).

4-(4-trifluoromethylphenyl)-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (10). The reaction
of 7 with 4-bromobenzotrifluoride was carried out in similar fashion to the synthesis of 3.
Modifications were made as follows, 7 (2.5107 g, 6.2878 mmol, 1.00 equiv.), 4bromobenzotrifluoride (1.10 mL, 7.86 mmol, 1.25 equiv.), K2CO3 (2.6796 g, 19.39 mmol,
3.08 equiv.) and Pd(PPh3)4 (154.1 mg, 0.1334 mmol, 2.12 mol%), DME (39 mL) and H2O
(13 mL). Following flash column chromatography, the product was triturated with EtOAc
to remove a soluble yellow impurity. The product was afforded as an off-white powder
(1.3681 g, 52%) 1H NMR (CDCl3, 400 MHz, 298 K): δ = 8.12 (s, 2H), 7.82 (d, J = 8.2 Hz,
2H), 7.75 (d, J = 8.3 Hz, 2H), 3.71 (q, J = 6.2 Hz, 8H), 2.02-1.87 (m, 8H) ppm.
(CDCl3, 376 MHz, 298 K): δ = -62.8 ppm (unreferenced).
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F NMR

4-(3,5-bis(trifluoromethyl)phenyl)-2,6-bis(1-pyrrolidinylcarbonyl)pyridine (11). The
reaction of 7 with 3,5-bis(trifluoromethyl)bromobenzene was carried out in similar fashion
to the synthesis of 3. Modifications were made as follows, 7 (2.5970 g, 6.5039 mmol, 1.00
equiv.), 3,5-bis(trifluoromethyl)bromobenzene (1.30 mL, 7.54 mmol, 1.16 equiv.), K2CO3
(2.6940 g, 19.493 mmol, 3.00 equiv.) and SPhos Pd G2 (23.8 mg, 0.0330 mmol, 0.508
mol%), DME (49 mL) and H2O (13 mL). 1H NMR (CDCl3, 600 MHz, 298 K): δ = 8.15 (s,
2H), 8.13 (s, 2H), 7.94 (s, 1H), 3.70 (dt, 13.9, 6.5 Hz, 8H), 1.98-1.88 (m, 8H) ppm. 13C{1H}
NMR (CDCl3, 151 MHz, 298 K): δ = 165.6, 147.2, 139.4, 132.9 (q, J = 33.7 Hz) ppm, 127.4
(d, J = 3.8 Hz), 123.2 (quint, J = 3.6 Hz), 123.1 (q, J = 273.0 Hz), 122.9, 49.3, 47.2, 26.7,
24.0 ppm. 19F NMR (CDCl3, 565 MHz, 298 K): δ = -62.9 ppm (unreferenced).

4-phenyl-2,6-dibenzoylpyridine (4). A 250 mL round bottom Schlenk flask was charged
with THF (150 mL) and 3.0 PhMgBr (26.0 mL, 78.0 mmol, 2.47 equiv., in Et2O). The lightyellow solution was cooled to -78 °C and treated slowly with a solution of 3 (11.0 g, 31.6
mmol, 1.00 equiv.) in THF (50 mL). The reaction mixture became dark red-orange and
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was removed from the cold bath. After stirring for 2 hours, the mixture was re-cooled and
slowly quenched by the dropwise addition of 2 M HCl. The product precipitated from
solution as a yellow solid. The solid was collected by vacuum filtration and rinsed with
copious amounts of water followed by copious amounts of Et 2O. The remaining off-white
solid was collected and dried under vacuum (7.0 g, 61%). 1H NMR (CDCl3, 600 MHz, 298
K): δ = 8.51 (s, 2H), 8.18 (d, J = 6.9 Hz, 4H), 7.82 (d, J = 7.0 Hz, 2H), 7.59-7.55 (m, 4H),
7.53-7.51 (m, 1H), 7.43 (t, J = 7.8, 4H) ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ =
192.9, 154.7, 151.1, 137.0, 136.2, 133.2, 131.3, 130.1, 129.6, 128.2, 127.4, 124.7 ppm.

4-phenyl-2,6-bis(4-fluorophenylmethanone)pyridine (12). A 250 mL two-neck round
bottom Schlenk flask was charged with THF (10 mL) and 2.0 M 4-fluorophenylmagnesium
bromide (4.00 mL, 8.00 mmol, 2.44 equiv., in Et2O). The solution was cooled to 0 °C and
treated dropwise with a solution of 3 (1.1474 g, 3.2836 mmol, 1.00 equiv.) in THF (25 mL).
The flask was removed from the cold bath. The solution was stirred for 2 hours while
warming to room temperature. The mixture was then re-cooled and quenched with 100
mL sat. NH4Cl. The biphasic mixture was extracted with 100 mL DCM, and the organic
layer was separated. The remaining aqueous layer was washed with 2 x 50 mL DCM. The
organic materials were combined, dried over MgSO 4 and concentrated under vacuum.
The resulting yellow product was recrystallized from hot 2:1 PhMe/Et 2O and then triturated
with 30 mL Et2O to remove a soluble impurity. The product was collected as an off-white
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powder and was dried under vacuum (846.6 mg, 65%). 1H NMR (CDCl3, 600 MHz, 298
K): δ = 8.52 (s, 2H), 8.25 (dd, J = 8.8, 5.5 Hz, 4H), 7.81 (d, J = 6.8 Hz, 2H), 7.58-7.54 (m,
2H), 7.54-7.50 (m, 1H), 7.10 (t, J = 8.6 Hz, 4H) ppm. 13C{1H} (CDCl3, 151 MHz, 298 K): δ
= 191.0, 165.9 (d, 1JCF = 255.6 Hz), 154.4, 151.3, 136.8, 134.1 (d, 3JCF = 9.2 Hz), 132.4 (d,
4

JCF = 2.9 Hz), 130.2, 129.6, 127.3, 124.9, 115.4 (d, 2JCF = 21.7 Hz) ppm. 19F NMR (CDCl3,

565 MHz, 298 K): δ = -104.5 ppm (unreferenced).

4-(4-fluorophenyl)-2,6-dibenzoylpyridine (13). The reaction of 9 with PhMgBr was
carried out in similar fashion to the synthesis of 12. Modifications were made as follows,
9 (1.3563 g, 3.6914 mmol, 1.00 equiv.) in THF (30 mL) and 3.0 M PhMgBr (3.00 mL, 9.00
mmol, 2.44 equiv., in Et2O) in THF (20 mL). After aqueous workup, the crude yellow
product was recrystallized from hot PhMe. The product was afforded as an off-white
powder (741.6 mg, 53%). 1H NMR (CDCl3, 400 MHz, 298 K): δ = 8.56 (s, 2H), 8.27 (d, J
= 7.0 Hz, 4H), 7.90 (dd, J = 8.8, 5.2 Hz, 2H), 7.72-7.63 (m, 2H), 7.52 (t, J = 7.8 Hz, 4H),
7.39-7.30 (m, 2H) ppm.
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F NMR (CDCl3, 376 MHz, 298 K): δ = -110.9 ppm

(unreferenced).
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4-(4-trifluoromethylphenyl)-2,6-dibenzoylpyridine (14). The reaction of 10 with
PhMgBr was carried out in similar fashion to the synthesis of 12. Modifications were made
as follows, 10 (1.3611 g, 3.2607 mmol, 1.00 equiv.) in THF (24 mL) and 3.0 M PhMgBr
(3.70 mL, 8.10 mmol, 2.48 equiv., in Et2O). In this instance, the Grignard solution was
directly added dropwise to a chilled solution of 10 in THF. The reaction was quenched with
28 mL 2 M HCl. After aqueous workup, the yellow product was dried under vacuum. The
product was afforded as a yellow powder (1.1944 g, 85%). 1H NMR (CDCl3, 400 MHz, 298
K): δ = 8.52 (s, 2H), 8.18 (d, J = , 4H), 7.93 (d, J = 8.2 Hz, 2H), 7.83 (d, J = 8.2 Hz, 2H),
7.64-7.54 (m, 2H), 7.43 (t, J = 7.8 Hz, 4H) ppm. 19F NMR (CDCl3, 376 MHz, 298 K): δ = 62.8 ppm (unreferenced).

4-(4-methoxyphenyl)-2,6-dibenzoylpyridine (15). The reaction of 8 with PhMgBr was
carried out in similar fashion to the synthesis of 12. Modifications were made as follows,
8 (1.3994 g, 3.6879 mmol, 1.00 equiv.) in THF (30 mL) and 3.0 M PhMgBr (2.80 mL, 8.40
mmol, 2.28 equiv., in Et2O). In this instance, the Grignard solution was directly added
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dropwise to a chilled solution of 8 in THF. The reaction was quenched with 31 mL 2 M
HCl. After aqueous workup, the crude yellow product was recrystallized from acetone. The
product was afforded as a light yellow powder (1.0062 g, 69%). 1H NMR (CDCl3, 400 MHz,
298 K): δ = 8.47 (s, 2H), 8.17 (d, J = 6.9 Hz, 4H), 7.79 (d, J = 8.8 Hz, 2H), 7.57 (t, J = 7.2
Hz, 2H), 7.42 (t, J = 7.8 Hz, 4H), 7.07 (d, J = 8.7 Hz, 2H), 3.90 (s, 3H) ppm.

4-(4-methoxyphenyl)-2,6-bis(4-p-tolylmethanone)pyridine (16). The reaction of 8 with
p-tolylmagnesium bromide was carried out in similar fashion to the synthesis of 12.
Modifications were made as follows, 8 (1.0731 g, 2.8280 mmol, 1.00 equiv.) in THF (15
mL) and 0.9 M p-tolylmagnesium bromide (7.30 mL, 6.57 mmol, 2.32 equiv., in THF). The
aqueous workup was performed with EtOAc, from which the crude product was
recrystallized at -20 °C. After filtering off the recrystallized product, the filtrate was
concentrated under vacuum to afford a yellow-white solid. A second crop of material was
obtained upon triturating the solid with acetone to remove a soluble impurity. This crop of
material was combined with the recrystallized material, affording the product as afforded
as an off-white powder (773.0 mg, 65%). 1H NMR (CDCl3, 600 MHz, 298 K): δ = 8.39 (s,
2H), 8.10 (d, J = 8.0 Hz, 4H), 7.77 (d, J = 8.8 Hz, 2H), 7.23 (d, J = 7.9 Hz), 4H), 7.05 (d, J
= 8.8 Hz, 2H), 3.88 (s, 3H), 2.43 (s, 6H) ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ =
192.8, 161.3, 155.0, 150.3, 144.0, 133.6, 131.5, 129.2, 129.0, 128.6, 123.7, 114.9, 55.6,
21.9 ppm.
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4-(4-methoxyphenyl)-2,6-bis(4-methoxyphenylmethanone)pyridine

(17).

The

reaction of 8 with p-methoxyphenylmagnesium bromide was carried out in similar fashion
to the synthesis of 12. Modifications were made as follows, 8 (786.7 g, 2.073 mmol, 1.00
equiv.) in THF (17 mL) and 0.8 M p-methoxyphenylmagnesium bromide (8.0 mL, 6.40
mmol, 3.09 equiv., in Et2O). After aqueous workup, the crude product was recrystallized
from hot acetone. The desired product was afforded as an off-white powder (697.0 mg,
65%). 1H NMR (CDCl3, 600 .4MHz, 298 K): δ = 8.37 (s, 2H), 8.24 (d, J = 8.5 Hz, 4 H), 7.76
(d, J = 8.4 Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.92 (d, J = 8.4 Hz, 4H), 3.88 (s, 3H), 3.87 (s,
6H) ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ = 191.5, 163.8, 161.3, 155.2, 150.3,
133.9, 129.3, 129.1, 128.6, 123.6, 114.9, 113.5, 55.6, 55.6 ppm.

4-(3,5-bis(trifluoromethyl)phenyl)-2,6-dibenzoylpyridine (18). The reaction of 11 with
PhMgBr was carried out in similar fashion to the synthesis of 12. Modifications were made
as follows, 11 (2.2277 g, 4.5891 mmol, 1.00 equiv.) in THF (20 mL) and 3.0 M PhMgBr
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(3.60 mL, 10.8 mmol, 2.35 equiv., in Et2O) in THF (20 mL). In this instance, the Grignard
solution was added to a chilled solution of 11. The reaction was quenched with 38 mL 2
M HCl. After aqueous workup, the product was recrystallized from 1:1 hexanes/Et 2O at 20 °C. The product was afforded as an off-white powder (1.3566 g, 59%). 1H NMR (CDCl3,
600 MHz, 298 K): δ = 8.54 (s, 2H), 8.23 (s, 2H), 8.18 (d, J = 7.8 Hz, 4H), 8.05 (s, 1H), 7.60
(t, J = 7.4 Hz, 2H), 7.43, J = 7.7 Hz, 4H) ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ
= 192.2, 155.1, 148.2, 139.4, 135.8, 133.4, 133.2 (q, J = 33.8 Hz), 131.3, 128.3, 127.6 (d,
J = 3.8 Hz), 124.7, 123.6 (quint, J = 3.8 Hz), 123.1 (q, J = 273.0 Hz) ppm. 19F NMR (CDCl3,
565 MHz, 298 K): δ = -62.8 ppm (unreferenced).

3Ph

[Sr]2+ (5). A 500 mL round bottom flask was charged with 4 (3.2433 g, 8.9244 mmol,

2.00 equiv.), Sr(OTf)2 (1.7222 mg, 2.4645 mmol, 1.00 equiv.), pTsOH (78.3 mg, 0.455
mmol, 10.2 mol%), 1,3-diaminopropane (0.750 mL, 8.97 mmol, 2.01 equiv.) and C6H6 (250
mL). The flask was equipped with a Dean-Stark apparatus and refluxed (oil bath set to
110 °C) for 48 hours. Solvent was removed under vacuum. The crude product was
extracted in minimal (ca. 30-40 mL) DCM and filtered over a pad of celite to remove
insoluble materials. The filtrate was treated with hexanes until the product precipitated
from solution. The product was collected by vacuum filtration, rinsed with copious amounts
of hexanes, and dried under vacuum (4.6052 mg, 87%). 1H NMR (CDCl3, 400 MHz, 298
K): δ = 7.60-7.48 (m, 12 H), 7.46-7.38 (m, 8H), 7.39-7.32 (m, 6H), 7.28 (s, 4H), 7.24-7.17
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(m, 4H), 3.93 (s, 8H), 1.80-1.73 (m, 4H) ppm.

19

F NMR (CDCl3, 376 MHz, 298 K): δ = -

78.1 ppm (unreferenced).

2/Ph

[Ca]2+ (19). A 500 mL round bottom flask was charged with 4 (2.4926 g, 6.8587 mmol,

2.00 equiv.), Ca(OTf)2 (1.2924 mg, 1.114 mmol, 1.11 equiv.), pTsOH (88.8 mg, 0.516
mmol, 15.0 mol%), ethylenediamine (0.460 mL, 6.88 mmol, 2.01 equiv.) and C6H6 (250
mL). The flask was equipped with a Dean-Stark apparatus and refluxed (oil bath set to
120 °C) for 96 hours. Solvent was removed under vacuum. The crude product was
extracted in CHCl3 (25 mL) and filtered over a pad of celite to remove insoluble materials.
The filtrate was concentrated under vacuum to afford a grey solid. The solid was triturated
with THF (25 mL) and collected by vacuum filtration. The filtrand was rinsed with 200 mL
pentane. The product, an off-white solid, was then dried under vacuum (3.4034 g, 89%).
1

H NMR (CDCl3, 600 MHz, 298 K): δ = 7.59-7.47 (m, 12H), 7.43-7.33 (m, 18H), 7.30-7.25

(m, 4H), 3.72 (s, 8H) ppm. 13C{1H} NMR (CDCl3, 151 MHz, 298 K): δ = 169.9, 154.7, 152.1,
136.9, 134.6, 129.9, 129.7, 129.5, 129.3, 127.5, 127.2, 125.1, 120.2 (q, J = 319.4 Hz),
54.4 ppm.
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4/Ph

[Ba]2+ (20). A 500 mL round bottom flask was charged with 4 (1.6059 g, 4.4189 mmol,

2.00 equiv.), Ba(OTf)2 (1.0670 mg, 2.4503 mmol, 1.11 equiv.), pTsOH (58.1 mg, 0.337
mmol, 15.3 mol%), 1,4-diaminobutane (0.450 mL, 4.48 mmol, 2.03 equiv.) and C6H6 (250
mL). The flask was equipped with a Dean-Stark apparatus and refluxed (oil bath set to
120 °C) for 72 hours. Solvent was removed under vacuum. The crude product was
extracted in minimal CHCl3 and filtered over a pad of celite to remove insoluble materials.
The filtrate was treated with hexanes until the product precipitated from solution. The
product was collected by vacuum filtration, rinsed with copious amounts of hexanes, and
dried under vacuum (990.8 mg, 35%). 1H NMR (CDCl3, 600 MHz, 298 K): δ = 7.58-7.43
(m, 12H), 7.41-7.35 (m, 8H), 7.35-7.30 (m, 6H), 7.29 (s, 4H), 7.20-7.14 (m, 4H), 3.76 (s,
8H), 1.98 (s, 8H) ppm.
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C{1H} NMR (CDCl3, 151 MHz, 298 K): δ = 171.3, 156.3, 151.4,

137.0, 135.9, 129.4, 129.29, 129.26, 127.4, 127.1, 126.4, 120.5 (q, JCF = 319.9 Hz), 53.8,
27.6 ppm. 19F NMR (CDCl3, 565 MHz, 298 K): δ = -78.1 ppm (unreferenced).
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3/PhF

[Sr]2+ (21). A 250 mL round bottom flask was charged with 12 (823.4 mg, 2.062 mmol,

2.00 equiv.), Sr(OTf)2 (438.7 mg, 1.137 mmol, 1.10 equiv.), pTsOH (25.8 mg, 0.150 mmol,
14.5 mol%), 1,3-diaminopropane (0.180 mL, 2.15 mmol, 2.09 equiv.) and C6H6 (100 mL).
The flask was equipped with a Dean-Stark apparatus and refluxed (oil bath set to 120 °C)
for 72 hours. Solvent was removed under vacuum. The crude product was extracted in
minimal DCM and filtered over a pad of celite to remove insoluble materials. The filtrate
was treated with hexanes until the product precipitated from solution. The product was
collected by vacuum filtration, rinsed with copious amounts of hexanes, and dried under
vacuum (1.2087 g, 93%). 1H NMR (CDCl3, 600 MHz, 298 K): δ = 7.45-7.36 (m, 14H), 7.317.25 (m, 10H), 7.23 (dd, J = 7.8, 1.8 Hz, 4H), 3.92 (s, 8H), 1.77 (quint., J = 6.6 Hz, 4H)
ppm. 19F NMR (CDCl3, 376 MHz, 298 K): δ = -78.2, -110.3 ppm (unreferenced).

3/PhF/Ph

[Sr]2+ (22). A 250 mL round bottom flask was charged with 13 (730.4 mg, 1.915

mmol, 2.00 equiv.), Sr(OTf)2 (377.5 mg, 0.9786 mmol, 1.02 equiv.), pTsOH (19.2 mg,
0.111 mmol, 11.6 mol%), 1,3-diaminopropane (0.160 mL, 1.91 mmol, 2.00 equiv.) and
C6H6 (100 mL). The flask was equipped with a Dean-Stark apparatus and refluxed (oil bath

112

set to 120 °C) for 48 hours. Solvent was removed under vacuum. The crude product was
extracted in minimal DCM and filtered over a pad of celite to remove insoluble materials.
The filtrate was treated with hexanes until the product precipitated from solution. The
product was collected by vacuum filtration, rinsed with copious amounts of hexanes, and
dried under vacuum (1.0266 g, 88%). 1H NMR (CDCl3, 400 MHz, 298 K): δ = 7.61-7.49
(m, 12H), 7.47-7.38 (m, 8H), 7.23 (s, 4H), 7.18 (dd, J = 8.8, 5.2 Hz, 4H), 7.04 (t, J = 8.6
Hz, 4H), 3.92 (s, 8H), 1.81-1.73 (m, 4H) ppm.
78.2, -110.9 ppm (unreferenced).
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F NMR (CDCl3, 376 MHz, 298 K): δ = -
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Figure 3.15 13C{1H} NMR spectrum of 6 in CDCl3.
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Figure 3.14 1H NMR spectrum of 6 in CDCl3.
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Figure 3.17 1H NMR spectrum of 3 in CDCl3.
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Figure 3.16 1H NMR spectrum of 7 in CDCl3.
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Figure 3.19 1H NMR spectrum of 8 in CDCl3.
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Figure 3.18 13C{1H} NMR spectrum of 3 in CDCl3.
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Figure 3.20 1H NMR spectrum of 9.

Figure 3.21 19F{1H} NMR spectrum of 9.
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Figure 3.22 1H NMR spectrum of 10 in CDCl3.

Figure 3.23 19F{1H} NMR spectrum of 10 in CDCl3.
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Figure 3.25 13C{1H} NMR spectrum of 11 in CDCl3.
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Figure 3.24 1H NMR spectrum of 11 in CDCl3.
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Figure 3.27 1H NMR spectrum of 4 in CDCl3.
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Figure 3.26 19F NMR spectrum of 11 in CDCl3.
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Figure 3.28 13C{1H} NMR spectrum of 4 in CDCl3.
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Figure 3.29 1H NMR spectrum of 12 in CDCl3.
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Figure 3.30 13C{1H} NMR spectrum of 12 in CDCl3.

Figure 3.31 19F NMR spectrum of 12 in CDCl3.
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Figure 3.32 1H NMR spectrum of 13 in CDCl3.

Figure 3.33 19F{1H} NMR spectrum of 13 in CDCl3.
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Figure 3.34 1H NMR spectrum of 14 in CDCl3.

Figure 3.35 19F{1H} NMR spectrum of 14 in CDCl3.
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Figure 3.37 1H NMR spectrum of 16 in CDCl3.
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Figure 3.36 1H NMR spectrum of 15 in CDCl3.
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Figure 3.38 13C{1H} NMR spectrum of 16 in CDCl3.
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Figure 3.39 1H NMR spectrum of 17 in CDCl3.
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Figure 3.40 13C{1H} NMR spectrum of 17 in CDCl3.
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Figure 3.41 1H NMR spectrum of 18 in CDCl3.
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Figure 3.43 19F NMR spectrum of 18 in CDCl3.
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Figure 3.42 13C{1H} NMR spectrum of 18 in CDCl3.
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Figure 3.44 1H NMR spectrum of 5 in CDCl3.

Figure 3.45 19F{1H} NMR spectrum of 5 in CDCl3.
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Figure 3.47 13C{1H} NMR spectrum of 19 in CDCl3.
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Figure 3.46 1H NMR spectrum of 19 in CDCl3.
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Figure 3.49 13{1H} NMR spectrum of 20 in CDCl3.
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Figure 3.48 1H NMR spectrum of 20 in CDCl3.
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Figure 3.51 1H NMR spectrum of 21 in CDCl3.
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Figure 3.50 19F NMR spectrum of 20 in CDCl3.
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Figure 3.53 1H NMR spectrum of 22 in CDCl3.
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Figure 3.52 19F{1H} NMR spectrum of 21 in CDCl3.
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3.5.4 High-Throughput Experimental Screening
Optimization of the cross-coupling of 7 and bromobenzene was carried out using
a 24-well plate reaction block. Variations in Pd (pre)catalyst, base and solvent were
screened amongst the 24 reactions. Reactions were carried out at on a 0.1 mmol scale
(respect to 7) at 100 °C for 2 hours. Following, the crude reactions were analyzed by LCMS with a 4,4’-di-tert-butylbiphenyl internal standard (IS). The ratio of the liquid
chromatography area percent (LACP) 3:IS was used to compare the performance of each
set of reagents (Table 3.1).
Table 3.1 HTE optimization of cross-coupling of 7 and bromobenzene.

DME/K2CO3
DME/K3PO4
PhMe/K2CO3
DME/K3PO4

Pd(PPh3)4

PCy3
Pd G2

PdCl2(dppf)

11.4
12.4
10.1
9.7

12.8
13.0
9.3
9.2

13.2
13.0
11.6
12.0

XantPhos SPhos XPhos
PdCl2
Pd G2 Pd G2
12.3
12.6
7.4
9.2

13.5
13.1
12.2
12.5

13.1
13.1
9.2
10.7

From the reaction screen, all the combinations of reagents afforded 3 in some
capacity. The best conditions of the screen (which also gave the cleanest LC-MS profile)
included DME as the solvent, K2CO3 as the base, and SPhos Pd G2 as the Pd precatalyst.
These conditions were then applied to a bench-scale reaction, in which 3 was prepared
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on a 5 g scale in 81% yield (see section 3.5.2). Monitoring on large-scale showed full
consumption of 7 by 1H NMR spectroscopy after one hour. Of note, applying other reagent
combinations to bench-scale work, albeit in lower yields. For example, when Pd(PPh 3)4 is
used in place of SPhos Pd G2, the yield drops to 75% on a 2 g scale. While this is a
modest decrease in yield, SPhos Pd G2 remained the best performing catalyst of the
series.
The same optimization was carried out, in parallel, using 4-bromoanisole in place
of bromobenzene. Again, all combinations of reagents afforded the desired product 9. The
most productive combination included DME as the solvent, K 3PO4 and SPhos Pd G2 as
the Pd precatalyst. Notably, K2CO3 was also a suitable base in the synthesis of 9.
However, the optimal conditions afforded the cleanest LC-MS profile and were applied to
bench-scale with slight modifications (see section 3.5.2).

% Pdt/% IS

20.0
15.0
10.0

PhMe/K3PO4
PhMe/K2CO3
DME/K3PO4
DME/K2CO3

5.0
0.0

DME/K2CO3

DME/K3PO4

PhMe/K2CO3

PhMe/K3PO4

Figure 3.55 HTE screen of 7 and 4-bromoanisole cross-coupling reaction.
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Table 3.2 HTE optimization of cross-coupling of 9 and 4-bromoanisole.

DME/K2CO3
DME/K3PO4
PhMe/K2CO3
DME/K3PO4

Pd(PPh3)4

PCy3
Pd G2

PdCl2(dppf)

13.9
2.6
12.1
12.4

14.9
8.1
12.0
12.5

15.4
15.7
13.8
11.7
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XantPhos SPhos XPhos
PdCl2
Pd G2 Pd G2
14.6
5.3
9.2
11.3

16.2
16.3
15.5
15.8

16.0
16.3
12.8
14.1

3.5.5 X-ray Crystallography
Table 3.3 Summary of structure determination of 5.
Empirical formula

C74.4H64.4F8.2N6O6.8S2Sr

Formula weight

1458.86

Temperature/K

100

Crystal system

monoclinic

Space group

C2/c

a

22.1685(4)Å

b

15.3758(3)Å

c

20.8854(4)Å

β

108.228(2)°

Volume

6761.7(2)Å3

Z

4

dcalc

1.433 g/cm3

μ

0.942 mm-1

F(000)

3004.0

Crystal size, mm

0.24 × 0.24 × 0.15

2θ range for data collection

4.76 - 56.562°

Index ranges

-29 ≤ h ≤ 29, -20 ≤ k ≤ 20, -27 ≤ l ≤ 27

Reflections collected

81775

Independent reflections

8328[R(int) = 0.0397]

Data/restraints/parameters

8328/258/585

2

Goodness-of-fit on F

1.035

Final R indexes [I>=2σ (I)]

R1 = 0.0353, wR2 = 0.0965

Final R indexes [all data]

R1 = 0.0394, wR2 = 0.0992

Largest diff. peak/hole

0.53/-0.63 eÅ-3
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CHAPTER 4 : E-H BOND (E = C, N) ACTIVATION BY LOW-TEMPERATURE STABLE
DICOPPER(II,II)-µ-OXO MACROCYCLIC COMPLEXES
4.1 Introduction
The reactive Cu2(II,II)-µ-oxo site within Cu(II)-ZSM-5 is capable of selectively
oxidizing methane to methanol (see Chapter 1). Radical trapping experiments have lent
evidence for a HAT mechanism, in which the µ-oxo abstracts a hydrogen atom from
methane to form a Cu2(I,II)-µ-hydroxide core that undergoes radical rebound with the
methyl radical. Solomon and coworkers provided a thorough computational analysis
supporting the HAT mechanism. From these computations, the driving force of the HAT
reaction is the formation of the strong O–H bond (90 kcal/mol) in the generation of the
mixed-valent hydroxide core.
[CuICuII-µ-OH]2+

+ e-

- e-

[CuIICuII-µ-OH]3+

- H+
+ H+
-H
+H
- H+
+ H+

[CuICuII-µ-O]+

+ e-

- e-

[CuIICuII-µ-O]2+

Thermodynamic Square Scheme

Figure 4.1 Generalized thermodynamic square scheme for a Cu2(II,II)-µ-oxo.
Identifying copper complexes that mimic the activity of the Cu2(II,II)-µ-oxo in
Cu(II)-ZSM-5 requires an understanding of the thermodynamics of HAT processes for
molecular (di)copper-oxygen complexes. Yet, it is difficult to directly measure the strength
of a chemical bond. Rather, the thermodynamic square scheme approach is used to
estimate bond dissociation free energies (BDFEs) in molecular examples (Figure
4.1).105,106 The diagonal of the square scheme represents the overall BDFE associated
with hydrogen atom loss/addition, which may also be viewed as separate proton and
electron transfer steps. The Bordwell relationship (eq. 1) defines the BDFE of the bond of
interest in terms of the relevant values of pKa, E0 (redox potential under standard state
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conditions – 1 M and 25 °C) and CG (a solvent dependent constant referring to the free
energy change associated with H + reduction), which are experimentally derived
thermodynamic quantities. Thus, in the case of a Cu2(II,II)-µ-oxo, both the basicity of the
unit and its oxidizing strength are important factors to consider when designing complexes
for hydrogen atom abstraction.
BDFE (O–H) = 1.37pKa + 23.06E0 + CG

(1)

Herein, the thermodynamic square scheme approach is applied to new Cu2(II,II)n/Ph

µ-OH complexes bearing the newly developed

PDI2 (n = 2,3) ligand (see Chapter 3).

Although the thermodynamic square scheme has been invoked for numerous transition
metal systems, few (di)copper-oxygen complexes have been studied using this approach
(see sections 4.1.1 – 4.1.3). By using the modularity of the present system to develop an
understand of the factors that govern hydrogen atom transfer in these complexes, this
work will aid in identifying new systems that are capable of oxidizing substrates with strong
C–H bonds.
4.1.1 Estimation of a Monocopper(III)-hydroxide O–H BDE
A limited number of examples are known of copper-oxygen systems with
experimentally determined BDFEs. Tolman and coworkers were the first to use the
Bordwell relationship in describing hydrogen atom abstraction thermodynamics by a
copper-oxygen

species.107

Upon

treating

the

copper(II)

acetonitrile

complex

[Cu(NCMe)]0 (PDA = N,N’-bis(2,6-diisopropylphenyl)-2,6-pyridinedicarboxamide) with

PDA

NBu4OH, the anionic hydroxide complex
electron oxidation of

PDA

[CuOH]- was isolated. Accessing the one-

PDA

[CuOH]- was possible with FcPF6, allowing for the generation of

the formally copper(III) hydroxide complex

PDA

[CuOH]0.

PDA

[CuOH]0 was found to react

with 9,10-dihydroanthracene (DHA, C–H BDFEDMSO = 72.9 kcal/mol) via rapid C–H
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activation to afford anthracene in 85% GC yield and the corresponding copper(II)-aqua
complex PDA[CuOH2]0.
PDA[CuIIOH ]0
2

O
iPr

O

N
N
iPr

iPr

N

Cu

- H+
+ H+

+ e-

-H

- e-

+H

i
OH2 Pr
PDA[CuIIOH

BDFETHF (O-H): 83.9 kcal/mol

2]

+

- H+
+ H+

PDA[CuIIOH]-

+ e-

- e-

PDA[CuIIIOH]0

Figure 4.2 Thermodynamic square Scheme of Tolman’s copper(III)-hydroxide complex
(Note: BDFE was determined using CG for THF – 59.9 kcal/mol).
The three complexes,

PDA

[CuOH]-,

PDA

[CuOH]0 and

PDA

[CuOH2]0 are related by

part of the thermodynamic square scheme presented in Figure 4.2. Recognizing this
relationship, Tolman identified the E1/2 for

PDA

[CuOH]- oxidation and pKa of

PDA

[CuOH2]0

for use in the Bordwell relationship (eq. 1).108 A reversible one-electron oxidation event at
-0.074 V (THF, vs. Fc/Fc+) was observed by cyclic voltammetry (CV) at fast scan rates.
Additionally, titration of

PDA

[CuOH]- with [HNEt3][OTf] (pKa in THF = 12.5) allowed for

determination of the pKa of

PDA

[CuOH2]0 as 18.8 ± 1.8. Together, the thermodynamic

quantities were used in the calculation of the O–H BDFE of

PDA

[CuOH2]0 as 83.9 ± 3

kcal/mol. (In Tolman’s initial report, a solution bond dissociation enthalpy (BDE) was
reported as 90 ± 3 kcal/mol under the assumption that entropic contributions were minor.)
The hydrogen atom abstraction reactivity of

PDA

[CuOH]0 was extended to

substrates with C–H bond strengths varying over the range of 77-99 kcal/mol. Of note,
both THF (C–H BDE = 92 kcal/mol) and cyclohexane (C–H BDE = 99 kcal/mol) underwent
hydrogen atom transfer reactions with

PDA

[CuOH]0. The methodology was later extended

to 4-substituted-phenols (4-NMe2, -OMe, -Me, -H, -Cl), which allowed for hydrogen atom
abstraction to be observed over a broad O–H BDFE range (BDFEDMSO = 75.6 – 85.6
kcal/mol).109
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Investigations into the influence of ligand substitution on the resulting O–H BDE of
the hydroxyl group in

PDA

[CuOH]0 were also carried out by Tolman.110, 111 Varying the

electron-donating or -withdrawing ability of the PDA ligand significantly influenced the
CuII/III redox potential, but the experimental BDEs were largely unchanged with respect to
the parent species (Figure 4.3). It was found that while the electronics of the ligand led to
predictable changes in E1/2, these changes were countered by shifts in the associated pKa
values, such that more oxidizing complexes are less basic and vice versa. This is known
as a scaling relationship and represents a major barrier to catalyst optimization in this field
of study (vide infra).

Figure 4.3 Derivatives of PDA ligand with respective BDEs (Note: Tolman and coworkers
reported BDEs in all reports).
4.1.2 Cu2(II,II)-µ-Peroxide/Hydroperoxide Couples with Estimated O–H BDFEs
Dinuclear copper-dioxygen complexes have also garnered interest with respect to
hydrogen atom transfer thermodynamics. Meyer and coworkers were the first to report an
estimated BDFE for the O–H bond in an electrophilic Cu2(II,II)-µ-OOH complex. Their work
made use of the pyrazolate/triazacyclononane ligand and invoked the thermodynamic
square scheme shown in Figure 4.4.

142

iPr

iPr

N

2+

pz/tacn[CuIICuII-µ-OOH]2+

N

N N
Cu N
N Cu
O
NiPr O iPrN
H
BDFEMeCN (O-H): 69.4 kcal/mol

+ e-

- e-

pz/tacn[CuIICuII-µ-OOH•]3+

- H+

pz/tacn[CuIICuII-µ-OO]+

+ H+
-H

+ e-

+H
- H+

- e-

pz/tacn[CuIICuII-µ-OO•]2+

+ H+

Figure 4.4 Thermodynamic square scheme of Meyer’s hydroperoxide complex.
Meyer’s analysis began with evidence for reversible protonation of the
Cu2(II,II)-µ-(1,2-peroxide) complex

pz/tacn

[Cu2OO]+.112 Full protonation of

pz/tacn

[Cu2OO]+

was achieved using 2,6-lutidinium triflate (pKa = 14.16 in MeCN). The product,
pz/tacn

[Cu2OOH]2+, was structurally and spectroscopically characterized. The pKa of

pz/tacn

[Cu2OOH]2+ was determined by monitoring the treatment of the hydroperoxide

complex with tetramethylguanidine (TMG, pKaH = 23.35 in MeCN) with UV-vis-NIR
spectroscopy. Equilibrium mixtures were observed upon titrating increasing amounts of
TMG into a solution of

pz/tacn

[Cu2OOH]2+, allowing for a pKa estimate of 22.2 ± 0.3 to be

obtained. This value is indicative of a basic peroxide unit in MeCN. Electrophilic reactivity
of

pz/tacn

[Cu2OOH]2+ was also observed through the quantitative conversion of PPh 3 to

PPh3O.
Electrochemical analysis was also performed on

pz/tacn

[Cu2OOH]2+.113 Its cyclic

voltammogram revealed a reversible one-electron oxidation feature at E1/2 = -0.59 ± 0.02
V. The oxidation event was chemically accessible with an equivalent of AgBF 4, generating
the superoxide species

pz/tacn

[Cu2OO·]2+ at -20 °C. The superoxide was characterized by

X-ray crystallography, UV-vis-NIR, Resonance Raman and EPR spectroscopy. With both
the pKa and E1/2 measurements, Meyer and coworkers used eq. 1 to estimate the O–H
BDFE of pz/tacn[Cu2OOH]2+ as 69.4 ± 1.1 kcal/mol.
In line with the complex’s reported O–H BDFE,

pz/tacn

[Cu2OOH]2+ was found to

react with the 2,4,6-tri-tert-butylphenoxyl radical (2,4,6-tri-tert-butylphenol O–H BDFEMeCN
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= 74.8 kcal/mol) to afford pz/tacn[Cu2OO·]2+. The superoxide complex was found, in turn, to
be reactive towards the weaker E-H bonds of TEMPOH (O–H BDFEMeCN = 66.0 kcal/mol)
and phenylhydrazine (N–H BDFEMeCN = 67.3 kcal/mol). The steric profiles of both
pz/tacn

[Cu2OO·]2+ and the HAT reagents were postulated to play a major role in the kinetics

of the HAT reactions. Although the N–H BDFE of phenylhydrazine is higher than the O–H
BDFE of TEMPOH, HAT was found to occur ~6 times faster for phenylhydrazine,
presumably due to its decreased steric profile.
More recently, Karlin and coworkers reported an analogous study on a Cu2(II,II)µ-OOH unit supported by the XYLO ligand framework (XYLO = 2,6-bis(2-{2pyridyl}ethyl)amine)phenolate).114 The complex

XYLO

[Cu2OOH]2+ sits on a thermodynamic

square scheme like Meyer’s system (Figure 4.5) with related, accessible µ-peroxide
(XYLO[Cu2OO]+) and µ-superoxide (XYLO[Cu2OO·]2+) complexes. A full deprotonation of
XYLO

[Cu2OOH]2+ to XYLO[Cu2OO]+ was achieved using the strong base EtP2(dma) (dma =

dimethylamino, EtP2(dma) = (dma)3P=NP(=NC2H5)(dma)2), pKa = 28.1 in THF).
Deprotonation was found to be reversible, as mild acids such as [HDBU][B(C 6F5)4] (pKa =
19.1 in THF) were suitable for reforming

XYLO

[Cu2OOH]2+. An equilibrium mixture was

observed when using the milder base tBuP1(pyrr) (pyrr = pyrrole, tBuP1(pyrr) =
(pyrr)3P=NtBu, pKa = 22.8 in THF). Spectroscopic titration afforded equilibrium mixtures
that allowed for an estimated pKa for XYLO[Cu2OOH]2+ in MeTHF of 24.0 ± 0.6.
The interconversion between XYLO[Cu2OO]+ and XYLO[Cu2OO·]2+ was demonstrated
through a chemical oxidation using dimethylferrocenium or octamethylferrocenium salts
at -125 °C in MeTHF. Both oxygen-containing species were extensively characterized
using UV-vis-NIR, resonance Raman, EPR and extended X-ray absorption fine structure
spectroscopy. Treating

XYLO

[Cu2OO]+ with a milder oxidant, the decamethylferrocenium

(Cp*2Fe+) cation, afforded an equilibrium mixture with the oxidized
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XYLO

[Cu2OO·]2+

product. A UV-vis-NIR spectroscopic titration of Cp*2Fe+ into a solution of

XYLO

[Cu2OO]+

afforded an estimate of E1/2 as -0.525 ± 0.01 V. Together with the pKa, this value was used
in eq. 1 to estimate the O–H BDFE of 80.7 ± 1.5 kcal/mol.
2+

- H+

XYLO[CuIICuII-µ-OOH]2+

N
N

Cu
O
O
H

N

XYLO[CuIICuII-µ-OO]+

N

O
Cu

+ H+

N

+ e-

-H

- e-

+H

N

- H+

XYLO[CuIICuII-µ-OOH•]3+

+ H+

+ e-

- e-

XYLO[CuIICuII-µ-OO•]2+

BDFEMeTHF (O-H): 80.7 kcal/mol

Figure 4.5 Thermodynamic square scheme of Karlin’s hydroperoxide complex.
The reported O–H BDFE is relatively high for a copper-dioxygen-based system.
The HAT chemistry was explored by Karlin and

XYLO

[Cu2OO·]2+ was found to react with a

range of substrates with varying O–H (65.4-82.0 kcal/mol) and C–H (71.1-77.6 kcal/mol)
bond strengths. A substrate of note from this study is p-methoxyphenol (O–H BDFETHF =
82.0 kcal/mol). The formation of XYLO[Cu2OOH]2+ from a substrate with a higher O-H BDFE
than the value for

XYLO

[Cu2OOH]2+ determined by the square scheme analysis described

above lent support to the notion that the true O–H BDFE of XYLO[Cu2OOH]2+ was similar to
or higher than the phenolic O–H BDFE value. The O–H BDFE of
further bracketed, as

[Cu2OOH]2+ was

XYLO

[Cu2OO·]2+ was not found to react with 4-methylphenol (O–H

BDFETHF = 85.3 kcal/mol). The higher reactivity of
pz/tacn

XYLO

XYLO

[Cu2OO·]2+ compared to Meyer’s

[Cu2OO·]2+ was thought to be driven by the higher basicity of the superoxide ligand.

4.1.3 A Cu2(II,II)-µ-O and Related HAT Reactivity
To date, the sole example of an experimentally derived O–H BDFE of a Cu2(I,II)µ-OH unit, like the one proposed to evolve in Cu-ZSM-5 during methane oxidation,
involves the in situ generation of a Cu2(II,II)-µ-oxo species. Kieber-Emmons and
coworkers reported the thermodynamic square scheme shown in Figure 4.6, using the
TMPA (TMPA = tris(2-pyridylmethyl)amine) ligand framework.26 The Cu2(II,II)-µ-OH
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complex

TMPA

[Cu2OH]3+ was found to be a suitable entry point into their thermodynamic

analysis. Using this study, Kieber-Emmons built upon the foundation outlined in Chapter
1 (see sections 1.3 and 1.4) and found the µ-oxo complex

TMPA

[Cu2O]2+ suitable for HAT

chemistry.
2+
TMPA[CuICuII-μ-OH]2+

NN

NN

H
O

N Cu

Cu N

N

+ e-

- H+
+ H+
-H

- e-

+H

N
TMPA[CuIICuII-μ-OH]3+

- H+
+ H+

TMPA[CuICuII-μ-O]+

+ e-

- e-

TMPA[CuIICuII-μ-O]2+

BDFEMeCN (O-H): 74.9 kcal/mol

Figure 4.6 Thermodynamic square scheme of Kieber-Emmons’s oxo complex.
Electrochemical measurements on

TMPA

[Cu2OH]3+ were performed using cyclic

voltammetry at -30 °C. Two notable redox events were observed in the cyclic
voltammogram. A one-electron reversible reduction event at -0.48 V followed by an
irreversible reduction event at -0.70 V. These two features were assigned as the
Cu(II,II)/Cu(I,II) and Cu(I,II)/Cu(I,I) redox couples. Thus, the event at -0.48 V gave a
reasonable estimate of E1/2 for the Bordwell relationship, as the one-electron reduction of
TMPA

[Cu2OH]3+ would afford TMPA[Cu2OH]2+ on the thermodynamic square scheme.
Deprotonation of

[Cu2OH]3+ was achieved using Verkade’s base, 2,8,9-

TMPA

triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (pKa = 33.53 in MeCN) to
afford TMPA[Cu2O]2+. The deprotonation was found to be reversible, as TMPA[Cu2OH]3+ was
formed upon treating
complexes,

TMPA

[Cu2O]2+ with 2,6-lutidinium triflate. Like other Cu2(II,II)-µ-oxo

TMPA

[Cu2O]2+ was EPR silent and displayed an NMR spectrum with

resonances in the typical “diamagnetic” region. Using a milder base, a pKa for
TMPA

[Cu2OH]3+ was determined through spectroscopic titration measurements. In this

case, DBU was found to be a suitable base for producing equilibrium mixtures of
TMPA

[Cu2OH]3+ and

TMPA

[Cu2O]2+. The estimated pKa was reported as 24.3 ± 1.9, and the
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corresponding O–H BDFE of
reactivity of

TMPA

[Cu2OH]2+ was estimated as 74.9 ± 2.3 kcal/mol. The

TMPA

[Cu2O]2+ was evaluated using TEMPOH and 1,4-cyclohexadiene.

TMPA

[Cu2O]2+ reacted slowly with 1,4-CHD (BDFEMeCN = 72.9 kcal/mol) to afford benzene

in 75% yield, while quantitative formation of TEMPO was observed by EPR spectroscopy.
Kieber-Emmons later extended the analysis of

TMPA

[Cu2OH]3+ by directly

measuring the BDFE of the Cu 2(II,II)-µ-OH complex in MeCN (thermodynamic square
scheme depicted in Figure 4.7).115 Electrochemical measurements of in situ generated
TMPA

[Cu2O]2+ revealed an irreversible one-electron oxidation event at 0.76 V (quasi-

reversible on the square wave voltammetry timescale). Assigning this oxidation event to
the formally CuIICuII/CuIICuIII couple, an O–H BDFE of 103.4 ± 2.6 kcal/mol was estimated
for TMPA[Cu2OH]3+ using the previously determined pKa of 24.3 ± 1.9. Attempts at observing
the mixed-valent Cu2(II,III)-µ-oxo
reactions solely afforded

TMPA

[Cu2O]3+ were met with difficulty, as oxidation

TMPA

[Cu2OH]3+, most likely due to

TMPA

[Cu2O]3+ rapidly

abstracting a hydrogen atom from the solvent.
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N Cu
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Figure 4.7 Extension of Kieber-Emmons’s thermodynamics square scheme.
4.2 Synthesis of 3/Ph[Cu2OH]3+
We sought to target the isolation of a discrete Cu 2(II,II)-µ-OH complex that would
provide entry into a thermodynamic square scheme analysis centered on the capacity for
a Cu2(II,II)-µ-O species to perform a hydrogen atom abstraction reaction to form a mixedvalent Cu2(I,II)-µ-OH product. We initially approached the synthesis by applying the
methods outlined Chapter 2. Treatment of a methanolic solution of [ 3/PhPDI2Sr][OTf]2
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(3/Ph[Sr]2+) with 2.0 equiv. CuCl2·2H2O afforded a deep green solution. Upon workup and
crystallization, the green, macrocycle-supported dicopper complex [3/PhPDI2Cu2Cl2][OTf]2
(3/Ph[Cu2Cl2]2+) was isolated in good yield (Figure 4.8). Compared with the analogous
species

3/Me

[Cu2Cl2]2+ (see section 2.2.1), the new phenyl derivative was less soluble in

common organic solvents.

Figure 4.8 Synthesis of 3/Ph[Cu2Cl2]2+ in MeOH.
The crystal structure of 3/Ph[Cu2Cl2]2+ depicts the macrocyclic ligand in an unfolded
conformation (as expected based on the observations in Chapter 2) with two molecules
occupying the asymmetric unit (Figure 4.9). In each case, the copper(II) centers are
bridged by two chloride ligands, one occupying an equatorial position and one occupying
an axial position on each metal. The metals adopt distorted octahedral geometries, with
elongated axial Cu–Cl (avg. 2.973(1) Å) and Cu–O (avg. 2.4308(12) Å) bond lengths due
to strong Jahn-Teller distortions. The average equatorial Cu–Cl distance of 2.1997(12) Å
agrees well that from

3/Me

[Cu2Cl2]2+, as does the Cu-Cl-Cu angle (avg. 77.46(4)°). In line

with other isolated Cu2(II,II) bis(pyridyldiimine) macrocycles, the average Cu–Cu distance
of 3.2920(10) Å falls in the expected range (Table 2.3). The average ∆ parameter of 0.185
Å also agrees with the values reported for the Cu 2(II,II) macrocycles described in Chapter
2, supporting a neutral ligand assignment.
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Figure 4.9 Crystal structure of 3/Ph[Cu2Cl2]2+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, phenyl and triflate disorder and macrocycle disorder omitted for clarity).
In pursuit of a Cu 2(II,II)-µ-OH complex, the removal of the chloride ligands was
attempted to promote metathesis chemistry between the metal centers. The addition of an
excess of TMS-OTf to a green acetonitrile slurry of 3/Ph[Cu2Cl2]2+ affords an insoluble, lightgreen macrocycle-containing material. Single crystals of the product were obtained by
diffusion of Et2O into a saturated MeCN solution. The product was identified as the
Cu2(II,II)-µ-Cl species [3/PhPDI2Cu2Cl][OTf]3 (3/Ph[Cu2Cl]2+) (Figure 4.10). As observed in
Chapter 2, incomplete chloride abstraction occurred, even in the presence of excess TMSOTf.

Figure 4.10 Attempt at halide abstraction from 3/Ph[Cu2Cl2]2+ in MeCN.
The crystal structure of

3/Ph

[Cu2Cl]3+ is almost identical to that of

3/Me

[Cu2Cl]3+,

except for the phenyl substitutions (Figure 4.11). The macrocycle adopts an arched
conformation to accommodate the Cu 2Cl core, which exhibits a Cu–Cu distance of
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3.7205(7) Å, a Cu-Cl-Cu angle of 109.00(3)°, and Cu–Cl distances of 2.2851(5) Å, which
are longer than those observed in the dichloride complex

3/Ph

[Cu2Cl2]2+. A neutral ligand

is assigned based on the ∆ parameter of 0.184 Å.

Figure 4.11 Crystal structure of 3/Ph[Cu2Cl]3+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, solvent molecules, triflate disorder and macrocycle disorder omitted for
clarity).
The desired hydroxide complex [3/PhPDI2Cu2OH][OTf]3 (3/Ph[Cu2OH]3+) was
synthesized using a one-pot procedure by combining 3/Ph[Sr]2+, Cu(OTf)2 and NBu4OH in
stoichiometric ratios (Figure 4.12). The new hydroxide complex was crystallized from DCM
and hexanes, affording dark green crystals that were suitable for crystallographic analysis.
The solid-state structure is similar to that of

3/Ph

[Cu2Cl]3+, with pseudo-C2v symmetry and

the two copper(II) centers residing in distorted octahedral geometries (Figure 4.13). Each
is bound by axially ligated triflate anions (avg. Cu–O distance is 2.452(2) Å), with the PDI
and hydroxide units occupying the equatorial plane positions. Moreover, the Cu–O(H)
distances of 1.9135(14) and 1.9156(14) Å fall within the expected bond distance range for
Cu2(II,II)-µ-OH complexes. The ligand adopts an arched conformation to accommodate
the bent dinuclear core and the Cu–Cu distance of 3.3936(7) Å. The bridging hydroxide
unit is displaced from the Cu–Cu vector, creating a Cu-O(H)-Cu angle of 124.80(8)°. The
∆ parameter of 0.181 Å supports a neutral ligand. Identification of the bridging hydroxide
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unit as such was further supported by the observation of a low intensity, sharp stretch at
3662 cm-1 in the IR spectrum for this material. This features results from the O–H
stretching mode and falls in the correct range for Cu2(II,II)-µ-OH complexes.

Figure 4.12 One-pot synthesis of 3/Ph[Cu2OH]3+ in DCM.

Figure 4.13 Crystal structure of 3/Ph[Cu2OH]3+(thermal ellipsoids set at 50% probability;
hydrogen atoms, solvent molecules, and macrocycle disorder omitted for clarity).
The

1

H NMR spectrum of

3/Ph

[Cu2OH]3+ displays broadened and shifted

resonances that likely result from the paramagnetic character of the Cu2(II,II) species (see
section 4.9.3). A shifted, broad resonance was observed as far downfield as 50.63 ppm.
The UV-vis-NIR spectrum displayed an absorption profile commonly associated with
Cu2(II,II) bis(pyridyldiimine) complexes. A low intensity absorption band was observed at
759 nm and assigned as a d→d transition, based on its energy and intensity profiles. For
similar reasons, an intense feature at 316 nm is assigned as an OH→Cu(II) LMCT
transition. An intense feature were also observed at 203 nm and likely results from ligandbased π→π* transitions, based on previous studies.
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4.3 Reduction of n/Ph[Cu2OH]3+ Complexes
4.3.1 Cyclic Voltammetry Studies
A thermodynamic square scheme centered on the capacity of a bis(pyridyldiimine)supported Cu2(II,II)-µ-O species to form a mixed-valent Cu2(I,II)-µ-OH product requires
determination of both the pKa of

3/Ph

[Cu2OH]3+ and the potential of the

3/Ph

[Cu2OH]3+/2+

redox couple. Cyclic voltammetry was carried out in MeCN; scanning cathodically
revealed two irreversible reduction events (Figure 4.14, see section 4.8.5 for more details).
The first peak (Ep,c1), at -0.510 V vs. Fc/Fc+, was assigned as the reduction of Cu2(II,II) to
Cu2(I,II) and the second (Ep,c2), at -0.845 V vs. Fc/Fc+, as the reduction of Cu2(I,II) to
Cu2(I,I). These assignments agree with Kieber-Emmons’ related

TMPA

[Cu2OH]3+ complex

(reversible Cu2(II,II)/Cu2(I,II) = -0.48 V and irreversible Cu2(I,II)/Cu2(I,I) = -0.70 V).

Figure 4.14 Cyclic voltammogram of 3/Ph[Cu2OH]3+ (initial Scan, 1000 mV/s scan rate).
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In terms of the thermodynamic square scheme and Bordwell relationship, more
positive values of E0 would lead to larger O–H BDFEs for the mixed-valent Cu2(I,II)-µ-OH
complex 3/Ph[Cu2OH]2+, provided the pKa remains the same. A useful approximation of E0
is E1/2 (half-wave potential) under nonstandard conditions. However, the irreversibility of
the first reduction event prevents an adequate estimate of E1/2 for the Cu2(II,II)/Cu2(I,II)
couple. Rather, we can use Ep,c1 as a lower bound for E1/2, meaning the BDFE derived
from this square scheme analysis would represent an underestimate of the actual BDFE.
The uncertainty of using irreversible redox features in the determination of BDFEs has
been previously highlighted by Bordwell and coworkers and has led to an estimated ~0.6
kcal/mol uncertainty in experimentally derived BDFEs when using Ep,c/Ep,a in place of E0
in eq. 1.116
4.3.2 Chemical Reduction Studies
To identify the one-electron reduced product associated with the first reduction
event, the chemical reduction of

3/Ph

[Cu2OH]3+ was carried out with Cp *2Fe, resulting in a

dark yellow solution at -45 °C that turned deep red in color on warming. Upon
crystallization of the dark red product, the monocopper(I) complex [3/PhPDI2Cu][OTf]
(3/Ph[Cu]+) was identified by X-ray crystallography (Figures 4.15 and 4.16). The solid-state
structure depicts a unique example of a copper(I) PDI complex. The macrocyclic ligand
twists in an uncharacteristic conformation to bind the Cu(I) center. Each PDI unit binds κ2
to the metal center, with one unbound imino moiety on each pyridyl unit pointed away from
the macrocyclic cavity. Because of the macrocyclic twisting, the Cu(I) center adopts a seesaw geometry (τ4 = 0.64)117 with an observed average Cu(I)–N bond length of 2.0438 Å.
The Cu(I) oxidation state is supported by the presence of one outersphere triflate anion
and a neutral ligand (∆ = 0.185 Å). Gilberton’s copper(I) PDI complexes are the only
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reported examples of PDI stabilizing a Cu(I) center; however, the geometries of these
complexes are quite different than observed for 3/Ph[Cu]+ (four-coordinate distorted square
planar and five-coordinate square pyramidal).51

Figure 4.15 Chemical reduction of
3/Ph
[Cu2OH]2+.

3/Ph

[Cu2OH]3+ in MeCN with proposed intermediate

Figure 4.16 Crystal structure of 3/Ph[Cu]+ (thermal ellipsoids set at 50% probability;
hydrogen atoms and triflate anion omitted for clarity).
Given the formation of a Cu(I) complex from this reduction reaction, along with the
color change observed at low temperature, we hypothesized that an initial reduction to a
Cu2(I,II)-µ-OH complex was occurring prior to irreversible loss of a [Cu(II)OH] unit to an
unidentified byproduct. Analogous reactivity with

3/Ph

room temperature, the one-electron reduction of

3/Ph

dark red

3/Ph

[Cu2Cl]2+ was initially observed. At
[Cu2Cl]2+ with Cp*2Fe afforded the

[Cu]+. Yet, in the presence of PPh 3, the orange macrocyclic complex
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[3/PhPDI2Cu2Cl2(PPh3)][OTf] (3/Ph[Cu2Cl2]+) was isolated and demonstrates a mixed-valent
Cu2(I,II) core is accessible (Figure 4.17). Attempts at purifying the mixed-valent Cu2(I,II)di(µ-Cl) species were met with unsatisfactory combustion analysis results and purification
remains an ongoing pursuit. However, single crystals were grown that informed on the
geometry of the dinuclear complex.

Figure 4.17 Synthesis of 3/Ph[Cu2Cl2]+ in MeCN.
The structure of

3/Ph

[Cu2Cl2]+ was elucidated using X-ray crystallography (Figure

4.18). A unique macrocyclic conformation was observed, in which the macrocycle twists
to accommodate the mixed-valent Cu2(I,II) core. The metal-based reduction was
supported by the neutral macrocyclic ligand (∆ = 0.184 Å). The Cu(I) center sits above the
macrocyclic pocket, capped by the PPh3 ligand (Cu(I)–P = 2.1940(7) Å), in a distorted
trigonal pyramidal geometry (τ4 = 0.75). To accommodate the Cu(I) geometry, one of the
imino moieties bends away from the macrocyclic pocket and remains uncoordinated. The
other imino group and pyridyl nitrogen bind to the Cu(I) center along with a µ-Cl ligand to
compose the base of the trigonal pyramid (Cu(I)–Cl = 2.23415(8) Å). The Cu(II) center
adopts a distorted square pyramidal geometry (τ4 = 0.09), with an elongated axial Cu(II)–
Cl bond of 2.4410(7) Å. The equatorial Cu(II)–Cl bond (2.239(1) Å) is the shortest of the
Cu–Cl bonds. The twisting of the ligand enforces a long Cu(I)–Cu(II) distance of 4.1103(5)
Å (the longest observed Cu–Cu distance of any macrocyclic complex presented in Chapter
2 and Chapter 4). Upon reduction of

3/Ph

[Cu2Cl]2+, the di(µ-Cl) interactions are disrupted.

The Cu(I)-Cl-Cu(II) angle increases to 118.50(3) (from 77.46(4) observed for
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3/Ph

[Cu2Cl2]2+). One chloride bridges the two metal centers instead of two, as the Cu(I) sits

4.4122(8) Å away from the second chloride ligand bound to the Cu(II) site.

Figure 4.18 Crystal structure of 3/Ph[Cu2Cl2]+ (thermal ellipsoids set at 50% probability;
hydrogen atoms, solvent molecules and triflate anion omitted for clarity).
Despite successful trapping of
dimethylphenyl isocyanide) with

3/Ph

[Cu2Cl2]+, similar attempts (using PPh 3 or 2,6-

3/Ph

[Cu2OH]3+ afforded

3/Ph

[Cu]+. Low-temperature UV-

vis-NIR spectroscopic studies were employed to provide a more quantitative analysis of
the reaction progress (see section 4.8.6). At -65 °C, the UV-vis-NIR spectrum of
3/Ph

[Cu2OH]3+ in isobutyronitrile (IBN) showed a broad d-d absorption band at 759 nm

(Figure 4.17). Treating

3/Ph

[Cu2OH]3+ with Cp*2Fe afforded a new spectral feature at 445

nm. Warming the reaction mixture to room temperature led to the growth of a new peak at
503 nm, with concomitant loss of the peak at 445 nm. An isosbestic point was not observed
during this decomposition, suggesting a complicated pathway with intermediate
complexes involved. The thermal decomposition product was identified independently as
3/Ph

[Cu]+, and remained even when heated to higher temperatures (95 °C) or when re-

cooled to -65 °C.
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Figure 4.19 Spectral traces of identified intermediates in the one-electron reduction of
3/Ph
[Cu2OH]3+ (3/Ph[Cu2OH]3+ at -65 °C, 2/Ph[Cu2OH]2+ at -65 °C and 3/Ph[Cu]+ at 95 °C; 0.1
mM; small peak at 776 nm corresponds to [Cp*2Fe][OTf]).
The low-temperature stable 445 nm feature associated with the one-electron
reduction of

3/Ph

[Cu2OH]3+ is assigned to the mixed-valent Cu2(I,II)-µ-OH complex

3/Ph

[Cu2OH]2+ (Figure 4.19). Monitoring the absorbance of the spectral feature at 445 nm

through the titration of 3/Ph[Cu2OH]3+ with Cp*2Fe at -65 °C yielded the plot shown in Figure
4.20. The exponential curve supports an equilibrium reduction reaction of

3/Ph

[Cu2OH]3+

with Cp*Fe2. Based on the titration data, we expected the stronger reductant Cp2Co118 to
allow for the full formation of 3/Ph[Cu2OH]2+. Surprisingly, the addition of an equiv. of Cp 2Co
to 3/Ph[Cu2OH]3+ led to a mixture of the one- and two-electron reduced species (see section
4.8.6).
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Figure 4.20 Titration of 3/Ph[Cu2OH]3+ with increasing quantities of Cp*2Fe at -30 °C.
4.4 Determination of the pKa the Hydroxide Unit
In accordance with the Bordwell relationship, both E0 and a pKa are necessary
components for estimating an O–H BDFE. To first demonstrate deprotonation of
3/Ph

[Cu2OH]3+ in MeCN, DBU (pKa = 24.31 in MeCN)119 was used. Treatment of

3/Ph

[Cu2OH]3+ with DBU at room temperature afforded a deep red solution. The formation

of the conjugate acid [H-DBU][OTf] was observed by the 1H NMR spectroscopy (see
section 4.8.7). Full consumption of 3/Ph[Cu2OH]3+ was also noted by the disappearance of
the paramagnetically-shifted signal at 50.63 ppm. Intriguingly, the isolated macrocyclic
product from the deprotonation reaction was

3/Ph

[Cu]+, the same product obtained from

the one-electron reduction of 3/Ph[Cu2OH]3+.
The similar product of both reduction and deprotonation suggested that the
deprotonated species may be reacting to form
3/Ph

3/Ph

[Cu2OH]2+ and then decomposing to

[Cu]+. To avoid this possibility, we turned to studying the deprotonation event using
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variable temperature 1H NMR spectroscopy (see section 4.8.7). The deprotonation of
3/Ph

[Cu2OH]3+ with DBU was carried out at -25 °C. Significant broadening of all resonances

was observed. Of note, the paramagnetically shifted

3/Ph

[Cu2OH]3+ resonances were still

present, suggesting an equilibrium reaction with DBU. Treating the reaction mixture with
2,6-lutidinium triflate re-formed 3/Ph[Cu2OH]3+, demonstrating reversible protonation of the
deprotonated species.
Further analysis of the deprotonation reaction was carried out using low
temperature UV-vis-NIR spectroscopy. To avoid an equilibrium mixture and ensure
complete deprotonation, DBU was replaced with the strong Verkade base 2,8,9triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (VerkadeiPr, pKa = 33.63 in
MeCN).120 Deprotonation of 3/Ph[Cu2OH]3+ at -65 °C afforded minor changes to the UV-visNIR spectrum (Figure 4.21). An isosbestic point was observed at 352 nm, indicating a 1:1
transformation without the buildup of an intermediate species. As the sample was warmed
to room temperature, the growth of the characteristic 503 nm feature for 3/Ph[Cu]+ occurred,
in line with the room temperature NMR spectroscopic observations. Together, these data
indicate that at low temperature, the deprotonation of

3/Ph

[Cu2OH]3+ occurs to form the

Cu2(II,II)-µ-O species 3/Ph[Cu2O]2+, which thermally decomposes to give the same product
as that observed on chemical reduction of 3/Ph[Cu2OH]3+.
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Figure 4.21 Deprotonation of 3/Ph[Cu2OH]3+ with VerkadeiPr at -65 °C (0.1 mM).
Due to the temperature instability of the deprotonated product, the pKa of
3/Ph

[Cu2OH]3+ was obtained using low temperature 1H NMR spectroscopy (see section

4.8.7). The base, 1,8-bis(tetramethylguanidino)naphthalene (pKa = 24.92 in MeCN) was
found to afford an equilibrium mixture with

3/Ph

[Cu2OH]3+ at -30 °C in CD3CN. The bulky,

substituted proton sponge has previously been identified as a suitable base for pKa
determination due to slow proton exchange on the NMR timescale. Titration of 1,8bis(tetramethylguanidino)naphthalene into a CD3CN solution of

3/Ph

[Cu2OH]3+ at -30 °C

allowed for the determination of a pKa of 24.4 ± 0.4.
4.5 Hydrogen Atom Transfer Reactivity
The thermodynamic quantities determined in the previous sections are those
needed for determining the O–H BDFE of

3/Ph

[Cu2OH]2+. Use of the pKa value of 24.4 ±

0.4 for 3/Ph[Cu2OH]3+, along with the lower-bound of its redox potential Ep,c1 = -0.510 V, in
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eq. 1 allowed us to estimate the BDFE for the O–H bond in 3/Ph[Cu2OH]2+ as equal to 74.3
± 1.4 kcal/mol. Given the inherent uncertainty associated with this value, we next sought
to assess the HAT chemistry of 3/Ph[Cu2O]2+ both to bracket the BDFE of the O–H bond in
3/Ph

[Cu2OH]2+ and to gain support for the BDFE value that was estimated by the square

scheme analysis.
Full deprotonation of

3/Ph

[Cu2OH]3+ to

3/Ph

[Cu2O]2+ was carried out using an

equivalent of VerkadeiPr and monitored by UV-vis-NIR spectroscopy. An initial reactivity
study was conducted using an equivalent of 9-cyanoxanthene as a hydrogen atom donor.
This substrate was chosen for its weak C–H bond (C–H BDFEDMSO = 63.7 kcal/mol).121
The addition of 9-cyanoxanthene to the solution of

3/Ph

[Cu2O]2+ at -65 °C led to a sharp

change in the mixture’s UV-vis-NIR spectrum, as two new features were observed to grow
in at 455 nm and 632 nm over 15 minutes; isosbestic points were observed at 380 and
765 nm (Figure 4.22). The peak at 455 nm overlays well with the spectrum of 3/Ph[Cu2OH]2+
generated in the low temperature, one-electron reduction reaction (see section 4.8.7),
indicating that the hydrogen atom transfer reaction was successful.
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Figure 4.22 Time course of 3/Ph[Cu2O]2+ + 9-cyanoxanthene at -65 °C (15 x 1 min. scans;
0.1 mM; bolded traces represent start and finish).
In line with the estimated BDFE value, 3/Ph[Cu2O]2+ was also observed to react with
phenylhydrazine (N–H BDFEDMSO = 67.3 kcal/mol) to afford the same HAT product
(3/Ph[Cu2OH]2+) as in the reaction with 9-cyanoxanthene, based on the appearance of a
spectral feature at 455 nm (Figure 4.68). However, stronger E–H bonds that would be
expected to react with

3/Ph

[Cu2O]2+ were found to be unreactive. Xanthene (C–H

BDFEDMSO = 70.2 kcal/mol), DHA (C–H BDFEDMSO = 72.9 kcal/mol) and 1,4cyclohexadiene (C–H BDFEMeCN = 72.9 kcal/mol) afforded no changes to the UV-vis-NIR
profile of the system, even when introduced in large excess and upon warming (aside from
background decomposition). While thermodynamically accessible, the lack of reactivity
suggests either the substrates are kinetically inaccessible for HAT or that the O–H BDFE
for 3/Ph[Cu2OH]2+ is overestimated.
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To further bracket the O–H BDFE of
hydrogen atom from

3/Ph

[Cu2OH]2+, we sought to abstract a

3/Ph

[Cu2OH]2+ by treatment with a hydrogen atom acceptor. As

expected, no reaction was observed upon treatment of

3/Ph

[Cu2OH]2+ with TEMPO

(TEMPOH, O–H BDFEMeCN = 66.5 kcal/mol) at low temperature. Based on the reactivity
of 3/Ph[Cu2O]2+ with phenylhydrazine, the O–H bond formed is stronger than 67.3 kcal/mol
and thus TEMPO is not capable of abstracting a hydrogen atom from

3/Ph

[Cu2OH]2+. The

stronger hydrogen atom abstracting agent, 2,4,6-tri-tert-butylphenoxyl radical (2,4,6t

Bu3PhOH, O-H BDFEMeCN = 74.8 kcal/mol), however, was found to react with

3/Ph

[Cu2OH]2+, leading to the loss of the feature at 445 nm and loss of a sharp feature at

405 nm that are associated with the phenol product. The observed reactivity supports the
notion that the O–H BDFE of

3/Ph

[Cu2OH]2+ is less than 74.8 kcal/mol. Thus, the

experimental O–H BDFE of 3/Ph[Cu2OH]2+ falls between 67.3 – 70.2 kcal/mol based upon
the reactivity observed with HAT reagents.
4.6 Preliminary Investigation into 2/Ph[Cu2OH]3+
Enhancement of the HAT reactivity was desirable due to the limited bond activation
demonstrated by the 3/Ph[Cu2O]2+ system. A folded macrocyclic ligand may provide both a
more oxidizing and basic Cu 2(II,II)-µ-oxo moiety for the activation of stronger bonds.
Through ligand folding, the orbital overlap between the copper centers and ligand is
expected to decrease causing a lowering of the dx2-y2 manifold (LUMO). The Cu2(II,II)-µoxo complex would thus be easier to reduce. Moreover, as the ligand folds, the oxygen
will be displaced from the Cu–Cu vector, enhancing the basicity of oxo unit. Typically,
strong bases are poor oxidants and strong oxidants are poor bases. However, ligand
folding may effectively break this scaling relationship, allowing for hydrogen atom
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abstraction from strong E–H bonds. Thus, we next targeted the synthesis of the smaller
Cu2(II,II)-µ-OH variant 2/Ph[Cu2OH]2+.
The synthesis of [2/PhPDI2Cu2OH][OTf]3 (2/Ph[Cu2OH]3+) was carried out in an
analogous fashion to 3/Ph[Cu2OH]3+. A one-pot reaction was carried out in which a mixture
of [2/PhPDI2Ca][OTf]2 (2/Ph[Ca]2+) and 2.0 equiv. Cu(OTf)2 were treated slowly with NBu4OH.
The desired product was afforded as large blue-green blocks following crystallization
(Figure 4.23). Like

3/Ph

[Cu2OH]3+,

2/Ph

[Cu2OH]3+ displayed a low intensity, sharp O–H

stretching frequency in the IR spectrum (3679 cm -1). The complex displayed broadened,
shifted resonances in the 1H NMR spectrum, most likely due to the paramagnetic nature
of 2/Ph[Cu2OH]3+.

Figure 4.23 Synthesis of 2/Ph[Cu2OH]3+ in DCM/MeCN.
The crystal structure of

2/Ph

[Cu2OH]3+ depicts the macrocyclic ligand in a folded

conformation (Figure 4.24). The copper(II) centers each adopt a distorted octahedral
geometry, with all three triflate anions bound in axial positions by the dinuclear core (JahnTeller distortions are evidenced by the elongated Cu–O bonds; avg. Cu–O distance is
2.495(3) Å). The equatorial plane of each copper(II) center consists of a PDI unit and a
hydroxide ligand. The hydroxide bridges the two copper(II) centers with Cu–O(H)
distances of 1.898(2) and 1.884(2) Å; these distances are slightly shorter than the
distances observed for 3/Ph[Cu2OH]3+ but agree well with the literature. The short ethylene
linker accompanied by the folding of the macrocyclic ligand enforces a Cu–Cu distance of
2.8910(5) Å, which is ~0.5 Å shorter than the Cu–Cu distance in 3/Ph[Cu2OH]3+. The close
copper(II) centers, in turn, force the hydroxide further away from the Cu–Cu vector than in
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3/Ph

[Cu2OH]3+, leading to a Cu-O(H)-Cu angle of 99.72(10)°. The angle is 25° smaller than

that observed for

3/Ph

[Cu2OH]3+. The ∆ parameter of 0.192 Å lends support for a neutral

bis(pyridyldiimine) macrocyclic ligand.

Figure 4.24 Crystal structure of 2/Ph[Cu2OH]3+ (thermal ellipsoids set at 50% probability;
hydrogen atoms and solvent molecules omitted for clarity).
Following the methodology used in analyzing the thermodynamic square scheme
for

3/Ph

[Cu2OH]3+, analysis of

4.25). As observed for

2/Ph

[Cu2OH]3+ began with electrochemical studies (Figure

3/Ph

[Cu2OH]3+, two irreversible reduction events appeared in the

cyclic voltammogram of 2/Ph[Cu2OH]3+. The two features were shifted anodically (-0.377 V
and -0.595 V vs. Fc/Fc+) from those observed for the larger macrocycle variant (-0.510 V
and -0.845 V vs. Fc/Fc+). Continuous cathodic scans showed loss of intensity and
coalescence of the two features (analogous to 3/Ph[Cu2OH]3+). Due to the similar behavior,
the two cathodic features are assigned as the reduction of a Cu IICuII core to CuICuII (Ep,c1’
= -0.375 V) and a CuICuII core to CuICuI (Ep,c2’ = -0.595 V). Thus, the first irreversible
reduction feature at -0.377 V is, again, a lower-bound approximation of E1/2 on the
thermodynamic square scheme.
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Figure 4.25 Cyclic voltammogram of 3/Ph[Cu2OH]3+ (initial Scan, 1000 mv/s scan rate).
The deprotonation of 2/Ph[Cu2OH]3+ was next explored using low-temperature UVvis-NIR spectroscopy. Full deprotonation of

2/Ph

[Cu2OH]3+ with an equiv. of Verkade iPr in

IBN at -30 °C led to minor changes in the UV-vis-NIR spectrum. As the solution sat for 90
minutes, a new feature slowly grew in at 479 nm, indicating the deprotonated species was
unstable at this temperature (see section 4.8.7). Performing the deprotonation at -65 °C
addressed this issue, as no decomposition was noted (Figure 4.26). Based on the similar
spectral changes as observed for

3/Ph

[Cu2OH]3+ at -65 °C, the deprotonated species is

assigned to the Cu2(II,II)-µ-oxo species 2/Ph[Cu2O]2+.
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Figure 4.26 Time course of 2/Ph[Cu2OH]3+ + VerkadeiPr at -65 °C (30 x 1 min. scans; 0.1
mM; bolded traces represent start and finish).
The determination of the pKa of
method employed for

2/Ph

[Cu2OH]3+ was carried out using the titration

3/Ph

[Cu2OH]3+ at -30 °C in CD3CN. Although

decomposes at this temperature, an estimate of the pKa of

2/Ph

[Cu2O]2+ slowly

2/Ph

[Cu2OH]3+ was obtained

successfully using 1,8-bis(tetramethylguanidino)naphthalene. The pKa of 25.6 ± 0.5 is an
order of magnitude more basic than for the larger macrocycle variant (24.4 ± 0.4). The
increased basicity of

2/Ph

[Cu2O]2+ compared with 3/Ph[Cu2O]2+ may arise from macrocycle

conformation differences (vide supra).
Together, the estimated pKa of

2/Ph

[Cu2OH]3+ and its irreversible redox couple -

0.377 V were used in eq. 1 to estimate the O–H BDFE of the mixed valent Cu2(I,II)-µ-OH
complex

2/Ph

[Cu2OH]2+. The O–H BDFE of 79.0 ± 1.5 kcal/mol is ~5 kcal/mol higher than

observed for the 3/Ph[Cu2OH]2+ (74.3 ± 1.4 kcal/mol). The anodic shift of the redox potential
accompanied with an increase in basicity of the µ-oxo moiety are thought to arise from an
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increase in the extent of folding of the macrocycle ligand. The positive shift in both
thermodynamic quantities demonstrates a breaking of the scaling relationship between
oxidizing strength and basicity. Like the estimated O–H BDFE of 3/Ph[Cu2OH]2+, the O–H
BDFE of

2/Ph

[Cu2OH2+ has an inherent uncertainty associated with the irreversible redox

process.
To probe if the

2/Ph

[Cu2O]2+ system is more reactive, we next explored the

hydrogen atom transfer reactivity of the system. At -30 °C,

2/Ph

[Cu2O]2+ was found to

quickly react with 9-cyanoxanthene over 15 minutes to afford a new spectral feature at
476 nm (Figure 4.27). An isosbestic point at 715 nm was observed during this
transformation, indicating a 1:1 transformation. Through an independent redox titration of
2/Ph

[Cu2OH]3+ with Cp*2Fe, we assign the feature at 476 nm to the mixed-valent

2/Ph

[Cu2OH]2+ (see section 4.8.6). This assignment supports a hydrogen atom transfer

reaction between 2/Ph[Cu2O]2+ and 9-cyanoxanthene.
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Figure 4.27 Time course of 2/Ph[Cu2O]2+ + 9-cyanoxanthene at -30 °C (15 x 1 min. scans;
0.1 mM; bolded traces represent start and finish).
Substrates with stronger C–H bonds, xanthene and DHA, were next assessed.
While DHA was found unreactive,

2/Ph

[Cu2O]2+ was found to react slowly with xanthene

over 15 minutes to afford the spectral feature at 476 nm. This reactivity contrasts with the
larger macrocyclic complex
reactivity of

3/Ph

[Cu2O]2+, which did not react with xanthene. The HAT

2/Ph

[Cu2O]2+ suggests a stronger O–H bond is forming and the O–H BDFE of

2/Ph

[Cu2OH]2+ is higher than 3/Ph[Cu2OH]3+. Further investigations with other HAT reagents

are necessary to effectively bracket the O–H BDFE of 2/Ph[Cu2OH]2+ and define the origin
of the enhanced reactivity.
4.7 Summary
A new Cu2(II,II)-µ-OH complex

3/Ph

[Cu2OH]3+ was synthesized and studied using

the thermodynamic square scheme approach. Estimates for E1/2 (more positive than -
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0.510 V) and pKa (24.1 ± 0.4) were obtained through cyclic voltammetry and low
temperature 1H NMR spectroscopic titrations, respectively, and used to estimate an O–H
BDFE = 74.3 ± 1.4 kcal/mol for the mixed-valent hydroxide complex 3/Ph[Cu2OH]2+.
A rare example of Cu2(II,II)-µ-O species,

3/Ph

[Cu2O]2+, was generated by

deprotonation of 3/Ph[Cu2OH]3+ and found to be suitable for HAT from substrates with weak
E–H bonds (9-cyanoxanthene, phenylhydrazine) to generate

3/Ph

[Cu2OH]2+. The O–H

BDFE was bracketed to fall within the lower bound of 67.3 kcal/mol and upper bound of
70.2 kcal/mol. The current system offers a new addition to the limited number of copperoxygen-based complexes with measurable O–H BDFEs.
Additionally, the methods used for analysis of

3/Ph

[Cu2OH]3+ were applied to the

smaller macrocycle variant 2/Ph[Cu2OH]3+. The estimates for E1/2 (more positive than -0.377
V) and pKa (25.6 ± 0.5) were used to estimate the O–H BDFE = 79.0 ± 1.5 kcal/mol for the
mixed-valent hydroxide complex

2/Ph

[Cu2OH]2+. The increase in redox potential and pKa

suggest that a ligand conformation change may aid in increasing the oxidizing strength
and basicity of the corresponding µ-oxo complex

2/Ph

[Cu2O]2+. Enhanced reactivity of

2/Ph

[Cu2O]2+ towards C–H bonds was demonstrated through a hydrogen atom transfer

reaction with xanthene. Ongoing studies are aimed defining the origin of reactivity
enhancement of 2/Ph[Cu2O]2+ in comparison to 3/Ph[Cu2O]2+.
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4.8 Experimental
4.8.1 General Considerations
Unless stated otherwise, all reactions were carried out under an inert atmosphere
of N2 using standard Schlenk techniques and worked up in air. Glassware, stir bars, filter
aid (Celite) and 4 Å molecular sieves, were dried in an oven at 175 °C for at least one hour
prior to use when applicable. Benchtop solvents (Pentane, Hexanes, Et2O, THF and DCM,
MeCN and MeOH) were purchased from Fisher Chemicals and used directly. Degassed
anhydrous solvents (THF, DCM, IBN and MeCN) were dried by passage through activated
alumina using a Solvent Purification System and stored over 4 Å molecule sieves for at
least one day before use. Acetonitrile-d3 was purchased from Cambridge Isotopes
Laboratories and was dried over CaH2, degassed by three freeze-pump-thaw cycles, and
stored over 4 Å molecular sieves under N2 for at least one day prior to use. DBU was dried
over CaH2 and vacuum distilled prior to use. Tetrabutylammonium hydroxide (1.0 M in
MeOH) was purchased from MilliporeSigma in a Sure/SealTM bottle. Tetrabutylammonium
hydroxide (40 wt. % in H2O) was purchased from TCI Chemicals. Decamethylferrocene
and Cu(OTf)2 were purchased from Strem Chemicals and were stored in the glovebox at
room temperature. 1,8-bis(tetramethylguanidino)naphthalene was purchased from Santa
Cruz Biotech, dried under vacuum, and stored in the glovebox at room temperature. 2,8,9Triisopropyl-2,5,8,9-tetraaza-1-phosphabicyclo[3,3,3]undecane

was purchased

from

Millipore Sigma and stored in the glovebox at -35 °C. All other chemicals were purchased
from typical commercial vendors and used directly as received.
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NMR Spectroscopy: 1H NMR spectra were recorded on either a Bruker DMX 500 or a
Bruker DRX 500 spectrometer. All chemical shifts are reported in units of ppm, with
reference to the residual proteo-solvent resonance proton chemical shifts.

Elemental Analysis: Analytical data were obtained from the CENTC Elemental Analysis
Facility at the University of Rochester. Microanalysis samples were weighed with a
PerkinElmer Model AD6000 Autobalance and their compositions were determined with a
PerkinElmer 2400 Series II Analyzer. Air-sensitive samples were handled in a VAC
Atmospheres glovebox and combusted in a tin capsule that was crimp-sealed with a die
apparatus.

Infrared Spectroscopy: Infrared spectra were recorded using a PerkinElmer Spectrum
Two FT-IR spectrometer. Samples were placed on an ATR crystal after collecting a blank
spectrum and spectral data were measured over the range of 450-4000 cm-1.

UV-vis-NIR Spectroscopy: Absorption spectra were collected over the range of 200-1000
nm using an Agilent Cary 60 UV-vis-NIR spectrophotometer. Each air/moisture-free
measurement was obtained using a 10 mm path-length quartz cuvette with screw cap.
Variable temperature experiments were conducted using an Unisoku USP-203A cryostat
to maintain the desired temperature. Absorption profiles of interest were collected in the
linear response range of the instrument (< 1.0 absorbance units). All

n/Ph

[Cu2OH]3+ (n =

2,3) stock solutions were prepared in isobutyronitrile (1.5-1.9 mM). Samples were then
diluted to 0.1 mM for absorption measurements.
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Cyclic Voltammetry: Cyclic voltammetry measurements were obtained with a CH
Instruments 620D potentiostat using a 3 mm glassy carbon working electrode, a platinum
wire auxilliary electrode, and a Ag wire quasi-reference electrode. CV measurements were
taken with a 0.005 V sample interval. All electrochemical measurements were taken in
MeCN

using

n-propylammonium

tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

([nPr4N][BArF4] electrolyte (100 mM). The concentration of the analyte was ca. 2 mM in all
cases. All potentials were referenced to the Fc/Fc + couple, measured by adding a known
amount of ferrocene to the solution.

X-ray Crystallography: X-ray intensity data for

3/Ph

[Cu2Cl2]2+,

3/Ph

[Cu2Cl]3+,

3/Ph

[Cu2Cl]2+

and 2/Ph[Cu2OH]3+ were collected on a Rigaku XtaLab Synergy-S diffractometer equipped
with

an

HPC

area

detector

(HyPix-6000He)

employing

confocal

multilayer-

monochromated Mo-Kα radiation (λ = 0.71073 Å) ( 2/Ph[Cu2OH]3+) or Cu-Kα radiation
(λ=1.54184 Å) (3/Ph[Cu2Cl2]2+, 3/Ph[Cu2Cl]3+ and
intensity data for

3/Ph

[Cu2OH]3+ and

3/Ph

3/Ph

[Cu2Cl]2+) at a temperature of 100 K. X-ray

[Cu]+ were collected on a Rigaku XtaLab Synergy-S

diffractometer equipped with an HPC area detector (Dectris Pilatus3 R 200K) employing confocal
multilayer optic-monochromated Mo-Kα radiation (λ = 0.71073 Å) at a temperature of 100 K.

Rotation frames were integrated using CrysAlisPro, producing a listing of unaveraged F 2
and σ(F2) values. The intensity data were corrected for Lorentz and polarization effects
and for absorption using SCALE3 ABSPACK. The structures were solved by direct or dual
(3/Ph[Cu2Cl2]2+) methods using SHELXT and refined by full-matrix least-squares, based on
F2 using SHELXL-2018. All reflections were used during refinement. Non-hydrogen atoms
were refined anisotropically and hydrogen atoms were refined using a riding model. For
3/Ph

[Cu2Cl2]2+, there are two crystallographically independent molecules, each of which lies

on a crystallographic center-of-symmetry (at ½, ½, ½ and 0, ½, 0). For
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3/Ph

[Cu2Cl]3+, the

complex lies on a crystallographic mirror plane (at x, ¼, z); the mirror passes through
Cl(1), C(9), C(11), S(4), O(4) and F(4) of the bidentate triflate ligand. For

3/Ph

[Cu2OH]3+,

the C(18)-C(19)-C(20)-N(1) moiety is disordered by twisting of the chain in a 58/42
proportion. For 3/Ph[Cu]+, the Cu(I) ion lies on a crystallographic 2-fold axis (at ½, y, ¼).

4.8.2 Synthetic Procedures

3/Ph

[Cu2Cl2]2+. A 500 mL round-bottom flask was charged with

3Ph

[Sr]2+ (1.5428 g, 1.2978

mmol, 1.00 equiv.) and MeOH (500 mL). The flask was equipped with an addition funnel
and cooled to -78 °C. The yellow-orange solution was treated dropwise with a solution of
CuCl2·2H2O (443.0 mg, 2.599 mmol, 2.00 equiv.) in MeOH (50 mL). An additional 50 mL
of MeOH were used to rinse the funnel to ensure quantitative transfer of the starting
material. The reaction flask was removed from the cold bath, and the solution was stirred
for an additional hour while warming to room temperature. Over time, a color change to
dark green was observed. Solvent was removed under vacuum to afford a green solid.
The product was extracted in ca. 80-90 mL MeCN and filtered through a pad of Celite to
remove the SrCl2 byproduct. The pad was rinsed until no color remained. The dark green
filtrate was then layered with 350 mL Et2O at room temperature. Mixing of the layers over
3 days afforded green, crystalline, solid. The product was collected, rinsed with 2 x 100
mL Et2O, and dried under vacuum. The product was collected as a green powder (1.2821,
76%). Single crystals suitable for X-ray crystallography were grown by vapor diffusion of
Et2O into a concentrated MeCN solution.
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3/Ph

[Cu2Cl]3+. To a 100 mL Schlenk tube,

3/Ph

[Cu2Cl2]2+ (350.1 mg, 0.2695 mmol, 1.00

equiv.) and MeCN (10 mL) were added. The dark green solution was cooled to 0 °C and
treated slowly with a solution of TMS-OTf (0.050 mL, 0.277 mmol, 1.03 equiv.) in MeCN
(10 mL). The solution was removed from the cold bath and stirred for 30 minutes while
warming to room temperature. During this time, the solution became lighter. Solvent was
then removed under vacuum to afford a light green powder. The powder was triturated
with Et2O and dried under vacuum (369.7 mg, 97%). Single crystals suitable for X-ray
crystallography were grown by vapor diffusion of Et 2O into a concentrated MeCN solution.
The undesired

3/Ph

[Cu2Cl]3+ was identified. No further purification was attempted as the

one-pot procedure was found to afford

3/Ph

[Cu2OH]3+ cleanly in good yield.

3/Ph

[Cu2OH]3+. To a 250 mL round bottom Schlenk flask was added

3Ph

[Sr]2+ (4.0765 g,

3.4292 mmol, 1.00 Eq.), Cu(OTf)2 (2.4979 g, 6.9066 mmol, 2.01 Eq.), and DCM (100 mL).
The resulting pale orange slurry was stirred and treated dropwise with 1.0 M NBu 4OH in
MeOH (3.45 mL, 3.45 mmol, 1.01 Eq.). The reaction mixture quickly became dark green
and was stirred for an additional 2 h at room temperature. The mixture was then directly
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filtered through a pad of Celite to remove all insoluble materials. The Celite cake was
rinsed with an additional 24 mL of DCM, then the filtrate was concentrated under vacuum
to afford the crude product as a green solid. After washing the crude product with 3 x 30
mL 2:1 Et2O/THF, the product was exposed to air and re-dissolved in 150 mL DCM. The
dark green solution was filtered through a pad of Celite and layered with ca. 350 mL
hexanes. After 2 days, crystals suitable for single crystal X-ray crystallography were grown
and collected via vacuum filtration. The crystals were rinsed with ca. 200-300 mL hexanes
and then were dried at 100 °C to remove residual DCM from the crystal lattice; the crystals
were intermittently crushed with a spatula to aid in this process. Once complete, the
product was isolated as a green powder (3.4415 g, 72%). 1H NMR (CD3CN, 500 MHz, 298
K): δ = 50.63 (br s), 8.48 (br s), 8.13 (t, J = 7.3 Hz), 8.03 (d, J = 7.6 Hz), 7.94 (br s), 6.94
(t, J = 7.5 Hz), 6.37 (d, 7.1 Hz) ppm. Anal. % Calcd. for C59H47Cu2F9N6O10S3 (1394.31
g/mol): C, 50.82; H, 3.40; N, 6.03. Found: C, 50.58; H, 3.19; N, 6.21. FTIR (ATR): 3662
(O-H), 1592 (C=N) cm-1.

2/Ph

[Cu2OH]3+. A 250 mL round bottom Schlenk flask was charged with

2/Ph

[Ca]2+ (3.4034

g, 3.0574 mmol, 1.00 equiv.), Cu(OTf)2 (2.2818 g, 6.3091 mmol, 2.06 equiv.) and DCM
(50 mL). The slurry was stirred and treated with MeCN (50 mL). The solution became dark
green and was stirred for a few minutes before the dropwise addition of NBu 4OH (2.10
mL, 3.15 mmol, 1.03 equiv., 40 wt. % in H2O). The solution turned dark blue and was
stirred for 4 h at room temperature. The reaction mixture was then directly filtered through
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a pad of Celite to remove insoluble materials. The Celite cake was rinsed with an additional
35 mL DCM. The volatile materials were removed from the dark blue filtrate under vacuum.
The resulting blue solid was triturated with 3 x 30 mL of 2:1 Et2O/THF, then dissolved in
ca. 75 mL DCM. The DCM solution was layered with 150 mL hexanes and stored at room
temperature. The layers were allowed to mix over 2 days, resulting the in the formation of
blue crystals suitable for crystallographic analysis. The crystals were collected by vacuum
filtration and rinsed with 100 mL pentane. The crystals were then dried under vacuum at
100 °C to remove DCM from the crystal lattice, affording the desired product as a dark
green powder (2.8079 g, 67% ). 1H NMR (CD3CN, 500 MHz, 298 K): δ = 74.53 (br s),
71.39 (s), 9.05 (br s), 8.90 (br s), 8.54 (d, J = 7.6 Hz), 8.48 (t, J = 7.4 Hz), 8.28 (br s), 8.14
(br s), 6.86 (t, J = 7.2 Hz), 5.39 (t, J = 7.1 Hz) ppm. Anal. % Calcd. for C57H43Cu2F9N6O10S3
(1366.26 g/mol): C, 50.11; H, 3.17; N, 6.15. Found: C, 49.89; H, 3.10; N, 6.08. FTIR (ATR):
3679 (O-H), 1586 (C=N) cm-1.
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Figure 4.28 1H NMR spectrum of 3/Ph[Cu2OH]3+ in CD3CN.
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Figure 4.29 Wider window of 1H NMR spectrum of 3/Ph[Cu2OH]3+ in CD3CN.
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Figure 4.31 Wider window of variable temperature 1H NMR spectra of
CD3CN.
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Figure 4.32 1H NMR spectrum of 2/Ph[Cu2OH]3+ in CD3CN.
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Figure 4.35 Wider window of Figure 4.34.
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4.8.4 Infrared Spectra

Figure 4.36 Infrared spectrum of 3/Ph[Cu2OH]3+.

Figure 4.37 Infrared spectrum of 2/Ph[Cu2OH]3+.
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4.8.5 Electrochemical Measurements of

n/Ph

[Cu2OH]3+ (n = 2,3) Complexes

Cyclic Voltammetry of 3/Ph[Cu2OH]3+
As multiple scans were performed (1000 mV/s scan rate), the initial reduction
features lost intensity, beginning to coalesce into one feature (Figure 4.38). The
coalescence was more pronounced at slower scan rates (100 mV/s). A single reduction
feature was observed in this instance (Ep,c = -0.92 V vs. Fc/Fc+, Figure 4.39). Attempting
to observe the two irreversible reduction features, the scan rate was further increased to
2000 mv/S. However, the single reduction feature remained (Figure 4.40). Upon rinsing
the working glassy carbon electrode with fresh solvent, the two irreversible features
reappeared in the CV (1000 mV/s scan rate, Figure 4.41). Again, the signals coalesced
over time. The loss and reappearance of signal suggests the product formed upon the
irreversible reduction events adheres to the electrode surface. Due to this behavior, the
calculation of the O–H BDFE of

3/Ph

[Cu2OH]2+ used the Cu2(II,II)/Cu2(I,II) irreversible

reduction feature from the initial scan of the first CV measurement (before any intensity
was lost).
Cyclic Voltammetry of 2/Ph[Cu2OH]3+
As observed for 3/Ph[Cu2OH]3+, the two irreversible reduction features lost intensity
over time in the CV of

2/Ph

[Cu2OH]3+ (Figure 4.42). The two features began to coalesce

over the course of multiple measurements at 1000 mV/s with different potential windows
(example shown in Figure 4.43). Because of the similar behavior, the calculation of the
O–H BDFE of 3/Ph[Cu2OH]2+ used the Cu2(II,II)/Cu2(I,II) irreversible reduction feature from
the initial scan of the first CV measurement (before any intensity was lost).
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Figure 4.38 Cyclic voltammograms of 3/Ph[Cu2OH]3+ at 1000 mV/s scan rate.

Figure 4.39 Cyclic voltammograms of 3/Ph[Cu2OH]3+ at 100 mV/s scan rate.
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Figure 4.40 Cyclic voltammograms of 3/Ph[Cu2OH]3+ at 2000 mV/s scan rate.

Figure 4.41 Reappearance of the irreversible reduction features of 3/Ph[Cu2OH]3+ after
washing of the glass carbon electrode (scan rate = 1000 mV/s).
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Figure 4.42 Cyclic voltammograms of 2/Ph[Cu2OH]3+ at 1000 mV/s scan rate.

Figure 4.43 Coalescence of irreversible reduction features of 2/Ph[Cu2OH]2+ over a
shorter potential window.
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4.8.6 Chemical Reduction of n/Ph[Cu2OH]3+ (n = 2,3) Complexes
Reduction of 3/Ph[Cu2OH]3+ with Decamethylferrocene
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 48 µL of 5.0 mM
Cp*2Fe in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
Spectra were recorded every 60 seconds for an hour. After 10 minutes, the traces
remained nearly identical. (Note: The same procedure was carried out at -30 °C. After 10
minutes, the intensity at 445 nm slowly began to decrease, indicating instability of the
reduced species.)

Titration of 3/Ph[Cu2OH]3+ with Decamethylferrocene
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 10 µL of 5.0 mM
Cp*2Fe in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe. A
spectrum of the reaction mixture was taken after 5 minutes. The procedure was repeated
until a total of 12 measurements were made. See Figure 4.18 for absorbance vs. equiv.
Cp*2Fe plot.
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Reduction of 3/Ph[Cu2OH]3+ with Cobaltocene
1e- Reduction: In the glovebox, a cuvette was charged with 2.5 mL of 0.1 mM
3/Ph

[Cu2OH]3+ in IBN and sealed with a screw cap equipped with a septum. The cuvette

was removed from the glovebox and placed in the pre-cooled cryostat (-40 °C). After 5
minutes, an initial “blank” spectrum was acquired of the complex. Following this
measurement, 43 µL of 5.8 mM Cp2Co in IBN was injected into the cuvette using a 100
µL Hamilton gas tight syringe. A spectrum of the reaction mixture was taken after 5
minutes. The spectrum of the product is shown in Figure 4.47.
2e- Reduction: In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM
3/Ph

[Cu2OH]3+ in IBN and sealed with a screw cap equipped with a septum. The cuvette

was removed from the glovebox and placed in the pre-cooled cryostat (-65 °C). After 5
minutes, an initial “blank” spectrum was acquired of the complex. Following this
measurement, 50 µL of 9.7 mM Cp2Co in IBN was injected into the cuvette using a 100
µL Hamilton gas tight syringe. Spectra were recorded every 60 seconds for 25 minutes.
(Note: Icing became an issue at -65 °C. After 5 minutes, the mixture was heated to -30 °C
and the issue was resolved. A sample spectrum of the product is shown in Figure 4.47)

Titration of 2/Ph[Cu2OH]3+ with Decamethylferrocene
In the glovebox, a cuvette was charged with 2.5 mL of 0.1 mM

2/Ph

[Cu2OH]3+ in IBN and

sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-30 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 10 µL of 5.0 mM
Cp*2Fe in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe. A
spectrum of the reaction mixture was taken after 3 minutes. The procedure was repeated
until a total of 12 measurements were made.
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Figure 4.44 Time course of 3/Ph[Cu2OH]3+ + Cp*2Fe at -65 °C (60 x 1 min. scan; bolded
traces represent start and finish).

Figure 4.45 Time course of 3/Ph[Cu2OH]3+ + Cp*2Fe at -30 °C (60 x 1 min. scan; bolded
traces represent start and finish).
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Figure 4.46 Titration of 3/Ph[Cu2OH]3+ with Cp*2Fe at -65 °C in 0.21 equiv. increments.

Figure 4.47 Comparison of one- vs. two-electron reduction of 3/Ph[Cu2OH]3+ with Cp*2Fe
or Cp2Co reductants (blue trace – 445 nm maximum; red trace – 460 nm maximum; yellow
trace – 475 nm maximum)
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Figure 4.48 Titration of 2/Ph[Cu2OH]3+ with Cp*2Fe at -30 °C in 0.21 equiv. increments
0.5
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Figure 4.49 Titration of 2/Ph[Cu2OH]3+ with increasing quantities of Cp*2Fe at -30 °C.
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4.8.7 Deprotonation of n/Ph[Cu2OH]3+ (n = 2,3) Complexes
Deprotonation of 3/Ph[Cu2OH]#+ with DBU
To a thin-wall J. young NMR tube,

3/Ph

[Cu2OH]3+ (14.9 mg, 0.0107 mmol, 1.00

equiv.) and CD3CN (ca. 0.6 mL) were added in the glovebox. The green solution was then
treated with DBU (1.75 µL, 0.0117 mmol, 1.10 equiv.) using a 10 µL Hamilton gas tight
syringe. 1H NMR spectra were taken at the following time points – 20 minutes, 170 minutes
(~3 hours) and 1560 minutes (26 hours). Over the course of the reaction, the NMR solution
darkened until red in color. Full protonation of DBU was observed in the final spectrum
(Figure 4.50). The time course is depicted in Figure (4.52). Comparison of the final product
spectrum to the spectra of DBU and

Deprotonation of
lutidinium triflate

3/Ph

[Cu2OH]3+ is shown in Figure 4.54).

3/Ph

[Cu2OH]3+ with DBU and Protonation of

In the glovebox a screw-cap NMR was charged with

3/Ph

[Cu2O]2+ with 2,6-

3/Ph

[Cu2OH]3+ (11.3 mg,

0.00810 mmol, 1.00 equiv.) and CD 3CN (ca. 0.6 mL), and sealed with a screw cap
equipped with a septum. The NMR tube was removed from the glovebox and cooled to 25 °C in a Bruker DMX 500 spectrometer. After 10 minutes, 9 µL of 0.99 MM DBU in
CD3CN was injected into the NMR tube using a 100 µL Hamilton gas tight syringe. After
10 minutes, the 1H spectrum of the deprotonated product was recorded. Then, 29 µL of
0.28 M 2,6-lutidinium triflate in CD3CN was injected into the NMR tube using a 100 µL
Hamilton gas tight syringe. After 10 minutes, the 1H spectrum of the re-protonated starting
material was recorded. A comparison of the corresponding spectra are presented in Figure
4.56.
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Figure 4.50 1H NMR spectrum of 3/Ph[Cu2OH]3+ + DBU in CD3CN (26 hours)
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Figure 4.51 Wider window 1H NMR spectrum of 3/Ph[Cu2OH]3+ + DBU in CD3CN (26 hours)
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1560 min
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*

170 min
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Figure 4.52 Time course of 3/Ph[Cu2OH]3+ + DBU in CD3CN (* = [HDBU][OTf]).

1560 min

170 min

20 min

Figure 4.53 Wider window of time course of 3/Ph[Cu2OH]3+ + DBU in CD3CN.
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DBU

3/Ph

[Cu2OH]3+ + DBU

3/Ph

[Cu2OH]3+

Figure 4.54 1H NMR Spectroscopic support for DBU protonation at -25 °C.
3/Ph

[Cu2OH]3+ + DBU

3/Ph

[Cu2OH]3+

Figure 4.55 Wider window of Figure 4.54.
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+ 2,6-lutidinium triflate

*

*

+ DBU

3/Ph

[Cu2OH]3+

Figure 4.56 Low-temperature (-25 °C) 1H NMR spectroscopic analysis of the
deprotonation of 3/Ph[Cu2OH]3+ with DBU followed by the protonation of 3/Ph[Cu2O]2+ with
2,6-lutidinium triflate (* = 2,6-lutidine).

+ 2,6-lutidinium triflate

+ DBU

3/Ph

[Cu2OH]3+

Figure 4.57 Wider window of the spectroscopic analysis in Figure 4.51.
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Deprotonation of 3/Ph[Cu2OH]3+ with VerkadeiPr
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 32 µL of 7.5 mM
VerkadeiPr in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
Spectra were recorded every 60 seconds for an hour. After 10 minutes, the traces
remained nearly identical. (Note: The same procedure was carried out at -30 °C. After 10
minutes, the traces remained nearly identical.)

Thermal Decomposition of 3/Ph[Cu2O]3+
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 32 µL of 7.5 mM
VerkadeiPr in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
Spectra were recorded every 60 seconds for an hour (Figure 4.X). Over the course of the
first 40 minutes, the temperature was ramped to 25 °C. A slow decomposition occurred
during this timespan. Over the final 20 minutes, the temperature was ramped to 95 °C,
showing an increase in the rate of decomposition to 3/Ph[Cu]+.

Deprotonation of 2/Ph[Cu2OH]3+ with VerkadeiPr – Method A
In the glovebox, a cuvette was charged with 2.5 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-30 °C). After 5 minutes, an initial “blank”
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spectrum was acquired of the complex. Following this measurement, 26 µL of 9.6 mM
VerkadeiPr in THF was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
Spectra were recorded every 15 minutes for 90 minutes.
Deprotonation of 2/Ph[Cu2OH]3+ with VerkadeiPr – Method B
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 39 µL of 6.2 mM
VerkadeiPr in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
Spectra were recorded every 60 seconds for 30 minutes. After 10 minutes, the traces
remained nearly identical.

Figure 4.58 Time course of 3/Ph[Cu2OH]3+ + VerkadeiPr at -65 °C (60 x 1 min. scans; bolded
traces represent start and finish).
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Figure 4.59 Zoomed in view of isosbestic point at 352 nm in reaction of
VerkadeiPr at -65 °C (bolded traces represent start and finish).

3/Ph

[Cu2OH]3+ +

Figure 4.60 Time course of 3/Ph[Cu2OH]3+ + VerkadeiPr at -30 °C (60 x 1 min. scans; bolded
traces represent start and finish).
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Figure 4.61 Time course of the thermal decomposition of 3/Ph[Cu2OH]3+ + VerkadeiPr (60
x 1 min. scans; first 40 minutes = ramp from -65 °C to 25 °C; final 20 minutes = ramp from
25 °C to 95 °C; bolded traces represent start and finish).

Figure 4.62 Time course of the decomposition of 2/Ph[Cu2OH]3+ + VerkadeiPr at -30 °C (6 x
15 min. scans; bolded traces represent start and finish).
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pKa Determination of 3/Ph[Cu2OH]3+ with 1,8-bis(tetramethylguanidino)naphthalene
In the glovebox, a screw-cap NMR tube was charged with 0.4 mL of 30.8 mM
3/Ph

[Cu2OH]3+ and 12 µL of 511 mM 1,3,5-trimethoxybenzene, both in CD3CN, and sealed

with a screw cap equipped with a septum. The NMR tube was removed from the glovebox
and cooled to -30 °C in a Bruker DRX 500 spectrometer. After 15 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 25 µL of 109 mM
1,8-bis(tetramethylguanidino)naphthalene in CD3CN was injected into the NMR tube using
a 100 µL Hamilton gas tight syringe. The sample was allowed to equilibrate for 15 minutes
before data acquisition. The procedure was repeated until 8 titrations points were
collected.
Equilibrium

concentrations

were

calculated

using

the

1,8-

bis(tetramethylguanidino)naphthalene (TMG-PS) peak integrations noted in Table 4.1
(see footnote). From the concentrations, Keq was calculated followed by pKeq. The value
of pKeq corresponds to the difference between the pKa of

3/Ph

[Cu2OH]3+ and the known

pKaH of 1,8-bis(tetramethylguanidino)naphthalene (24.92). Subtraction of pKeq from 24.92
yielded the pKa of 3/Ph[Cu2OH]3+. Values in each set (1-3) were averaged to afford three
unique pKa values, which were subsequently averaged to afford the final pKa of 24.4 ± 0.4.
We believe this value to be an overestimate of the true pKa of 3/Ph[Cu2OH]3+. For data sets
1 and 2, uncertainty may arise from possible overlap of the associated 1,8bis(tetramethylguanidino)naphthalene proton resonances with the proton resonances of
3/Ph

[Cu2O]2+. For data set 3, a doublet associated with the conjugate acid of 1,8-

bis(tetramethylguanidino)naphthalene (6.44 ppm) overlaps with a broad resonance of
3/Ph

[Cu2OH]3+ (6.38 ppm) introducing a large source of uncertainty into the measurement.
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1.76 equiv.
1.54 equiv.
1.32 equiv.
1.10 equiv.
0.88 equiv.
0.66 equiv.
0.44 equiv.
0.22 equiv.
0 equiv.

Figure 4.63 1H NMR spectroscopic titration of
bis(tetramethylguanidino)naphthalene at -30 °C in CD3CN.

3/Ph

[Cu2OH]3+

1.76 equiv.
1.54 equiv.
1.32 equiv.
1.10 equiv.
0.88 equiv.
0.66 equiv.
0.44 equiv.
0.22 equiv.
0 equiv.

Figure 4.64 Aromatic region of 3/Ph[Cu2OH]3+ 1H NMR spectroscopic titration.
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with

1,8-

Table 4.1 3/Ph[Cu2OH]3+ equilibrium mixtures determined from titration points.a

1b

2c

TMG-PS
-

[TMG-PS]H+
-

3.68
8.12
12.2
15.3
18.8
20.7
25.8
30.2

4.65
6.03
7.34
8.10
9.34
9.41
12.6
15.7

3.96
8.24
12.1
15.3
18.6
20.9
24.5
27.2

5.41
7.55
9.42
10.7
12.3
12.8
16.2
19.3

4.78
8.98
12.6
15.6
18.5
20.4
23.9
27.1

3.12
3.15
3.36
2.69
4.14
3.99
7.11
9.06

3/Ph

[Cu2OH]3+
30.8

3/Ph

[Cu2O]2+
-

Keq
-

pKeq
-

pKa
-

23.5
4.65
20.6
6.03
18.0
7.34
16.2
8.10
14.0
9.34
13.1
9.41
9.12
12.6
5.32
15.7
Average
Standard Deviation

0.249
0.217
0.246
0.265
0.331
0.327
0.671
1.53

0.603
0.663
0.608
0.577
0.480
0.486
0.171
-0.184

24.3
24.3
24.3
24.3
24.4
24.4
24.7
25.1
24.5
0.3

22.8
5.41
19.1
7.55
15.9
9.42
13.6
10.7
11.0
12.3
9.77
12.8
5.50
16.2
1.67
19.3
Average
Standard Deviation

0.325
0.362
0.461
0.544
0.741
0.797
1.95
8.18

0.488
0.442
0.336
0.265
0.130
0.098
-0.291
-0.913

24.4
24.5
24.6
24.7
24.8
24.8
25.2
25.8
24.9
0.5

25.1
3.12
0.0813
1.09
23.8
23.5
3.15
0.0469
1.33
23.6
21.9
3.36
0.408
1.39
23.5
21.6
2.69
0.0214
1.67
23.3
19.2
4.14
0.0482
1.32
23.6
3d
18.5
3.99
0.0421
1.38
23.5
14.6
7.11
0.145
0.840 24.1
11.9
9.06
0.254
0.596 24.3
Average
23.7
Standard Deviation
0.3
a – All concentrations are reported in units of mM.
b – Concentrations determined using integrations of signals at 7.20 and 7.39 ppm.
c – Concentrations determined using integrations of signals at 7.12 and 7.32 ppm.
d – Concentrations determined using integrations of signals at 6.20 and 6.44 ppm.
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pKa Determination of 2/Ph[Cu2OH]3+ with 1,8-bis(tetramethylguanidino)naphthalene
In the glovebox, a screw-cap NMR tube was charged with 0.4 mL of 29.0 mM
3/Ph

[Cu2OH]3+ and 25 µL of 511 mM 1,3,5-trimethoxybenzene, both in CD3CN, and sealed

with a screw cap equipped with a septum. The NMR tube was removed from the glovebox
and cooled to -30 °C in a Bruker DRX 500 spectrometer. After 15 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 20 µL of 129 mM
1,8-bis(tetramethylguanidino)naphthalene in CD3CN was injected into the NMR tube using
a 100 µL Hamilton gas tight syringe. The sample was allowed to equilibrate for 15 minutes
before data acquisition. The procedure was repeated until 8 titrations points were
collected.
Equilibrium concentrations (Table 4.2) were calculated using the 1,8bis(tetramethylguanidino)naphthalene (TMG-PS) peak integrations at 6.44 and 6.20 ppm.
From the concentrations, Keq was calculated followed by pKeq. The value of pKeq
corresponds to the difference between the pKa of 2/Ph[Cu2OH]3+ and the known pKaH of 1,8bis(tetramethylguanidino)naphthalene (24.92). Subtraction of pKeq from 24.92 yielded the
pKa of 2/Ph[Cu2OH]3+. Values were averaged to afford the pKa of 25.6 ± 0.5. We believe this
value to be an overestimate of the true pKa of

2/Ph

[Cu2OH]3+. At later titration points, the

signal at 6.20 ppm began to broaden. Along with this change, a shoulder grew in on the
1,3,5-trimethoxybenzene signal at 6.08 ppm, suggesting a new species was forming. Slow
background decomposition may also be occurring on the NMR timescale, as observed in
the UV-vis-NIR experiment.
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1.76 equiv.
1.54 equiv.
1.32 equiv.
1.10 equiv.
0.88 equiv.
0.66 equiv.
0.44 equiv.
0.22 equiv.
0 equiv.

Figure 4.65 1H NMR spectroscopic titration of
bis(tetramethylguanidino)naphthalene at -30 °C in CD3CN.

2/Ph

[Cu2OH]3+

1.76 equiv.
1.54 equiv.
1.32 equiv.
1.10 equiv.
0.88 equiv.
0.66 equiv.
0.44 equiv.
0.22 equiv.
0 equiv.

Figure 4.66 Aromatic region of 3/Ph[Cu2OH]3+ 1H NMR spectroscopic titration.
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with

1,8-

Table 4.2 2/Ph[Cu2OH]3+ equilibrium mixtures determined from titration points. a
TMG-PS
1.71
2.86
4.30
4.76
5.80
6.63
7.94
9.50

[TMG-PS]H+
4.69
8.83
12.0
14.8
16.9
17.2
16.9
16.5

3/Ph

[Cu2OH]3+

3/Ph

21.4
16.1
11.9
8.21
5.22
4.10
3.60
3.29

[Cu2O]2+
4.69
8.83
12.0
14.8
16.9
17.2
16.9
16.5

Average
Standard Deviation
a – All concentrations are reported in units of mM.
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Keq

pKeq

pKa

0.604
1.69
2.81
5.58
9.41
10.9
10.0
8.76

0.219
-0.229
-0.449
-0.746
-0.974
-1.04
-1.00
-0.943

24.7
25.1
25.4
25.7
25.9
26.0
25.9
25.9
25.6
0.5

4.8.8 Hydrogen Atom Transfer Reactivity of

n/Ph

[Cu2OH]3+ (n = 2,3) Complexes

General Procedure for HAT Reactions with 3/Ph[Cu2O]2+
In the glovebox, a cuvette was charged with 2.4 mL of 0.1 mM 3/Ph[Cu2OH]3+ in IBN
and sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-65 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, 32 µL of 7.5 mM
VerkadeiPr in IBN was injected into the cuvette using a 100 µL Hamilton gas tight syringe.
A spectrum of the deprotonated product was taken after 10 minutes. To the cooled
cuvette, the HAT reagent was added using a 100 µL Hamilton gas tight syringe. Spectra
were recorded every 60 seconds for 15 minutes.

General Procedure for HAT Reactions with 2/Ph[Cu2O]2+
In the glovebox, a cuvette was charged with 0.1 mM

2/Ph

[Cu2OH]3+ in IBN and

sealed with a screw cap equipped with a septum. The cuvette was removed from the
glovebox and placed in the pre-cooled cryostat (-30 °C). After 5 minutes, an initial “blank”
spectrum was acquired of the complex. Following this measurement, Verkade iPr in IBN
was injected into the cuvette using a 100 µL Hamilton gas tight syringe. A spectrum of the
deprotonated product was taken after 10 minutes. To the cooled cuvette, the HAT reagent
was added using a 100 µL Hamilton gas tight syringe. Spectra were recorded every 60
seconds for 15 minutes.
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The general procedure for

3/Ph

[Cu2O]2+ was followed for the addition of 9-

cyanoxanthene. In this case, 32 µL of 7.5 mM 9-cyaonoxanthene in IBN was added to the
cuvette containing 3/Ph[Cu2O]2+. A reaction occurred based on the changes in the UV-visNIR profile.

Figure 4.67 Comparison of 3/Ph[Cu2OH]2+ generated from HAT (red trace) and
3/Ph
[Cu2OH]2+ generated from the reduction (yellow trace) at 65°C.
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The general procedure for

3/Ph

[Cu2O]2+ was followed for the addition of

phenylhydrazine. In this case, 25 µL of 9.8 mM phenylhydrazine in IBN was added to the
cuvette containing 3/Ph[Cu2O]2+. A reaction occurred based on the changes in the UV-visNIR profile.

Figure 4.68 Time course of 3/Ph[Cu2O]2+ + phenylhydrazine at -65 °C (15 x 1 min. scans;
bolded traces represent start and finish).
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The general procedure for

3/Ph

[Cu2O]2+ was followed for the addition of xanthene

with modification. In this case, 25 µL of 9.8 mM phenylhydrazine in IBN was added to the
cuvette containing

3/Ph

[Cu2O]2+ at -30 °C. No reaction occurred upon the addition of the

HAT reagent. (Note: No change to the spectrum was observed with longer reaction times).

Figure 4.69 Time course of 3/Ph[Cu2O]2+ + xanthene at -65 °C (15 x 1 min. scans; bolded
traces represent start and finish).
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The general procedure for

3/Ph

[Cu2O]2+ was followed for the addition of 1,4-CHD.

In this case, 44 µL of 541 mM 1,4-CHD in IBN was added to the cuvette containing
3/Ph

[Cu2O]2+. No reaction occurred upon the addition of the HAT reagent. (Note: No change

to the spectrum was observed with longer reaction times).

Figure 4.70 Time course of 3/Ph[Cu2O]2+ + 1,4-CHD at -65 °C (15 x 1 min. scans; bolded
traces represent start and finish).
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The general procedure for 3/Ph[Cu2O]2+ was followed for the addition of DHA. In this case,
42 µL of 576 mM DHA in IBN was added to the cuvette containing

3/Ph

[Cu2O]2+. While

there was no appearance of the 455 nm feature associated with 3/Ph[Cu2OH]2+, the growth
of the sharp feature at 377 nm signified HAT from DHA (Tolman and coworkers observed
the same signals in HAT experiments with

PDA

[Cu2OH]0.) The origin of this HAT event is

unknown and appears unrelated to 3/Ph[Cu2O]2+.

Figure 4.71 Time course of 3/Ph[Cu2O]2+ + DHA at -65 °C (15 x 1 min. scans; bolded traces
represent start and finish).
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The general procedure for

2/Ph

[Cu2O]2+ was followed for the addition of 9-

cyanoxanthene. In this case, 2.4 mL of 0.1 mM

2/Ph

[Cu2OH]3+ was used. To the chilled

cuvette, 39 µL of 6.2 mM Verkade iPr in IBN was added to the cuvette containing
2/Ph

[Cu2OH]3+. Following, 32 µL of 7.5 mM 9-cyaonoxanthene in IBN was added to the

cuvette containing 3/Ph[Cu2O]2+. A reaction occurred based on the changes in the UV-visNIR profile (see Figure 4.27).

The general procedure for

2/Ph

[Cu2O]2+ was followed for the addition of xanthene. In this

case, 2.0 mL of 0.1 mM 2/Ph[Cu2OH]3+ was used. To the chilled cuvette, 21 µL of 9.6 mM
VerkadeiPr in THF was added to the cuvette containing 2/Ph[Cu2OH]3+. Following, 19 µL of
10.5 mM xanthene in IBN was added to the cuvette containing

3/Ph

[Cu2O]2+. A slow

reaction occurred based on the changes in the UV-vis-NIR profile.

Figure 4.72 Time course of 2/Ph[Cu2O]2+ + xanthene at -30 °C (15 x 1 min. scans; bolded
traces represent start and finish).
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The general procedure for

2/Ph

[Cu2O]2+ was followed for the addition of DHA with

slight modification. In this case, 2.4 mL of 0.1 mM

2/Ph

[Cu2OH]3+ was used at -65 °C. To

the chilled cuvette, 32 µL of 7.5 mM VerkadeiPr in IBN was added to the cuvette containing
2/Ph

[Cu2OH]3+. Following, 42 µL of 576 mM DHA in IBN was added to the cuvette

containing 3/Ph[Cu2O]2+. While there was no appearance of the 455 nm feature associated
with

3/Ph

[Cu2OH]2+, the growth of the sharp feature at 377 nm signified HAT from DHA

(Tolman and coworkers observed the same signals in HAT experiments with
PDA

[Cu2OH]0.) The origin of this HAT is unknown and appears unrelated to

2/Ph

[Cu2O]2+.

Figure 4.73 Time course of 2/Ph[Cu2O]2+ + DHA at -65 °C (15 x 1 min. scans; bolded traces
represent start and finish).
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4.8.9 X-ray Crystallography
Table 4.3 Summary of structure determination of 3/Ph[Cu2Cl2]2+.
Empirical formula

C58H46Cl2Cu2F6N6O6S2

Formula weight

1299.11

Diffractometer

Rigaku XtaLAB Synergy-S (HyPix-6000HE)

Temperature/K

100

Crystal system

monoclinic

Space group

P21/c

a

18.64740(10)Å

b

17.25520(10)Å

c

17.07510(10)Å

β

96.2690(10)°

Volume

5461.31(5)Å3

Z

4

dcalc

1.580 g/cm3

μ

3.256 mm-1

F(000)

2648.0

Crystal size, mm

0.13 × 0.08 × 0.07

2θ range for data collection

7 - 149.004°

Index ranges

-23 ≤ h ≤ 23, -18 ≤ k ≤ 21, -21 ≤ l ≤ 21

Reflections collected

90126

Independent reflections

11157[R(int) = 0.0574]

Data/restraints/parameters

11157/810/943

Goodness-of-fit on F2

1.061

Final R indexes [I>=2σ (I)]

R1 = 0.0540, wR2 = 0.1376

Final R indexes [all data]

R1 = 0.0585, wR2 = 0.1404

Largest diff. peak/hole

0.82/-0.60 eÅ-3
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Table 4.4 Summary of structure determination of 3/Ph[Cu2Cl]3+.
Empirical formula

C63H52ClCu2F9N8O9S3

Formula weight

1494.83

Diffractometer

Rigaku XtaLAB Synergy-S

Temperature/K

100

Crystal system

monoclinic

Space group

P21/m

a

10.05130(10)Å

b

25.0638(2)Å

c

12.90280(10)Å

β

101.8810(10)°

Volume

3180.89(5)Å3

Z

2

dcalc

1.561 g/cm3

μ

2.917 mm-1

F(000)

1524.0

Crystal size, mm

0.1 × 0.06 × 0.04

2θ range for data collection

7 - 148.942°

Index ranges

-12 ≤ h ≤ 12, -31 ≤ k ≤ 31, -14 ≤ l ≤ 16

Reflections collected

52956

Independent reflections

6649[R(int) = 0.0482]

Data/restraints/parameters

6649/204/562

Goodness-of-fit on F2

1.055

Final R indexes [I>=2σ (I)]

R1 = 0.0411, wR2 = 0.1093

Final R indexes [all data]

R1 = 0.0447, wR2 = 0.1119

Largest diff. peak/hole

0.74/-0.85 eÅ-3
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Table 4.5 Summary of structure determination of 3/Ph[Cu2OH]3+.
Empirical formula

C61H51Cl4Cu2F9N6O10S3

Formula weight

1564.13

Diffractometer

Rigaku XtaLAB Synergy-S (Dectris Pilatus3 R 200K)

Temperature/K

100

Crystal system

monoclinic

Space group

P21/c

a

10.0481(2)Å

b

25.2110(4)Å

c

25.7624(4)Å

β

101.061(2)°

Volume

6405.0(2)Å3

Z

4

dcalc

1.622 g/cm3

μ

1.018 mm-1

F(000)

3176.0

Crystal size, mm

0.36 × 0.32 × 0.17

2θ range for data collection

4.564 - 56.564°

Index ranges

-13 ≤ h ≤ 13, -33 ≤ k ≤ 33, -34 ≤ l ≤ 34

Reflections collected

122275

Independent reflections

15834[R(int) = 0.0436]

Data/restraints/parameters

15834/111/896

Goodness-of-fit on F2

1.060

Final R indexes [I>=2σ (I)]

R1 = 0.0409, wR2 = 0.1093

Final R indexes [all data]

R1 = 0.0520, wR2 = 0.1146

Largest diff. peak/hole

1.02/-0.96 eÅ-3
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Table 4.6 Summary of structure determination of 3/Ph[Cu]+.
Empirical formula

C57H46CuF3N6O3S

Formula weight

1015.60

Diffractometer

Rigaku XtaLAB Synergy-S

Temperature/K

100

Crystal system

monoclinic

Space group

C2/c

a

20.2610(6)Å

b

14.5387(4)Å

c

15.9567(4)Å

β

90.972(3)°

Volume

4699.7(2)Å3

Z

4

dcalc

1.435 g/cm3

μ

0.576 mm-1

F(000)

2104.0

Crystal size, mm

0.16 × 0.13 × 0.06

2θ range for data collection

5.106 - 56.562°

Index ranges

-26 ≤ h ≤ 26, -19 ≤ k ≤ 19, -21 ≤ l ≤ 21

Reflections collected

47569

Independent reflections

5834[R(int) = 0.0450]

Data/restraints/parameters

5834/95/339

Goodness-of-fit on F2

1.022

Final R indexes [I>=2σ (I)]

R1 = 0.0463, wR2 = 0.1176

Final R indexes [all data]

R1 = 0.0548, wR2 = 0.1225

Largest diff. peak/hole

0.77/-0.46 eÅ-3
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Table 4.7 Summary of structure determination of 3/Ph[Cu2Cl2]2+.
Empirical formula

C83H77Cl2Cu2F3N6O5PS

Formula weight

1556.51

Diffractometer

Rigaku XtaLAB Synergy-S (HyPix-6000HE)

Temperature/K

100

Crystal system

triclinic

Space group

_
P1

a

11.74710(10)Å

b

16.8904(2)Å

c

20.0531(3)Å

α

70.1480(10)°

β

84.1010(10)°

γ

86.8810(10)°

Volume

3721.73(8)Å3

Z

2

dcalc

1.389 g/cm3

μ

2.356 mm-1

F(000)

1614.0

Crystal size, mm

0.18 × 0.12 × 0.01

2θ range for data collection

5.564 - 149.002°

Index ranges

-14 ≤ h ≤ 14, -21 ≤ k ≤ 21, -19 ≤ l ≤ 23

Reflections collected

91476

Independent reflections

15053[R(int) = 0.0492]

Data/restraints/parameters

15053/702/1054

Goodness-of-fit on F2

1.052

Final R indexes [I>=2σ (I)]

R1 = 0.0574, wR2 = 0.1582

Final R indexes [all data]

R1 = 0.0623, wR2 = 0.1626

Largest diff. peak/hole

0.87/-1.11 eÅ-3
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Table 4.8 Summary of structure determination of 2/Ph[Cu2OH]3+.
Empirical formula

C59H47Cl4Cu2F9N6O10S3

Formula weight

1536.08

Diffractometer

Rigaku XtaLAB Synergy-S (HyPix-6000HE)

Temperature/K

100

Crystal system

monoclinic

Space group

P21

a

10.1659(3)Å

b

23.7638(6)Å

c

12.8259(4)Å

β

99.377(3)°

Volume

3057.08(15)Å3

Z

2

dcalc

1.669 g/cm3

μ

1.065 mm-1

F(000)

1556.0

Crystal size, mm

0.28 × 0.23 × 0.11

2θ range for data collection

3.646 - 56.558°

Index ranges

-13 ≤ h ≤ 13, -31 ≤ k ≤ 31, -15 ≤ l ≤ 17

Reflections collected

61481

Independent reflections

15121[R(int) = 0.0349]

Data/restraints/parameters

15121/1/839

Goodness-of-fit on F

2

1.041

Final R indexes [I>=2σ (I)]

R1 = 0.0327, wR2 = 0.0882

Final R indexes [all data]

R1 = 0.0349, wR2 = 0.0893

Largest diff. peak/hole

0.54/-0.93 eÅ-3

Flack parameter

0.495(8)

220

BIBLIOGRAPHY
(1) Administration, U. S. E. I. Annual Energy Outlook 2022 (AEO2022). 2022. (accessed
2022 April 29, 2022).
(2) Caballero, A.; Pérez, P. J. Methane as raw material in synthetic chemistry: the final
frontier. Chem. Soc. Rev. 2013, 42, 8809.
(3) Sun, L.; Wang, Y.; Guan, N.; Li, L. Methane Activation and Utilization: Current Status
and Future Challenges. Energy Technol. 2020, 8, 1.
(4) Olah, G. A. Beyond Oil and Gas: The Methanol Economy. Angew. Chem. Int. Ed. 2005,
44, 2636.
(5) da Silva, M. J. Synthesis of methanol from methane: Challenges and advances on the
multi-step (syngas) and one-step routes (DMTM). Fuel Process. Technol. 2016, 145, 42.
(6) Park, M. B.; Park, E. D.; Ahn, W.-S. Recent Progress in Direct Conversion of Methane
to Methanol Over Copper-Exchanged Zeolites. Front. Chem. 2019, 7, 1.
(7) Tomkins, P.; Ranocchiari, M.; van Bokhoven, J. A. Direct Conversion of Methane to
Methanol under Mild Conditions over Cu-Zeolites and beyond. Acc. Chem. Res. 2017, 50,
418.
(8) Snyder, B. E. R.; Bols, M. L.; Schoonheydt, R. A.; Sels, B. F.; Solomon, E. I. Iron and
Copper Active Sites in Zeolites and Their Correlation to Metalloenzymes. Chem. Rev.
2018, 118, 2718.
(9) Newton, M. A.; Knorpp, A. J.; Sushkevich, V. L.; Palagin, D.; van Bokhoven, J. A. Active
sites and mechanisms in the direct conversion of methane to methanol using Cu in zeolitic
hosts: a critical examination. Chem. Soc. Rev. 2020, 49, 1449.
(10) Díaz, I.; Kokkoli, E.; Terasaki, O.; Tsapatsis, M. Surface Structure of Zeolite (MFI)
Crystals. Chem. Mater. 2004, 16, 5226.
(11) Kokotailo, G. T.; Lawton, S. L.; Olson, D. H.; Meier, W. M. Structure of synthetic
zeolite ZSM-5. Nature 1978, 272, 437.
(12) Woertink Julia, S.; Smeets Pieter, J.; Groothaert Marijke, H.; Vance Michael, A.; Sels
Bert, F.; Schoonheydt Robert, A.; Solomon Edward, I. A [Cu2O]2+ core in Cu-ZSM-5, the
active site in the oxidation of methane to methanol. Proc. Natl. Acad. Sci. U.S.A. 2009,
106, 18908.
(13) Mentzen, B. F.; Bergeret, G. Crystallographic Determination of the Positions of the
Copper Cations in Zeolite MFI. J. Phys. Chem. C. 2007, 111, 12512.

221

(14) Groothaert, M. H.; Smeets, P. J.; Sels, B. F.; Jacobs, P. A.; Schoonheydt, R. A.
Selective Oxidation of Methane by the Bis(μ-oxo)dicopper Core Stabilized on ZSM-5 and
Mordenite Zeolites. J. Am. Chem. Soc. 2005, 127, 1394.
(15) Groothaert, M. H.; van Bokhoven, J. A.; Battiston, A. A.; Weckhuysen, B. M.;
Schoonheydt, R. A. Bis(μ-oxo)dicopper in Cu-ZSM-5 and Its Role in the Decomposition of
NO: A Combined in Situ XAFS, UV−Vis−Near-IR, and Kinetic Study. J. Am. Chem. Soc.
2003, 125, 7629.
(16) Smeets, P. J.; Hadt, R. G.; Woertink, J. S.; Vanelderen, P.; Schoonheydt, R. A.; Sels,
B. F.; Solomon, E. I. Oxygen Precursor to the Reactive Intermediate in Methanol Synthesis
by Cu-ZSM-5. J. Am. Chem. Soc. 2010, 132, 14736.
(17) Wu, J.-F.; Gao, X.-D.; Wu, L.-M.; Wang, W. D.; Yu, S.-M.; Bai, S. Mechanistic Insights
on the Direct Conversion of Methane into Methanol over Cu/Na–ZSM-5 Zeolite: Evidence
from EPR and Solid-State NMR. ACS Catal. 2019, 9, 8677.
(18) Narsimhan, K.; Iyoki, K.; Dinh, K.; Román-Leshkov, Y. Catalytic Oxidation of Methane
into Methanol over Copper-Exchanged Zeolites with Oxygen at Low Temperature. ACS
Cent. Sci. 2016, 2, 424.
(19) Haack, P.; Limberg, C. Molecular CuII-O-CuII Complexes: Still Waters Run Deep.
Angew. Chem. Int. Ed. 2014, 53, 4282.
(20) Karlin, K. D.; Gultneh, Y.; Hayes, J. C.; Zubieta, J. Copper(I)-dioxygen reactivity. 2.
Reaction of a three-coordinate copper(I) complex with dioxygen, with evidence for a
binuclear oxo-copper(II) species: structural characterization of a parallel-planar dihydroxobridged dimer. Inorg. Chem. 1984, 23, 519.
(21) Sanyal, I.; Mahroof-Tahir, M.; Nasir, M. S.; Ghosh, P.; Cohen, B. I.; Gultneh, Y.;
Cruse, R. W.; Farooq, A.; Karlin, K. D. Reactions of dioxygen (O2) with mononuclear
copper(I) complexes: temperature-dependent formation of peroxo- or oxo- (and
dihydroxo-) bridged dicopper(II) complexes. Inorg. Chem. 1992, 31, 4322.
(22) Obias, H. V.; Lin, Y.; Murthy, N. N.; Pidcock, E.; Solomon, E. I.; Ralle, M.; Blackburn,
N. J.; Neuhold, Y.-M.; Zuberbühler, A. D.; Karlin, K. D. Peroxo-, Oxo-, and HydroxoBridged Dicopper Complexes: Observation of Exogenous Hydrocarbon Substrate
Oxidation. J. Am. Chem. Soc. 1998, 120, 12960.
(23) Kitajima, N.; Koda, T.; Hashimoto, S.; Kitagawa, T.; Morooka, Y. Synthesis and
characterization of the dinuclear copper(II) complexes [Cu(HB(3,5-Me2pz)3)]2X (X = O2, (OH)22-, CO22-, O22-). J. Am. Chem. Soc. 1991, 113, 5664.
(24) Kitajima, N.; Koda, T.; Iwata, Y.; Morooka, Y. Reaction aspects of a .mu.-peroxo
binuclear copper(II) complex. J. Am. Chem. Soc. 1990, 112, 8833.
(25) Nobumasa, K.; Takayuki, K.; Yoshihiko, M.-o. Synthesis of a Novel μ-Oxo Binuclear
Copper(II) Complex Ligated by Hydrotris(3,5-dimethyl-1-pyrazolyl)borate. Chem. Lett.
1988, 17, 347.

222

(26) Ali, G.; VanNatta, P. E.; Ramirez, D. A.; Light, K. M.; Kieber-Emmons, M. T.
Thermodynamics of a μ-oxo Dicopper(II) Complex for Hydrogen Atom Abstraction. J. Am.
Chem. Soc. 2017, 139, 18448.
(27) Réglier, M.; Jorand, C.; Waegell, B. Binuclear copper complex model of tyrosinase.
J. Chem. Soc., Chem. Commun. 1990, 1752.
(28) Haack, P.; Kärgel, A.; Greco, C.; Dokic, J.; Braun, B.; Pfaff, F. F.; Mebs, S.; Ray, K.;
Limberg, C. Access to a CuII–O–CuII Motif: Spectroscopic Properties, Solution Structure,
and Reactivity. J. Am. Chem. Soc. 2013, 135, 16148.
(29) Jurgeleit, R.; Grimm-Lebsanft, B.; Flöser, B. M.; Teubner, M.; Buchenau, S.; Senft,
L.; Hoffmann, J.; Naumova, M.; Näther, C.; Ivanović-Burmazović, I.; et al. Catalytic
Oxygenation of Hydrocarbons by Mono-μ-oxo Dicopper(II) Species Resulting from O−O
Cleavage of Tetranuclear CuI/CuII Peroxo Complexes. Angew. Chem. Int. Ed. 2021, 60,
14154.
(30) Solomon, E. I.; Heppner, D. E.; Johnston, E. M.; Ginsbach, J. W.; Cirera, J.; Qayyum,
M.; Kieber-Emmons, M. T.; Kjaergaard, C. H.; Hadt, R. G.; Tian, L. Copper Active Sites in
Biology. Chem. Rev. 2014, 114, 3659.
(31) Mendy, J. S.; Saeed, M. A.; Fronczek, F. R.; Powell, D. R.; Hossain, M. A. Anion
Recognition and Sensing by a New Macrocyclic Dinuclear Copper(II) Complex: A
Selective Receptor for Iodide. Inorg. Chem. 2010, 49, 7223.
(32) Rhaman, M. M.; Alamgir, A.; Wong, B. M.; Powell, D. R.; Hossain, M. A. A highly
efficient dinuclear Cu(ii) chemosensor for colorimetric and fluorescent detection of cyanide
in water. RSC Adv. 2014, 4, 54263.
(33) Mateus, P.; Lima, L. M. P.; Delgado, R. Di- and trinuclear copper(II) complexes of
polyaza macrocycles and cryptands as anion receptors. Polyhedron 2013, 52, 25.
(34) Carsch, K. M.; Lukens, J. T.; DiMucci, I. M.; Iovan, D. A.; Zheng, S.-L.; Lancaster, K.
M.; Betley, T. A. Electronic Structures and Reactivity Profiles of Aryl Nitrenoid-Bridged
Dicopper Complexes. J. Am. Chem. Soc. 2020, 142, 2264.
(35) Ziegler, M. S.; Lakshmi, K. V.; Tilley, T. D. Dicopper Cu(I)Cu(I) and Cu(I)Cu(II)
Complexes in Copper-Catalyzed Azide–Alkyne Cycloaddition. J. Am. Chem. Soc. 2017,
139, 5378.
(36) Ziegler, M. S.; Levine, D. S.; Lakshmi, K. V.; Tilley, T. D. Aryl Group Transfer from
Tetraarylborato Anions to an Electrophilic Dicopper(I) Center and Mixed-Valence μ-Aryl
Dicopper(I,II) Complexes. J. Am. Chem. Soc. 2016, 138, 6484.
(37) Drew, M. G. B.; McCann, M.; Nelson, S. M. Bi-copper(I) and bi-copper(II) complexes
of a 30-membered macrocyclic ligand: the inclusion of substrate molecules and the crystal
and molecular structures of a µ-hydroxo- and a µ-imidazolato-complex. J. Chem. Soc.,
Dalton Trans. 1981, 1868.

223

(38) Drew, M. G. B.; McCann, M.; Nelson, S. M. Binuclear macrocyclic copper(II)
complexes as receptors for small bridging ligands: X-ray crystal and molecular structure
of a µ-azido complex. J. Chem. Soc., Chem. Commun. 1979, 481.
(39) Drew, M. G. B.; Nelson, J.; Esho, F.; McKee, V.; Nelson, S. M. Dicopper(II) complexes
of a macrocyclic ligand containing single hydroxo-, methoxo-, or 1,1-azido-bridges:
synthesis, magnetic properties, electron spin resonance spectra, and the crystal and
molecular structure of a µ-hydroxo-derivative. J. Chem. Soc., Dalton Trans. 1982, 1837.
(40) Nelson, S. M.; Esho, F. S.; Drew, M. G. B. Metal-ion controlled reactions of 2,6diacetylpyridine with 1,2-di-aminoethane and 2,6-diformylpyridine with ophenylenediamine and the crystal and molecular structure of a pentagonal pyramidal
cadmium(II) complex containing unidentate o-phenylenediamine. J. Chem. Soc., Dalton
Trans. 1982, 407.
(41) Groom, C. R.; Bruno, I. J.; Lightfoot, M. P.; Ward, S. C. The Cambridge Structural
Database. Acta Crystallogr., Sect. B. 2016, 72, 171.
(42) Römelt, C.; Weyhermüller, T.; Wieghardt, K. Structural characteristics of redox-active
pyridine-1,6-diimine complexes: Electronic structures and ligand oxidation levels. Coord.
Chem. Rev. 2019, 380, 287.
(43) Davis, R. N.; Tanski, J. M.; Adrian, J. C.; Tyler, L. A. Variations in the coordination
environment of Co2+, Cu2+ and Zn2+ complexes prepared from a tridentate
(imino)pyridine ligand and their structural comparisons. Inorganica Chim. Acta. 2007, 360,
3061.
(44) Trivedi, M.; Pandey, D. S.; Xu, Q. Nickel and copper complexes based on tridentate
nitrogen donor ligand 2,6-bis-(1-phenyliminoethyl) pyridine: Synthesis, spectral and
structural characterization. Inorganica Chim. Acta. 2007, 360, 2492.
(45) Fan, R.-Q.; Wang, P.; Yang, Y.-L.; Zhang, Y.-J.; Yin, Y.-B.; Hasi, W. Syntheses,
structures, and luminescent properties of copper(II) complexes based on 2,6bis(imino)pyridyl ligands. Polyhedron 2010, 29, 2862.
(46) Su, B.; Feng, G. Influence of the metal centers of 2,6-bis(imino)pyridyl transition metal
complexes on ethylene polymerization/ oligomerization catalytic activities. Polym. Int.
2010, 59, 1058.
(47) Le Gall, B. t.; Conan, F.; Cosquer, N.; Kerbaol, J.-M.; Kubicki, M. M.; Vigier, E.; Le
Mest, Y.; Sala Pala, J. Unexpected behaviour of copper(I) towards a tridentate Schiff base:
synthesis, structure and properties of new Cu(I) Cu(II) and Cu(II) complexes. Inorganica
Chim. Acta. 2001, 324, 300.
(48) Jurca, T.; Ouanounou, S.; Shih, W.-C.; Ong, T.-G.; Yap, G. P. A.; Korobkov, I.;
Gorelsky, S.; Richeson, D. Structural and electronic trends for five coordinate 1st row
transition metal complexes: Mn(ii) to Zn(ii) captured in a bis(iminopyridine) framework.
Dalton Trans. 2016, 45, 14327.

224

(49) Restivo, R. J.; Ferguson, G. Structural characterization of metal complexes of 2,6diacetylpyridine-bis(imines). Crystal and molecular structure of dinitrato{2,6-bis[1(phenylimino)ethyl]pyridine}copper(II). J. Chem. Soc., Dalton Trans. 1976, 518.
(50) Alyea, E. C.; Ferguson, G.; Restivo, R. J. Preparation and characterization of metal
complexes of 2,6-diacetylpyridine bis(imines). Crystallographic study of dinitrato[2,6diacetylpyridine bis(anil)]nickel(II). Inorg. Chem. 1975, 14, 2491.
(51) Cheung, P. M.; Berger, R. F.; Zakharov, L. N.; Gilbertson, J. D. Square planar Cu(i)
stabilized by a pyridinediimine ligand. Chem. Comm. 2016, 52, 4156.
(52) Cui, P.; Wang, Q.; McCollom, S. P.; Manor, B. C.; Carroll, P. J.; Tomson, N. C. RingSize-Modulated Reactivity of Putative Dicobalt-Bridging Nitrides: C−H Activation versus
Phosphinimide Formation. Angew. Chem. Int. Ed. 2017, 56, 15979.
(53) Liu, T.; Gau, M. R.; Tomson, N. C. Mimicking the Constrained Geometry of a NitrogenFixation Intermediate. J. Am. Chem. Soc. 2020, 142, 8142.
(54) Spentzos, A. Z.; Gau, M. R.; Carroll, P. J.; Tomson, N. C. Unusual cyanide and methyl
binding modes at a dicobalt macrocycle following acetonitrile C–C bond activation. Chem.
Comm. 2020, 56, 9675.
(55) Thierer, L. M.; Brooks, S. H.; Weberg, A. B.; Cui, P.; Zhang, S.; Gau, M. R.; Manor,
B. C.; Carroll, P. J.; Tomson, N. C. Macrocycle-Induced Modulation of Internuclear
Interactions in Homobimetallic Complexes. Inorg. Chem. 2022, 61, 6263.
(56) Wang, Q.; Zhang, S.; Cui, P.; Weberg, A. B.; Thierer, L. M.; Manor, B. C.; Gau, M.
R.; Carroll, P. J.; Tomson, N. C. Interdependent Metal–Metal Bonding and Ligand RedoxActivity in a Series of Dinuclear Macrocyclic Complexes of Iron, Cobalt, and Nickel. Inorg.
Chem. 2020, 59, 4200.
(57) Zhang, S.; Cui, P.; Liu, T.; Wang, Q.; Longo, T. J.; Thierer, L. M.; Manor, B. C.; Gau,
M. R.; Carroll, P. J.; Papaefthymiou, G. C.; et al. N−H Bond Formation at a Diiron Bridging
Nitride. Angew. Chem. Int. Ed. 2020, 59, 15215.
(58) Zhang, S.; Wang, Q.; Thierer, L. M.; Weberg, A. B.; Gau, M. R.; Carroll, P. J.; Tomson,
N. C. Tuning Metal–Metal Interactions through Reversible Ligand Folding in a Series of
Dinuclear Iron Complexes. Inorg. Chem. 2019, 58, 12234.
(59) Wang, Q.; Brooks, S. H.; Liu, T.; Tomson, N. C. Tuning metal–metal interactions for
cooperative small molecule activation. Chem. Comm. 2021, 57, 2839.
(60) Addison, A. W.; Rao, T. N.; Reedijk, J.; van Rijn, J.; Verschoor, G. C. Synthesis,
structure, and spectroscopic properties of copper(II) compounds containing nitrogen–
sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(Nmethylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate. J. Chem. Soc., Dalton
Trans. 1984, 1349.

225

(61) McKee, V.; Smith, J. Synthesis and X-ray structure of a bicopper(II) Schiff base
macrocyclic complex having a single endogenous alkoxy bridge. J. Chem. Soc., Chem.
Commun. 1983, 1465.
(62) Bower, J. K.; Cypcar, A. D.; Henriquez, B.; Stieber, S. C. E.; Zhang, S. C(sp3)–H
Fluorination with a Copper(II)/(III) Redox Couple. J. Am. Chem. Soc. 2020, 142, 8514.
(63) Bower, J. K.; Cypcar, A. D.; Henriquez, B.; Stieber, S. C. E.; Zhang, S. Correction to
“C(sp3)–H Fluorination with a Copper(II)/(III) Redox Couple”. J. Am. Chem. Soc. 2022,
144, 6118.
(64) Chattopadhyay, S.; Ray, M. S.; Drew, M. G. B.; Figuerola, A.; Diaz, C.; Ghosh, A.
Facile synthesis of Cu(II) complexes of monocondensed N,N,N donor Schiff base ligands:
Crystal structure, spectroscopic and magnetic properties. Polyhedron 2006, 25, 2241.
(65) Adhikary, C.; Mal, D.; Sen, R.; Bhattacharjee, A.; Gütlich, P.; Chaudhuri, S.; Koner,
S. Synthesis, X-ray crystal structure and magnetic study of a novel μ2-1,1-azido bridged
dimeric copper(II) complex. Polyhedron 2007, 26, 1658.
(66) Rahaman, S. H.; Bose, D.; Ghosh, R.; Mostafa, G.; Fun, H.-K.; Ghosh, B. K.
Synthesis, crystal and molecular structures of 1D and 2D supramers of copper(II) with
N,N′-{bis(pyridin-2-yl) benzylidene}butane-1,4-diamine. Struct. Chem. 2007, 18, 237.
(67) Nandy, M.; Shit, S.; Garribba, E.; Gómez-García, C. J.; Mitra, S. Double
azido/cyanato bridged copper(II) dimers incorporating tridentate nitrogen donors Schiff
base: Structure, EPR and magnetic studies. Polyhedron 2015, 102, 137.
(68) Camus, A.; Marsich*, N.; Manotti Lanfredi*, A. M.; Ugozzoli, F.; Massera, C.
Copper(II)nitrito complexes with 2,2′-dipyridylamine. Crystal structures of the
[(acetato)(2,2′-dipyridylamine)(nitrito-O,O′)copper(II)] and [(2,2′-dipyridylamine) (nitritoO,O′)(μ-nitrito-O)copper(II)]2·2(acetonitrile). Inorganica Chim. Acta. 2000, 309, 1.
(69) Arnold, P. J.; Davies, S. C.; Durrant, M. C.; Griffiths, D. V.; Hughes, D. L.; Sharpe, P.
C. Copper(II) nitrite complexes of tripodal ligands derived from 1,1,1-tris(2pyridyl)methylamine. Inorganica Chim. Acta. 2003, 348, 143.
(70)
Zhu,
R.-Q.
Di-[mu]-nitrito-[kappa]4O:O-bis[bis(1-ethyl-1H-imidazole[kappa]N3)(nitrito-[kappa]O)copper(II)]. Acta Crystallogr., Sect. E. 2011, 67, m869.
(71)
Zhu,
R.-Q.
Bis([mu]-nitrito-[kappa]2O:O)bis[bis(1-methyl-1H-imidazole[kappa]N3)(nitrito-[kappa]O)copper(II)]. Acta Crystallogr., Sect. E. 2012, 68, m398.
(72) McGeary, M. J.; Wedlich, R. C.; Coan, P. S.; Folting, K.; Caulton, K. G. Synthesis and
thermal decomposition of copper(I) silyloxide complexes. X-ray crystal structures of
[Cu(OSiPh3)]4 and [Cu(OSiPh3)(PMe2Ph)]2. Polyhedron 1992, 11, 2459.
(73) Dai, X.; Warren, T. H. Dioxygen activation by a neutral β-diketiminato copper(i)
ethylene complex. Chem. Comm. 2001, 1998.

226

(74) Chaudhuri, P.; Ventur, D. C.; Wieghardt, K.; Peters, E. M.; Peters, K. Preparation,
Magnetism, and Crystal Structures of the Tautomers [LCu(μ2-OH)2CuL](ClO4)2 (Blue)
and [LCu(μ2-OH2)(μ2-O)CuL](ClOμ4)μ2 (Green): μ-Aqua-μ-oxo vs. Di-μ-hydroxo
Linkage. Angew. Chem. Int. Ed. 1985, 24, 57.
(75) Thierer, L. M.; Wang, Q.; Brooks, S. H.; Cui, P.; Qi, J.; Gau, M. R.; Manor, B. C.;
Carroll, P. J.; Tomson, N. C. Pyridyldiimine macrocyclic ligands: Influences of template
ion, linker length and imine substitution on ligand synthesis, structure and redox
properties. Polyhedron 2021, 198, 115044.
(76) Gibson, V. C.; Redshaw, C.; Solan, G. A. Bis(imino)pyridines: Surprisingly Reactive
Ligands and a Gateway to New Families of Catalysts. Chem. Rev. 2007, 107, 1745
(77) Flisak, Z.; Sun, W.-H. Progression of Diiminopyridines: From Single Application to
Catalytic Versatility. ACS Catal. 2015, 5, 4713.
(78) Small, B. L.; Brookhart, M. Iron-Based Catalysts with Exceptionally High Activities
and Selectivities for Oligomerization of Ethylene to Linear α-Olefins. J. Am. Chem. Soc.
1998, 120, 7143.
(79) Small, B. L.; Brookhart, M.; Bennett, A. M. A. Highly Active Iron and Cobalt Catalysts
for the Polymerization of Ethylene. J. Am. Chem. Soc. 1998, 120, 4049.
(80) van der Vlugt, J. I. Redox-Active Pincer Ligands. In Metal-Ligand Co-operativity:
Catalysis and the Pincer-Metal Platform, van Koten, G., Kirchner, K., Moret, M.-E. Eds.;
Springer International Publishing, 2021; pp 135.
(81) Lions, F.; Martin, K. V. Tridentate Chelate Compounds. I. J. Am. Chem. Soc. 1957,
79, 2733.
(82) Figgins, P. E.; Busch, D. H. Complexes of Iron(II), Cobalt(II) and Nickel(II) with
Biacetyl-bis-methylimine, 2-Pyridinal-methylimine and 2,6-Pyridindial-bis-methylimine. J.
Am. Chem. Soc. 1960, 82, 820.
(83) Alyea, E. C.; Merrell, P. H. Terdentate NNN Donor Ligands Derived from 2,6Diacetylpyridine. Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry
1974, 4, 535.
(84) Nückel, S.; Burger, P. Transition Metal Complexes with Sterically Demanding
Ligands, 3.1 Synthetic Access to Square-Planar Terdentate Pyridine−Diimine Rhodium(I)
and Iridium(I) Methyl Complexes: Successful Detour via Reactive Triflate and Methoxide
Complexes. Organometallics 2001, 20, 4345.
(85) Cámpora, J.; Pérez, C. M.; Rodríguez-Delgado, A.; Naz, A. M.; Palma, P.; Álvarez,
E. Selective Alkylation of 2,6-Diiminopyridine Ligands by Dialkylmanganese Reagents: A
“One-Pot” Synthetic Methodology. Organometallics 2007, 26, 1104.
(86) Juan, C.; Naz, A. M.; Pilar, P.; Antonio, R.-D.; Eleuterio, Á.; Incoronata, T.; Laura, B.
Iron and Cobalt Complexes of 4-Alkyl-2,6-diiminopyridine Ligands: Synthesis and
Ethylene Polymerization Catalysis. Wiley-VCH: 2008.

227

(87) Bhattacharya, S.; Snehalatha, K.; George, S. K. Synthesis of Some Copper(II)Chelating (Dialkylamino)pyridine Amphiphiles and Evaluation of Their Esterolytic
Capacities in Cationic Micellar Media. J. Org. Chem. 1998, 63, 27.
(88) Chessa, G.; Canovese, L.; Visentin, F.; Santo, C.; Seraglia, R. Synthesis of
poly(pyridylthioether) dendrimers incorporating a Fe2(CO)6 cluster core. Tetrahedron
2005, 61, 1755.
(89) De Bo, G.; De Winter, J.; Gerbaux, P.; Fustin, C.-A. Rotaxane-Based Mechanically
Linked Block Copolymers. Angew. Chem. Int. Ed. 2011, 50, 9093.
(90) Darmon, J. M.; Turner, Z. R.; Lobkovsky, E.; Chirik, P. J. Electronic Effects in 4Substituted Bis(imino)pyridines and the Corresponding Reduced Iron Compounds.
Organometallics 2012, 31, 2275.
(91) Ivchenko, P. V.; Nifant’ev, I. E.; Buslov, I. V. A convenient approach for the synthesis
of 2,6-diformyl- and 2,6-diacetylpyridines. Tetrahedron Lett. 2013, 54, 217.
(92) Takalo, H.; Kankare, J.; Lund, H.; Makmur, L.; Norrestam, R. Synthesis of Dimethyl
and Diethyl 4-(Phenylethynyl)-2,6-pyridinedicarboxylate. Acta Chemica Scandinavica ACTA CHEM SCAND 1987, 41, 219.
(93) Zohuri, G. H.; Seyedi, S. M.; Sandaroos, R.; Damavandi, S.; Mohammadi, A. Novel
Late Transition Metal Catalysts Based on Iron: Synthesis, Structures and Ethylene
Polymerization. Catal. Lett. 2010, 140, 160.
(94) Dammann, W.; Buban, T.; Schiller, C.; Burger, P. Dinuclear tethered pyridine, diimine
complexes. Dalton Trans. 2018, 47, 12105.
(95) Matsui, J. K.; Primer, D. N.; Molander, G. A. Metal-free C–H alkylation of heteroarenes
with alkyltrifluoroborates: a general protocol for 1°, 2° and 3° alkylation. Chem. Sci. 2017,
8, 3512.
(96) Zhang, L.; Tang, Y.; Han, Z.; Ding, K. Lutidine-Based Chiral Pincer Manganese
Catalysts for Enantioselective Hydrogenation of Ketones. Angew. Chem. Int. Ed. 2019,
58, 4973.
(97) Gygi, D.; Hwang, S. J.; Nocera, D. G. Scalable Syntheses of 4-Substituted Pyridine–
Diimines. J. Org. Chem. 2017, 82, 12933.
(98) Esteruelas, M. A.; López, A. M.; Méndez, L.; Oliván, M.; Oñate, E. Preparation,
Structure, and Ethylene Polymerization Behavior of Bis(imino)pyridyl Chromium(III)
Complexes. Organometallics 2003, 22, 395.
(99) Steves, J. E.; Kennedy, M. D.; Chiang, K. P.; Kassel, W. S.; Dougherty, W. G.; Dudley,
T. J.; Zubris, D. L. Synthesis of a bulky bis(imino)pyridine compound: a methodology for
systematic variation of steric bulk and energetic implications for metalation. Dalton Trans.
2009, 1214.

228

(100) Smit, T. M.; Tomov, A. K.; Britovsek, G. J. P.; Gibson, V. C.; White, A. J. P.; Williams,
D. J. The effect of imine-carbon substituents in bis(imino)pyridine-based ethylene
polymerisation catalysts across the transition series. Catalysis Science & Technology
2012, 2, 643.
(101) Kleigrewe, N.; Steffen, W.; Blömker, T.; Kehr, G.; Fröhlich, R.; Wibbeling, B.; Erker,
G.; Wasilke, J.-C.; Wu, G.; Bazan, G. C. Chelate Bis(imino)pyridine Cobalt Complexes:
Synthesis, Reduction, and Evidence for the Generation of Ethene Polymerization
Catalysts by Li+ Cation Activation. J. Am. Chem. Soc. 2005, 127, 13955.
(102) Ye, S.-h.; Li, L.; Zhang, M.; Zhou, Z.; Quan, M.-h.; Guo, L.-F.; Wang, Y.; Yang, M.;
Lai, W.-y.; Huang, W. Pyridine linked fluorene hybrid bipolar host for blue, green, and
orange phosphorescent organic light-emitting diodes toward solution processing. J. Mater.
Chem. C. 2017, 5, 11937.
(103) Kumar, S.; Paul, D.; Hundal, G.; Hundal, M. S.; Singh, H. Heterocalixarenes Part 3:
Bis-oxo-bridged calix[1]cyclicurea[3]arene and calix[1]cyclicurea[1]pyridine[2]arenes.
Synthesis, X-ray crystal structure and conformational analysis 1. J. Chem. Soc., Perkin
Trans. 1 2000, 1037.
(104) Anbarasan, P.; Neumann, H.; Beller, M. A Convenient Synthesis of Benzonitriles via
Electrophilic Cyanation with N-Cyanobenzimidazole. Chemistry – A European Journal
2010, 16, 4725.
(105) Warren, J. J.; Tronic, T. A.; Mayer, J. M. Thermochemistry of Proton-Coupled
Electron Transfer Reagents and its Implications. Chem. Rev. 2010, 110, 6961.
(106) Agarwal, R. G.; Coste, S. C.; Groff, B. D.; Heuer, A. M.; Noh, H.; Parada, G. A.;
Wise, C. F.; Nichols, E. M.; Warren, J. J.; Mayer, J. M. Free Energies of Proton-Coupled
Electron Transfer Reagents and Their Applications. Chem. Rev. 2022, 122, 1.
(107) Donoghue, P. J.; Tehranchi, J.; Cramer, C. J.; Sarangi, R.; Solomon, E. I.; Tolman,
W. B. Rapid C–H Bond Activation by a Monocopper(III)–Hydroxide Complex. J. Am.
Chem. Soc. 2011, 133, 17602.
(108) Dhar, D.; Tolman, W. B. Hydrogen Atom Abstraction from Hydrocarbons by a
Copper(III)-Hydroxide Complex. J. Am. Chem. Soc. 2015, 137, 1322.
(109) Dhar, D.; Yee, G. M.; Markle, T. F.; Mayer, J. M.; Tolman, W. B. Reactivity of the
copper(iii)-hydroxide unit with phenols. Chem. Sci. 2017, 8, 1075.
(110) Dhar, D.; Yee, G. M.; Spaeth, A. D.; Boyce, D. W.; Zhang, H.; Dereli, B.; Cramer, C.
J.; Tolman, W. B. Perturbing the Copper(III)–Hydroxide Unit through Ligand Structural
Variation. J. Am. Chem. Soc. 2016, 138, 356.
(111) Dhar, D.; Yee, G. M.; Tolman, W. B. Effects of Charged Ligand Substituents on the
Properties of the Formally Copper(III)-Hydroxide ([CuOH]2+) Unit. Inorg. Chem. 2018, 57,
9794.

229

(112) Kindermann, N.; Dechert, S.; Demeshko, S.; Meyer, F. Proton-Induced, Reversible
Interconversion of a μ-1,2-Peroxo and a μ-1,1-Hydroperoxo Dicopper(II) Complex. J. Am.
Chem. Soc. 2015, 137, 8002.
(113) Kindermann, N.; Günes, C.-J.; Dechert, S.; Meyer, F. Hydrogen Atom Abstraction
Thermodynamics of a μ-1,2-Superoxo Dicopper(II) Complex. J. Am. Chem. Soc. 2017,
139, 9831.
(114) Quist, D. A.; Ehudin, M. A.; Schaefer, A. W.; Schneider, G. L.; Solomon, E. I.; Karlin,
K. D. Ligand Identity-Induced Generation of Enhanced Oxidative Hydrogen Atom Transfer
Reactivity for a CuII2(O2•–) Complex Driven by Formation of a CuII2(−OOH) Compound
with a Strong O–H Bond. J. Am. Chem. Soc. 2019, 141, 12682.
(115) VanNatta, P. E.; Ramirez, D. A.; Velarde, A. R.; Ali, G.; Kieber-Emmons, M. T.
Exceptionally High O–H Bond Dissociation Free Energy of a Dicopper(II) μ-Hydroxo
Complex and Insights into the Geometric and Electronic Structure Origins Thereof. J. Am.
Chem. Soc. 2020, 142, 16292.
(116) Bordwell, F. G.; Cheng, J. P.; Harrelson, J. A. Homolytic bond dissociation energies
in solution from equilibrium acidity and electrochemical data. J. Am. Chem. Soc. 1988,
110, 1229.
(117) Yang, L.; Powell, D. R.; Houser, R. P. Structural variation in copper(i) complexes
with pyridylmethylamide ligands: structural analysis with a new four-coordinate geometry
index, τ4. Dalton Trans. 2007, 955.
(118) Connelly, N. G.; Geiger, W. E. Chemical Redox Agents for Organometallic
Chemistry. Chem. Rev. 1996, 96, 877.
(119) Tshepelevitsh, S.; Kütt, A.; Lõkov, M.; Kaljurand, I.; Saame, J.; Heering, A.; Plieger,
P. G.; Vianello, R.; Leito, I. On the Basicity of Organic Bases in Different Media. Eur. J.
Org. Chem. 2019, 2019, 6735.
(120) Kisanga, P. B.; Verkade, J. G.; Schwesinger, R. pKa Measurements of
P(RNCH2CH3)3N. J. Org. Chem. 2000, 65, 5431.
(121) Zhang, X.; Bordwell, F. G. Acidities and homolytic bond dissociation energies of the
acidic carbon-hydrogen bonds in radical cations. J. Org. Chem. 1992, 57, 4163.

230

